CANADA GOOSE HOLDINGS INC., 20-F filed on 5/16/2024
Annual and Transition Report (foreign private issuer)
v3.24.1.1.u2
Cover Page
12 Months Ended
Mar. 31, 2024
shares
Document Information [Line Items]  
Document Type 20-F
Document Registration Statement false
Document Annual Report true
Document Period End Date Mar. 31, 2024
Current Fiscal Year End Date --03-31
Document Transition Report false
Document Shell Company Report false
Entity File Number 001-38027
Entity Registrant Name CANADA GOOSE HOLDINGS INC.
Entity Incorporation, State or Country Code A1
Entity Address, Address Line One Floor 22, 100 Queens Quay East
Entity Address, City or Town Toronto
Entity Address, State or Province ON
Entity Address, Country CA
Entity Address, Postal Zip Code M5E 1V3
Title of 12(b) Security Subordinate voting shares
Trading Symbol GOOS
Security Exchange Name NYSE
Entity Well-known Seasoned Issuer Yes
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Large Accelerated Filer
Entity Emerging Growth Company false
ICFR Auditor Attestation Flag true
Document Financial Statement Error Correction [Flag] false
Document Accounting Standard International Financial Reporting Standards
Entity Shell Company false
Amendment Flag false
Entity Central Index Key 0001690511
Document Fiscal Year Focus 2024
Document Fiscal Period Focus FY
Subordinate voting shares  
Document Information [Line Items]  
Entity Common Stock, Shares Outstanding 45,528,438
Multiple voting shares  
Document Information [Line Items]  
Entity Common Stock, Shares Outstanding 51,004,076
Business Contact  
Document Information [Line Items]  
Entity Address, Address Line One Floor 22, 100 Queens Quay East
Entity Address, City or Town Toronto
Entity Address, State or Province ON
Entity Address, Country CA
Entity Address, Postal Zip Code M5E 1V3
Contact Personnel Name David M. Forrest
City Area Code 416
Local Phone Number 780-9850
v3.24.1.1.u2
Audit Information
12 Months Ended
Mar. 31, 2024
Auditor Information [Abstract]  
Auditor Firm ID 1208
Auditor Name Deloitte LLP
Auditor Location Toronto, Canada
v3.24.1.1.u2
Consolidated Statements of Income - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Profit or loss [abstract]      
Revenue $ 1,333.8 $ 1,217.0 $ 1,098.4
Cost of sales 416.4 401.8 364.8
Gross profit 917.4 815.2 733.6
Selling, general & administrative expenses 792.9 667.6 574.1
Profit (loss) from operating activities 124.5 147.6 159.5
Net interest, finance and other costs 48.8 54.1 41.8
Income before income taxes 75.7 93.5 117.7
Income tax expense 17.6 24.6 23.1
Net income 58.1 68.9 94.6
Attributable to:      
Shareholders of the Company 58.4 72.7 94.6
Non-controlling interest (0.3) (3.8) 0.0
Net income $ 58.1 $ 68.9 $ 94.6
Earnings per share attributable to shareholders of the Company      
Basic (in CAD per share) $ 0.58 $ 0.69 $ 0.87
Diluted (in CAD per share) $ 0.57 $ 0.69 $ 0.87
v3.24.1.1.u2
Consolidated Statements of Comprehensive Income - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Statement of comprehensive income [abstract]      
Net income (loss) $ 58.1 $ 68.9 $ 94.6
Items that will not be reclassified to earnings, net of tax:      
Actuarial gain on post-employment obligation 0.0 0.6 0.1
Items that may be reclassified to earnings, net of tax:      
Cumulative translation adjustment (loss) gain (0.2) 16.1 (25.5)
Net (loss) gain on derivatives designated as cash flow hedges (0.5) 0.4 8.7
Reclassification of net (gain) loss on cash flow hedges to income (1.1) 6.0 4.7
Other comprehensive (loss) income (1.8) 23.1 (12.0)
Comprehensive income 56.3 92.0 82.6
Attributable to:      
Shareholders of the Company 57.8 95.7 82.6
Non-controlling interest (1.5) (3.7) 0.0
Comprehensive income $ 56.3 $ 92.0 $ 82.6
v3.24.1.1.u2
Consolidated Statements of Financial Position - CAD ($)
$ in Millions
Mar. 31, 2024
Apr. 02, 2023
Current assets    
Cash $ 144.9 $ 286.5
Trade receivables 70.4 50.9
Inventories 445.2 472.6
Income taxes receivable 28.0 0.9
Other current assets 52.3 52.3
Total current assets 740.8 863.2
Deferred income taxes 76.3 67.5
Property, plant and equipment 171.8 156.0
Intangible assets 135.1 135.1
Right-of-use assets 279.8 291.8
Goodwill 70.8 63.9
Other long-term assets 7.0 12.5
Total assets 1,481.6 1,590.0
Current liabilities    
Accounts payable and accrued liabilities 177.7 195.6
Provisions 26.1 21.6
Income taxes payable 16.8 31.5
Short-term borrowings 9.4 27.6
Current portion of lease liabilities 79.9 76.1
Total current liabilities 309.9 352.4
Provisions 37.3 36.5
Deferred income taxes 17.2 16.4
Revolving Facility 0.0 0.0
Term Loan 388.5 391.6
Lease liabilities 250.6 258.7
Other long-term liabilities 54.6 56.9
Total liabilities 1,058.1 1,112.5
Equity    
Equity attributable to shareholders of the Company 417.0 469.5
Non-controlling interests 6.5 8.0
Total equity 423.5 477.5
Total liabilities and equity $ 1,481.6 $ 1,590.0
v3.24.1.1.u2
Consolidated Statements of Changes in Equity - CAD ($)
$ in Millions
Total
Subordinate voting shares
Total attributable to shareholders
Share capital
Share capital
Multiple voting shares
Share capital
Subordinate voting shares
Contributed surplus
Retained earnings
Retained earnings
Subordinate voting shares
Accumulated other comprehensive (loss) income
Non-controlling interest
Shareholders’ equity, beginning balance at Mar. 28, 2021 $ 577.6   $ 577.6 $ 120.5 $ 1.4 $ 119.1 $ 25.2 $ 437.1   $ (5.2) $ 0.0
Normal course issuer bid purchase of subordinate voting shares (253.2) $ (253.2) (253.2) (11.9)   (11.9)   (241.3) $ (241.3)    
Issuance of shares 7.1   7.1 9.9 0.0 9.9 (2.8)        
Net income (loss) 94.6   94.6         94.6      
Other comprehensive (loss) income (12.0)   (12.0)             (12.0)  
Share-based payment 14.0   14.0       14.0        
Deferred tax on share-based payment (0.2)   (0.2)       (0.2)        
Shareholders’ equity, ending balance at Apr. 03, 2022 427.9   427.9 118.5 1.4 117.1 36.2 290.4   (17.2) 0.0
Non-controlling interest on business combination 11.7                   11.7
Put option for non-controlling interest (21.2)   (21.2)         (21.2)      
Normal course issuer bid purchase of subordinate voting shares (26.7) $ (26.7) (26.7) (2.4)   (2.4)   (24.3) $ (25.4)    
Normal course issuer bid purchase of subordinate voting shares held for cancellation (1.2)   (1.2) (0.1)   (0.1)   (1.1)      
Liability to broker under automatic share purchase plan (20.0)   (20.0)       (20.0)        
Issuance of shares 0.0   0.0 2.7 0.0 2.7 (2.7)        
Net income (loss) 68.9   72.7         72.7     (3.8)
Other comprehensive (loss) income 23.1   23.0             23.0 0.1
Share-based payment 15.0   15.0       15.0        
Shareholders’ equity, ending balance at Apr. 02, 2023 477.5   469.5 118.7 1.4 117.3 28.5 316.5   5.8 8.0
Normal course issuer bid purchase of subordinate voting shares (140.2)   (140.2) (17.8)   (17.8)   (122.4)      
Liability to broker under automatic share purchase plan 20.0   20.0       20.0        
Issuance of shares 0.1   0.1 4.0 0.0 4.0 (3.9)        
Net income (loss) 58.1   58.4         58.4     (0.3)
Other comprehensive (loss) income (1.8)   (0.6)             (0.6) (1.2)
Share-based payment 9.8   9.8       9.8        
Shareholders’ equity, ending balance at Mar. 31, 2024 $ 423.5   $ 417.0 $ 104.9 $ 1.4 $ 103.5 $ 54.4 $ 252.5   $ 5.2 $ 6.5
v3.24.1.1.u2
Consolidated Statements of Cash Flows - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Operating activities      
Net income (loss) $ 58.1 $ 68.9 $ 94.6
Items not affecting cash:      
Depreciation and amortization 126.0 109.1 95.8
Income tax expense 17.6 24.6 23.1
Interest expense 44.4 34.0 38.1
Foreign exchange loss 0.8 0.3 9.0
Acceleration of unamortized costs on debt extinguishment 0.0 0.0 9.5
Impairment losses 1.2 1.0 7.7
Loss (gain) on disposal of assets 0.1 (0.1) 0.1
Share-based payment 10.2 15.0 14.0
Remeasurement of put option 1.6 10.9 0.0
Remeasurement of contingent consideration 2.8 (2.9) 0.0
Total items not affecting cash 262.8 260.8 291.9
Changes in non-cash operating items 10.5 (75.4) (82.8)
Income taxes paid (66.3) (37.0) (25.2)
Interest paid (42.4) (32.1) (32.3)
Net cash from operating activities 164.6 116.3 151.6
Investing activities      
Purchase of property, plant and equipment (54.9) (45.2) (34.5)
Investment in intangible assets (1.0) (2.2) (1.5)
Initial direct costs of right-of-use assets (0.6) (0.7) (1.2)
Net cash (outflow) inflow from business combination (15.9) 2.8 0.0
Net cash used in investing activities (72.4) (45.3) (37.2)
Financing activities      
Transaction costs on financing activities (0.2) 0.0 (1.0)
Normal course issuer bid purchase of subordinate voting shares (141.4) (26.7) (253.2)
Principal payments on lease liabilities (69.2) (62.2) (46.9)
Settlement of term loan derivative contracts 0.0 8.6 0.0
Issuance of shares 0.1 0.0 7.1
Net cash used in financing activities (232.8) (80.7) (298.2)
Effects of foreign currency exchange rate changes on cash (1.0) 8.5 (6.4)
Decrease in cash (141.6) (1.2) (190.2)
Cash, beginning of period 286.5 287.7 477.9
Cash, end of period 144.9 286.5 287.7
Mainland China Facilities      
Financing activities      
Revolving Facility (repayments) borrowings (9.8) 9.8 0.0
Japan Facility      
Financing activities      
Japan Facility repayments and Term loan repayments (8.3) (5.7) 0.0
Term Loan      
Financing activities      
Japan Facility repayments and Term loan repayments (4.0) (4.0) (4.7)
The Revolving Facility      
Financing activities      
Revolving Facility (repayments) borrowings $ 0.0 $ (0.5) $ 0.5
v3.24.1.1.u2
The Company
12 Months Ended
Mar. 31, 2024
Corporate information and statement of IFRS compliance [abstract]  
The Company The Company
Organization
Canada Goose Holdings Inc. and its subsidiaries (the “Company”) design, manufacture, and sell performance luxury apparel for men, women, youth, children, and babies. The Company’s product offerings include various styles of parkas, lightweight down jackets, rainwear, windwear, apparel, fleece, footwear, and accessories for the fall, winter, and spring seasons. The Company’s head office is located at 100 Queens Quay East, Toronto, Canada, M5E 1V3. The use of the terms “Canada Goose”, “we”, and “our” throughout these notes to the consolidated financial statements refer to the Company.
Canada Goose is a public company listed on the Toronto Stock Exchange and the New York Stock Exchange under the trading symbol “GOOS”. The principal shareholders of the Company are investment funds advised by Bain Capital LP and its affiliates (“Bain Capital”), and DTR LLC, (“DTR”), an entity indirectly controlled by the Chairman and Chief Executive Officer of the Company. The principal shareholders hold multiple voting shares representing 52.8% of the total shares outstanding as at March 31, 2024, or 91.8% of the combined voting power of the total voting shares outstanding. Subordinate voting shares that trade on public markets represent 47.2% of the total shares outstanding as at March 31, 2024, or 8.2% of the combined voting power of the total voting shares outstanding.
Statement of compliance
The consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).
These consolidated financial statements were authorized for issuance by the Company’s Board of Directors on May 15, 2024.
Fiscal year
The Company's fiscal year is a 52 or 53-week reporting cycle with the fiscal year ending on the Sunday closest to March 31. Each fiscal quarter is 13 weeks for a 52-week fiscal year. The additional week in a 53-week fiscal year is added to the third quarter. Fiscal 2022 was the first 53-week fiscal year, which ended on April 3, 2022. Fiscal 2024 is a 52-week fiscal year.
Operating segments
The Company classifies its business in three operating and reportable segments: Direct-to-Consumer (“DTC”), Wholesale, and Other. The DTC segment comprises sales through country-specific e-Commerce platforms available across numerous markets, which includes the newly launched recommerce platform Canada Goose Generations, currently available in the United States and Canada, and our Company-owned retail stores located in luxury shopping locations.
The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market. The Wholesale segment includes the introduction of travel retail in the second quarter of fiscal 2024.
The Other segment comprises revenue and costs that are not related to the Company’s DTC or Wholesale segments, such as sales to employees, friends and family sales, and results from the
newly acquired Paola Confectii business (see "Note 5. Business Combinations" for details and definitions).
Seasonality
Our business is seasonal, and we have historically realized a significant portion of our Wholesale revenue and operating income in the second and third quarters of the fiscal year and DTC revenue and operating income in the third and fourth quarters of the fiscal year. Thus, lower-than-expected revenue in these periods could have an adverse impact on our annual operating results.
Cash flows from operating activities are typically highest in the third and fourth quarters of the fiscal year due to revenue from the DTC segment and the collection of trade receivables from Wholesale revenue earlier in the year. Working capital requirements typically increase as inventory builds. Borrowings have historically increased in the first and second quarters and been repaid in the third quarter of the fiscal year.
v3.24.1.1.u2
Material accounting policy information
12 Months Ended
Mar. 31, 2024
Accounting Policies, Changes In Accounting Estimates And Errors [Abstract]  
Material accounting policy information Material accounting policy information
(a)Basis of presentation
The consolidated financial statements are presented in Canadian dollars, the Company’s functional and presentation currency.
These consolidated financial statements have been prepared on the historical cost basis except for the following items, which are recorded at fair value:
financial instruments, including derivative financial instruments, at fair value in other comprehensive income and through profit or loss as described in “Note 21. Financial instruments and fair values” and
initial recognition of assets acquired and liabilities assumed in a business combination.
Certain comparative figures have been reclassified to conform with the current year presentation. Foreign exchange gains and losses related to the outstanding principal balance on the Term Loan, net of hedging, are reflected in the presentation of net interest, finance and other costs as outlined below (see “Note 17. Borrowings” for details and definitions); previously this was presented in SG&A expenses. This change was made to present all financing costs related to the Term Loan within the same financial statement caption in the consolidated statements of income. For the year ended April 2, 2023 and April 3, 2022, the Company reclassified foreign exchange losses of $12.1m and $2.8m, respectively. This reclassification did not impact net income, earnings per share, or the consolidated statements of financial position in the comparative year.
As at March 31, 2024, the Company amended the allocation basis for certain SG&A expenses between the operating segments to provide more relevant information on financial performance of each operating segment. The reclassification did not impact net income, earnings per share, or the consolidated statements of financial position in the comparative year. Comparative figures have been reclassified to conform with the current year presentation.
(b)Principles of consolidation
The consolidated financial statements include the accounts of Canada Goose Holdings Inc. and its subsidiaries. All intercompany transactions and balances have been eliminated.
(c)Foreign currency translation and transactions
The functional currency of each of the Company’s subsidiaries is the currency of the primary economic environment in which each entity operates. The assets and liabilities of subsidiaries whose functional currency is not the Canadian dollar are translated into the functional currency of the Company using the exchange rate at the reporting date. Revenues and expenses are translated at exchange rates prevailing at the transaction date. The resulting foreign exchange translation differences are recorded as a currency translation adjustment in other comprehensive income.
Foreign currency transactions are translated into the functional currency of each of the Company’s subsidiaries using the exchange rates prevailing at the date of the transactions or valuation when items are remeasured. Foreign exchange gains and losses resulting from the settlement of such transactions and from the changes at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the statements of income in SG&A expenses, except when included in other comprehensive income for qualifying cash flow and net investment hedges.
    Functional currency of subsidiary
Each entity within the Company determines its functional currency based on the primary economic environment in which the entity operates. Once an entity's functional currency is determined, it is not changed unless there is a change to the underlying transactions, events, and conditions that determine the entity's primary economic environment.
(d)Revenue recognition
Revenue comprises DTC, Wholesale and Other segment revenues. Revenue is measured at the amount of consideration to which the Company expects to be entitled in exchange for the sale of goods in the ordinary course of the Company’s activities. Revenue is presented net of sales tax, estimated returns, sales allowances, and discounts. The Company recognizes revenue when the Company has agreed terms with its customers, the contractual rights and payment terms have been identified, the contract has commercial substance, it is probable that consideration will be collected by the Company, and when control of the goods is transferred to the customer.
It is the Company’s policy to sell merchandise through the DTC channel with a limited right of return, typically within 30 days. Accumulated experience is used to estimate and provide for such returns.
(e)Business combination
Acquisitions of businesses are accounted for using the acquisition method as of the acquisition date, which is the date when control is transferred to the Company. The consideration transferred in a business combination is measured at fair value, calculated as the sum of the acquisition date fair values of the assets transferred, liabilities incurred by the Company, and the equity interests issued by the Company in exchange for control of the acquiree. Transaction costs that the Company incurs in connection with a business combination are recognized in the statements of income as incurred.
Goodwill is measured as the excess of the sum of the fair value of the consideration transferred over the net of the acquisition date amounts of the identifiable assets acquired and the liabilities assumed.
When the consideration transferred in a business combination includes contingent consideration, the contingent consideration is measured at its acquisition date fair value. Contingent consideration is remeasured at subsequent reporting dates at its fair value, and the resulting gain or loss recognized in the statements of income.
(f)Non-controlling interest
Non-controlling interest is measured based on the proportionate share of the acquiree's identifiable net assets. Transactions with non-controlling interests are treated as transactions with equity owners of the Company. Changes in the Company's ownership interest are accounted for as equity transactions.
(g)Earnings per share
Basic earnings per share is calculated by dividing net income attributable to ordinary equity holders by the weighted average number of multiple and subordinate voting shares outstanding during the year.
Diluted earnings per share is calculated by dividing net income attributable to ordinary equity holders of the Company by the weighted average number of multiple and subordinate voting shares outstanding during the year plus the weighted average number of subordinate shares that would be issued on the exercise of stock options and settlement of restricted share units (“RSUs”) and performance share units (“PSUs”).
(h)Income taxes
Current and deferred income taxes are recognized in the statements of income, except when it relates to a business combination, or items recognized in equity or in other comprehensive income.
Current income tax
Current income tax is the expected income tax payable or receivable on the taxable income or loss for the period, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to income tax payable in respect of previous years.
Deferred income tax
Deferred income tax is provided using the liability method for temporary differences at the reporting date between the income tax bases of assets and liabilities and their carrying amounts for financial reporting purposes.
Deferred income tax is measured using enacted or substantively enacted income tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled. A deferred tax asset is recognized for unused income tax losses and credits to the extent that it is probable that future taxable income will be available against which they can be utilized.
The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable income will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are reassessed at each reporting date and are recognized to the extent that it has become probable that future taxable income will allow the deferred tax asset to be recovered.
Deferred income tax relating to items recognized outside profit or loss is recognized outside profit or loss. Deferred tax items are recognized in correlation to the underlying transaction either in other comprehensive income or directly in equity.
Deferred tax assets and deferred tax liabilities are offset if a legally enforceable right exists to set off current income tax assets against current income tax liabilities and the deferred tax relates to the same taxable entity and the same taxation authority.
Deferred income tax is provided on temporary differences arising on investments in subsidiaries, except where the timing of the reversal of the temporary difference is controlled by the Company and it is probable that the temporary difference will not reverse in the foreseeable future.
As disclosed in Note 4. Changes in accounting policies, the Company has applied the mandatory exception to recognizing and disclosing information about deferred tax assets and liabilities related to Pillar Two rules in accordance with amendments to IAS 12 Income Taxes.
(i)Cash
Cash consists of cash and cash equivalents, including cash on hand, deposits in banks, and short-term deposits with maturities of less than three months. The Company uses the indirect method of reporting cash flows from operating activities.
(j)Trade receivables
Trade receivables, including credit card receivables, consist of amounts owing on product sales where we have extended credit to customers, and are initially recognized at fair value and subsequently measured at amortized cost using the effective interest method, less expected credit loss and sales allowances. The allowance for expected credit losses is recorded against trade receivables and is based on historical experience.
(k)Inventories
Raw materials, work-in-process, and finished goods are valued at the lower of cost and net realizable value. Cost is determined using the weighted average cost method. The cost of work-in-process and finished goods inventories include the cost of raw materials and an applicable share of the cost of labour and fixed and variable production overhead costs, including the depreciation of property, plant and equipment used in the production of finished goods, design costs, and other costs incurred to bring the inventories to their present location and condition.
The Company estimates net realizable value as the amount at which inventories are expected to be sold, taking into consideration fluctuations in selling prices due to seasonality, less estimated costs necessary to complete the sale.
Inventories are written down to net realizable value when the cost of inventories is estimated to be unrecoverable due to obsolescence, damage, or declining selling prices. Inventory is adjusted to reflect estimated loss (“shrinkage”) incurred since the last inventory count. Shrinkage is based on historical experience. When circumstances that previously caused inventories to be written down below cost no longer exist or when there is clear evidence of an increase in realizable value, the amount of the write-down previously recorded is reversed.
Storage costs, indirect administrative overhead and certain selling costs related to inventories are expensed in the period that these costs are incurred.
(l)Property, plant and equipment
Property, plant and equipment is stated at cost, net of accumulated depreciation and any accumulated impairment losses. Cost includes expenditures that are directly attributable to the acquisition of the asset, including costs incurred to prepare the asset for its intended use and capitalized borrowing costs, when the recognition criteria are met. The commencement date for capitalization of costs occurs when the Company first incurs expenditures for the qualifying assets and undertakes the required activities to prepare the assets for their intended use.
Property, plant and equipment assets are depreciated on a straight-line basis over their estimated useful lives when the assets are available for use. When significant parts of a fixed asset have different useful lives, they are accounted for as separate components and depreciated separately. Depreciation methods and useful lives are reviewed annually and are adjusted for prospectively, if appropriate. Estimated useful lives are as follows:
Asset CategoryEstimated Useful Life
Plant equipment (except moulds)10 years
Footwear moulds5 years
Computer equipment3 years
Leasehold improvementsLesser of the lease term or useful life of the asset
Show displays5 years
Furniture and fixtures
5 to 10 years
An item of property, plant and equipment and any significant part initially recognized is derecognized upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising on derecognition of the asset, calculated as the difference between the net disposal proceeds and the carrying amount of the asset, is included in the statements of income when the asset is derecognized.
The cost of repairs and maintenance of property, plant and equipment is expensed as incurred and recognized in the statements of income.
Property, plant and equipment are reviewed at the end of each reporting period to determine whether there is any indication of impairment. If any such indication exists, the asset is then tested for impairment by comparing its recoverable amount to its carrying value. Impairment losses are recorded in the statements of income.
(m)Intangible assets
Intangible assets acquired separately are measured on initial recognition at cost. The cost of an intangible asset acquired in a business combination is its fair value as at the date of acquisition. Following initial recognition, intangible assets with finite lives are carried at cost less any accumulated amortization and any accumulated impairment losses.
The useful lives of intangible assets are assessed as either finite or indefinite.
Asset CategoryEstimated Useful Life
Brand nameIndefinite
Domain nameIndefinite
Software
5 to 7 years
Intellectual property
1 to 8 years
Customer lists (Canada Goose)10 years
Customer lists (Paola Confectii SRL)4 years
Distribution rights10 years
In connection with the acquisition of the business of Paola Confectii SRL during fiscal 2024 (See “Note 5. Business combinations” for more details), identifiable intangible assets acquired consist of the customer list and brand.
Intangible assets with indefinite useful lives consists of the Canada Goose, Baffin, and Paola Confectii SRL brand names, as well as the Canada Goose and Baffin domain names, which were acquired as part of an acquisition and were recorded at their estimated fair value. The brand names and domain name are considered to have an indefinite life based on a history of revenue and cash flow performance, and the intent and ability of the Company to support the brand with spending to maintain its value for the foreseeable future. The brand names and domain name are tested at least annually for impairment, at the cash-generating unit (“CGU”) level. The assessment of indefinite life is reviewed annually to determine whether the indefinite life assessment continues to be supportable. If not, the change in the useful life assessment from indefinite to finite is made on a prospective basis.
Intangible assets with finite lives are amortized over the useful economic life on a straight-line basis. The amortization period and the amortization method for an intangible
asset with a finite useful life are reviewed at least at the end of each reporting period. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate, and treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in the statements of income over the asset’s estimated useful life.
An intangible asset is derecognized on disposal or when no future economic benefits are expected from its use. Gains or losses arising from the derecognition of an intangible asset are measured as the difference between the net disposal proceeds and the carrying amount of the asset and are included in the statements of income when the asset is derecognized.
Intangible assets are reviewed at the end of each reporting period to determine whether there is any indication of impairment. If any such indication exists, the asset is then tested for impairment by comparing its recoverable amount to its carrying value. Any resulting impairment loss is recorded in the statements of income.
(n)Leases
The Company recognizes a right-of-use asset and a lease liability based on the present value of the future lease payments at the commencement date. The commencement date is when the lessor makes the leased asset available for use by the Company, typically the possession date. The discount rate used in the present value calculation for lease payments is the incremental borrowing rate, if the rate implicit in the lease is not readily determinable, for each leased asset or portfolio of leased assets with similar characteristics by reference to the Company’s creditworthiness, the security, term and value of the underlying leased asset, and the economic environment in which the leased asset operates. The lease term is determined as the non-cancellable periods of a lease, together with periods covered by a renewal option if the Company is reasonably certain to exercise that option and a termination option if the Company is reasonably certain not to exercise that option.
Leases of low-value assets and short-term leases are not included in the calculation of lease liabilities. These lease expenses are recognized in cost of sales or SG&A expenses on a straight-line or other systematic basis.
    Lease liabilities
Lease liabilities are measured at the present value of future lease payments, discounted using the Company’s incremental borrowing rates, and include the fixed payments, variable lease payments that depend on an index or a rate, less any lease incentives receivable. Subsequent to initial measurement, the Company measures lease liabilities at amortized cost using the effective interest rate method. Lease liabilities are remeasured when there are changes to the lease payments, lease term, assessment of an option to purchase the underlying asset, expected residual value guarantee, or future lease payments due to a change in the index or rate tied to the payment.
    Right-of-use assets
Right-of-use assets are measured at the initial amount of the lease liabilities, lease payments made at or before the commencement date less any lease incentives received, initial direct costs, if any, and decommissioning costs to restore the site to the
condition required by the terms and conditions of the lease, and net of accumulated impairment losses. Subsequent to initial measurement, the Company applies the cost model to the right-of-use assets and measures the asset at cost less any accumulated depreciation, accumulated impairment losses in accordance with IAS 36, Impairment of Assets and any remeasurements of the lease liabilities. Assets are depreciated from the commencement date on a straight-line basis over the earlier of the end of the assets’ useful lives or the end of the lease terms.
Right-of-use assets are reviewed at the end of each reporting period to determine whether there is any indication of impairment. If any such indication exists, the asset is then tested for impairment by comparing its recoverable amount to its carrying value. Impairment losses are recorded in the statements of income.
(o)Goodwill
Goodwill represents the difference between the purchase price of an acquired business and the Company’s share of the net identifiable assets acquired and liabilities assumed and any contingent liabilities assumed. It is initially recorded at cost and subsequently measured at cost less any accumulated impairment losses.
For the purpose of impairment testing, goodwill acquired in a business combination is, from the acquisition date, allocated to CGUs based on the lowest level within the entity in which the goodwill is monitored for internal management purposes. The allocation is made to the CGUs that are expected to benefit from the business combination in which the goodwill arose. Any potential impairment of goodwill is identified by comparing the recoverable amount of a CGU to its carrying value. An impairment loss is recognized if the carrying amount of CGU exceeds its recoverable amount. Any loss identified is first applied to reduce the carrying amount of goodwill allocated to the CGU, and then to reduce the carrying amounts of the remaining assets in the CGU on a pro-rata basis. The Company tests goodwill for impairment annually at the reporting date.
The recoverable amount of a CGU is the higher of the estimated fair value less costs of disposal or value-in-use of the CGU. In assessing the recoverable amount, the estimated future cash flows are discounted using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset.
The Company has determined that there are 12 CGUs, 11 for which goodwill contributes to the cash flows (April 2, 2023 - 11 CGUs, 10 for which goodwill contributed to the cash flows). The increase in CGUs from the comparative period is attributable to the Paola Confectii acquisition which represents an additional CGU. No other changes were made to the existing CGUs from the previous year. See “Note 5. Business combinations” for more details.
(p)Provisions
Provisions are recognized when the Company has a present obligation, legal or constructive, as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation, and a reliable estimate can be made of the amount of the obligation. Where the Company expects some or all of a provision to be reimbursed, for example under an insurance contract, the reimbursement is recognized as a separate asset but only when the reimbursement is virtually certain. The expense relating to any provision is presented in the statements of income net of any reimbursement. If the effect of the time value of money is material, provisions are discounted using a current pre-tax rate that reflects, where appropriate, the risks specific to the liability. Where discounting is used, the increase in the provision due to the passage of time is recognized in the statements of income.
The provision for warranty returns relates to the Company’s obligation for defective goods sold to customers that have yet to be returned for exchange or repair. Accruals for warranty returns are estimated on the basis of historical returns and are recorded so as to allocate them to the same period the corresponding revenue is recognized.
(q)Fair values
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:
in the principal market for the asset or liability, or
in the absence of a principal market, in the most advantageous market for the asset or liability.
The Company uses valuation techniques that it believes are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs. All assets and liabilities for which fair value is measured or disclosed in the financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:
Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
Level 2: inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly or indirectly.
Level 3: unobservable inputs for the asset or liability. Unobservable inputs are used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.
For the purpose of fair value disclosures, the Company determines classes of assets and liabilities on the basis of the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy as explained above.
There was no change in the valuation techniques applied to financial instruments during all periods presented. The following table describes the valuation techniques used in the determination of the fair values of financial instruments:
Type
Valuation Approach
Cash, trade receivables, accounts payable and accrued liabilities
The carrying amount approximates fair value due to the short term maturity of these instruments.
Derivatives (included in other current assets, other long-term assets, accounts payable and accrued liabilities or other long-term liabilities)

Specific valuation techniques used to value derivative financial instruments include:
- quoted market prices or dealer quotes for similar instruments;
- observable market information as well as valuations determined by external valuators with experience in the financial markets.
Revolving Facility, Term Loan, Mainland China Facilities, and Japan Facility
The fair value is based on the present value of contractual cash flows, discounted at the Company’s current incremental borrowing rate for similar types of borrowing arrangements or, where applicable, market rates.
Put option liability
The fair value is based on the present value of the amount expected to be paid to the non-controlling shareholder if the put option is exercised. Subsequent changes in the present value of the amount that could be required to be paid at each reporting date are recorded with the statements of income until the put option is exercised or expires.
Contingent considerationThe fair value of the applicable contingent consideration is determined based on the estimated financial outcome and the resulting expected contingent consideration to be paid, discounted using an appropriate rate. Subsequent changes in the fair value is recognized in the statements of income.
Earn-Out included in other long-term liabilities
The fair value is based on a pre-determined percentage of net equity value of Paola Confectii SRL, determined as a multiple of EBITDA and EBITDA margin for the fiscal year ending March 30, 2025, subject to a floor, less net debt adjustments. Subsequent changes in the fair value are recognized in the statements of income.
(r)Financial instruments
Financial assets and financial liabilities are recognized when the Company becomes a party to the contractual provisions of the financial instrument.
Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issuance of financial assets and financial liabilities (other than financial assets and financial liabilities classified at fair value through profit or loss) are added to, or deducted from, the fair value of the financial
assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities classified at fair value through profit or loss are recognized immediately in profit or loss.
Financial assets and financial liabilities are measured subsequently as described below.
i)Non-derivative financial assets
Non-derivative financial assets include cash and trade receivables which are measured at amortized cost. The Company initially recognizes receivables and deposits on the date that they are originated. The Company derecognizes a financial asset when the contractual rights to the cash flows from the asset expire, or it transfers the rights to receive the contractual cash flows on the financial asset in a transaction in which substantially all the risks and rewards of ownership of the financial asset are transferred.
ii)Non-derivative financial liabilities
Non-derivative financial liabilities include accounts payable, accrued liabilities, the Revolving Facility (as defined below), the Term Loan (as defined below), the Mainland China Facilities (as defined below), and the Japan Facility (as defined below). The Company initially recognizes debt instruments on the date that they are originated. All other financial liabilities are recognized initially on the trade date on which the Company becomes a party to the contractual provisions of the instrument. Financial liabilities are recognized initially at fair value less any directly attributable transaction costs. Subsequent to initial recognition, these financial liabilities are measured at amortized cost using the effective interest method. The Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expire.
In respect of non-controlling interests, a financial liability is recognized for the put option based on the present value of the amount expected to be paid to the non-controlling shareholder if exercised. Subsequently, the put option liability is adjusted to reflect changes in the present value of the amount that could be required to be paid at each reporting date, with fluctuations being recorded within the statements of income, until it is exercised or expires. The put option is measured at fair value through profit or loss.
iii)Derivative financial instruments
Derivatives are initially recognized at fair value on the date a derivative contract is entered into and are subsequently remeasured to their fair value at each reporting date. The method of recognizing the resulting gain or loss depends on whether the derivative is designated and effective as a hedging instrument. When a derivative financial instrument, including an embedded derivative, is not designated and effective in a qualifying hedge relationship, all changes in its fair value are recognized immediately in the statements of income; attributable transaction costs are recognized in the statements of income as incurred. The Company does not use derivatives for trading or speculative purposes.
Embedded derivatives are separated from a host contract and accounted for separately if the economic characteristics and risks of the host contract and the embedded derivative are not closely related.
iv)Hedge accounting
The Company is exposed to the risk of currency fluctuations and has entered into currency derivative contracts to hedge its exposure on the basis of planned transactions. Where hedge accounting is applied, the criteria are documented at the inception of the hedge and updated at each reporting date. The Company documents the relationship between hedging instruments and hedged items, as well as its risk management objectives and strategy for undertaking the hedging transactions. The Company also documents its assessment, at hedge inception and on an ongoing basis, of whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flows of hedged items.
The fair value of a hedging derivative is classified as a current asset or liability when the maturity of the hedged item is less than 12 months, and as a non-current asset or liability when the maturity of the hedged item is more than 12 months.
The effective portion of changes in the fair value of derivatives that are designated and qualify as cash flow hedges is recognized, net of tax, in other comprehensive income. The gain or loss relating to the ineffective portion is recognized immediately in the statements of income. Amounts accumulated in other comprehensive income are transferred to the statements of income in the periods when the hedged item affects net income. When a forecasted transaction that is hedged results in the recognition of a non-financial asset or liability, such as inventory, the amounts are included in the measurement of the cost of the related asset or liability. The deferred amounts are ultimately recognized in the statements of income.
Hedges of net investments are accounted for similarly to cash flow hedges, with unrealized gains and losses recognized, net of tax, in other comprehensive income. Amounts included in other comprehensive income are transferred to the statements of income in the period when the foreign operation is disposed of or sold.
(s)Share-based payments
Share-based payments are valued based on the grant date fair value of these awards and the Company records compensation expense over the corresponding service period. The fair value of the share-based payments is determined using acceptable valuation techniques.
The Company has issued stock options to purchase subordinate voting shares, RSUs, and PSUs under its equity incentive plans, prior to the public offering on March 21, 2017 (the “Legacy Plan”) and subsequently (the “Omnibus Plan”). All Legacy Plan options have fully vested or been cancelled prior to the year ended March 31, 2024. Under the terms of the Omnibus Plan, options are granted to certain executives of the Company with vesting, generally over four years, contingent upon meeting the service conditions of the Omnibus Plan. The compensation expense related to the options, RSUs, and PSUs is recognized ratably over the requisite service period, provided it is probable that the
vesting conditions will be achieved and the occurrence of the exit event, if applicable, is probable.
v3.24.1.1.u2
Significant accounting judgments, estimates, and assumptions
12 Months Ended
Mar. 31, 2024
Accounting Policies, Changes In Accounting Estimates And Errors [Abstract]  
Significant accounting judgments, estimates, and assumptions Significant accounting judgments, estimates, and assumptions
The preparation of the consolidated financial statements requires management to make estimates and judgments in applying the Company’s accounting policies that affect the reported amounts and disclosures made in the consolidated financial statements and accompanying notes.
Estimates and assumptions are used mainly in determining the measurement of balances recognized or disclosed in the consolidated financial statements and are based on a set of underlying data that may include management’s historical experience, knowledge of current events and conditions and other factors that are believed to be reasonable under the circumstances. Management continually evaluates the estimates and judgments it uses. These estimates and judgments have been applied in a manner consistent with prior periods and there are no known trends, commitments, events or uncertainties that we believe will materially affect the methodology or assumptions utilized in making these estimates and judgments in these financial statements.
The following are the accounting policies subject to judgments and key sources of estimation uncertainty that the Company believes could have the most significant impact on the amounts recognized in the consolidated financial statements.
Functional currency
Judgments Made in Relation to Accounting Policies Applied: The Company assesses the relevant factors related to the primary economic environment in which its entities operate to determine the functional currency. Where the assessment of primary indicators is mixed, management assesses the secondary indicators, including the relationship between the foreign operations and reporting entity.
Income and other taxes
Key Sources of Estimation: In determining the recoverable amount of deferred tax assets, the Company forecasts future taxable income by legal entity and the period in which the income occurs to ensure that sufficient taxable income exists to utilize the attributes. Inputs to those projections are Board-approved financial forecasts and statutory tax rates.
Judgments Made in Relation to Accounting Policies Applied: The calculation of current and deferred income taxes requires management to make certain judgments regarding the tax rules in jurisdictions where the Company performs activities. Application of judgments is required regarding the classification of transactions and in assessing probable outcomes of claimed deductions including expectations about future operating results, the timing and reversal of temporary differences and possible audits of income tax and other tax filings by the tax authorities.
Trade receivables
Key Sources of Estimation: The Company has a significant number of customers which minimizes the concentration of credit risk. The Company does not have any customers which account for more than 10% of sales or accounts receivable. Ongoing estimates are made
relating to the ability to collect our accounts receivable and maintain an allowance for estimated credit losses resulting from the inability of our customers to make required payments. In determining the amount of expected credit losses, the Company considers the historical level of credit losses and makes judgments about the creditworthiness of significant customers based on ongoing credit evaluations.
Inventories
Key Sources of Estimation: Inventories are carried at the lower of cost and net realizable value. In estimating net realizable value, the Company uses estimates related to fluctuations in inventory levels, planned production, customer behaviour, obsolescence, future selling prices, seasonality and costs necessary to sell the inventory. Inventory is adjusted to reflect shrinkage incurred since the last inventory count. Shrinkage is based on historical experience.
Leases
Judgments Made in Relation to Accounting Policies Applied: The Company exercises judgment when contracts are entered into that may give rise to a right-of-use asset that would be accounted for as a lease. Judgment is required in determining the appropriate lease term on a lease by lease basis. The Company considers all facts and circumstances that create an economic incentive to exercise a renewal option or to not exercise a termination option at inception and over the term of the lease, including investments in major leaseholds, operating performance, and changed circumstances. The periods covered by renewal or termination options are only included in the lease term if the Company is reasonably certain to exercise that option. Changes in the economic environment or changes in the retail industry may impact the assessment of the lease term and any changes in the estimate of lease terms may have a material impact on the Company’s statement of financial position.
Key Sources of Estimation: The critical assumptions and estimates used in determining the present value of future lease payments require the Company to estimate the incremental borrowing rate specific to each leased asset or portfolio of leased assets. Management determines the incremental borrowing rate of each leased asset or portfolio of leased assets by incorporating the Company’s creditworthiness, the security, term, and value of the underlying leased asset, and the economic environment in which the leased asset operates. The incremental borrowing rates are subject to change mainly due to macroeconomic changes in the environment.
Impairment of non-financial assets (goodwill, intangible assets, property, plant & equipment, and right-of-use assets)
Judgments Made in Relation to Accounting Policies Applied: Management is required to use judgment in determining the grouping of assets to identify their CGUs for the purposes of testing non-financial assets for impairment. Judgment is further required to determine appropriate groupings of CGUs for the level at which goodwill and intangible assets are tested for impairment. For the purpose of goodwill and intangible assets impairment testing, CGUs are grouped at the lowest level at which goodwill and intangible assets are monitored for internal management purposes. Judgment is also applied in allocating the carrying amount of assets to CGUs. In addition, judgment is used to determine whether a triggering event has occurred requiring an impairment test to be completed. The Company has concluded that it has 12 CGUs (April 2, 2023 - 11 CGUs) and tests impairment of non-financial assets on that basis.
Key Sources of Estimation: In determining the recoverable amount of a CGU or a group of CGUs, various estimates are employed. The Company determines value-in-use by using estimates including projected future revenues, margins, costs, and capital investment consistent with strategic plans presented to the Board of Directors. Fair value less costs of disposal are estimated with reference to observable market transactions. Discount rates are consistent with external industry information reflecting the risk associated with the Company and its cash flows.
Warranty
Key Sources of Estimation: The critical assumptions and estimates used in determining the warranty provision at the statement of financial position date are: the number of jackets expected to require repair or replacement; the proportion to be repaired versus replaced; the period in which the warranty claim is expected to occur; the cost to repair a jacket; the cost to replace a jacket, and the risk-free rate used to discount the provision to present value.
Financial instruments
Key Sources of Estimation: The critical assumptions and estimates used in determining the fair value of financial instruments are: equity prices; future interest rates; the relative creditworthiness of the Company to its counterparties; estimated future cash flows; discount rates, and volatility utilized in option valuations.
Share-based payments
Key Sources of Estimation: Compensation expense for share-based compensation granted is measured at the fair value at the grant date using the Black Scholes option pricing model for the year ended March 31, 2024. The critical assumptions used under both of these option valuation models at the grant date are: stock price valuation; exercise price; risk-free interest rate; expected time to exercise in years; expected dividend yield, and volatility.
Consolidation
Judgments Made in Relation to Accounting Policies Applied: The Company uses judgment in determining the entities that it controls and therefore consolidates. The Company controls an entity when the Company has the existing rights that give it the current ability to direct the activities that significantly affect the entity’s returns. Judgment is applied in determining whether the Company controls the entities in which it does not have full ownership rights. Most often, judgment involves reviewing contractual rights to determine if rights are participating (giving power over the entity) or protective rights (protecting the Company’s interest without giving it power).
v3.24.1.1.u2
Changes in accounting policies
12 Months Ended
Mar. 31, 2024
Accounting Policies, Changes In Accounting Estimates And Errors [Abstract]  
Changes in accounting policies Changes in accounting policies
Standards issued and not yet adopted
Certain new standards, amendments, and interpretations to existing IFRS standards have been published but are not yet effective and have not been adopted early by the Company. Management anticipates that pronouncements will be adopted in the Company’s accounting policy for the first period beginning after the effective date of the pronouncement. Information on new standards, amendments, and interpretations is provided below.
In January 2020, the IASB issued an amendment to IAS 1, Presentation of Financial Statements (“IAS 1”) to clarify its requirements for the presentation of liabilities in the statement of financial position. The limited scope amendment affected only the presentation of liabilities in the statement of financial position and not the amount or timing of its recognition. The amendment clarified that the classification of liabilities as current or non-current is based on rights that are in existence at the end of the reporting period and specified that classification is unaffected by expectations about whether an entity will exercise its right to defer settlement of a liability. It also introduced a definition of ‘settlement’ to make clear that settlement refers to the transfer to the counterparty of cash, equity instruments, other assets or services. On October 31, 2022, the IASB issued Non-Current Liabilities with Covenants (Amendments to IAS 1). These amendments specify that covenants to be complied with after the reporting date do not affect the classification of debt as current or non-current at the reporting date. The amendment is effective for annual reporting periods beginning on or after January 1, 2024. Earlier application is permitted, however the Company has elected not to early adopt this amendment. The Company has performed an initial assessment on the impact of the amendment and the Company expects that adoption will result in a reclassification of the non-current portion of warranty provisions to be reported as current in nature, based on the terms and conditions of the Company’s warranty program. The impact is expected to be material in the consolidated statements of financial position.
Standards issued and adopted
In February 2021, the IASB issued narrow-scope amendments to IAS 1, IFRS Practice Statement 2, Making Materiality Judgements and IAS 8, Accounting Polices, Changes in Accounting Estimates and Errors. The amendments require the disclosure of material accounting policy information rather than disclosing significant accounting policies and clarified how to distinguish changes in accounting policies from changes in accounting estimates. Beginning April 3, 2023, the Company adopted the amendments. The adoption of the amendments did not have a material impact on the Annual Financial Statements.
In May 2023, the IASB issued International Tax Reform, Pillar Two Model Rules, Amendments to IAS 12, Income Taxes (the “Amendments”). The Amendments provide the Company with an exception from recognition and disclosure requirements for deferred tax assets and liabilities arising from the OECD Pillar Two international tax reform. The mandatory temporary exception has been adopted by the Company.
v3.24.1.1.u2
Business combinations
12 Months Ended
Mar. 31, 2024
Disclosure of detailed information about business combination [abstract]  
Business combinations Business combinations
Transactions during the year ended March 31, 2024
On November 1, 2023, a newly incorporated subsidiary of the Company, Paola Confectii Manufacturing Limited (“Paola Confectii”), acquired the business of Paola Confectii SRL, a luxury knitwear manufacturer for total cash consideration of $15.9m. This acquisition is expected to enhance product margins and supply control, while deepening in-house product expertise and capability.
The aggregate purchase consideration for the business combination is as follows:
$
Cash16.4
Working capital adjustments(0.5)
Total purchase consideration15.9
Management determined that the assets and substantive processes comprised a business and therefore accounted for the transaction as a business combination under IFRS 3, Business Combinations using the acquisition method of accounting. Under the acquisition method, assets and liabilities of the acquiree are recorded at their fair values.
Assets acquired and liabilities assumed have been recorded at the date of acquisition as follows:
$
Assets acquired
Trade receivables7.2
Inventories1.6
Prepaid expenses0.1
Property, plant and equipment2.6
Intangible assets
Customer list3.5
Brand1.0
Right-of-use assets1.2
Goodwill8.3
Accounts payable and accrued liabilities(8.4)
Lease liability(1.2)
Total assets acquired, net of liabilities assumed15.9
The determination of the fair value of assets acquired and liabilities assumed is based on estimates and certain assumptions with respect to the fair values of the assets acquired and liabilities assumed that were finalized as at the reporting date, within one year of the acquisition.
Goodwill of $8.3m was recognized as the excess of the acquisition cost over the fair value of net identifiable assets at the date of acquisition. Goodwill is mainly attributable to the strengthening of our vertically integrated supply chain and expected future growth potential of the knitwear category. Goodwill recognized is not expected to be deductible for income tax purposes.
Identifiable intangible assets acquired consist of the customer list and brand. The fair value of the customer list was $3.5m, measured using the multi-period excess earnings method, which will be amortized over a 4-year period on a straight-line basis. The fair value of the brand was $1.0m, measured using the relief-from-royalty method.
In connection with the business combination, subject to the controlling shareholders of Paola Confectii SRL ("PCML Vendors") remaining employees through November 1, 2025, a further amount is payable to the PCML Vendors if certain performance conditions are met based on financial results (“Earn-Out”). The estimated value is calculated as a pre-determined percentage of net equity value, determined as a multiple of EBITDA and EBITDA margin for the fiscal year ending March 30, 2025, subject to a floor, less net debt adjustments. As at the reporting date, the estimated value of the payout was $7.4m. The Company recognized the amount payable to the PCML Vendors as a separate transaction that was not included in applying the acquisition method as the amount reflects remuneration for future services to be performed conditional on employment until November 1, 2025, and therefore this amount will be expensed over two years.
The Company incurred $0.8m in transaction related costs which are included in SG&A expenses in the consolidated statements of income and comprehensive income for the year ended March 31, 2024.
Paola Confectii’s results are consolidated into the Company’s financial results effective from the date of acquisition and are presented in the Company’s Other operating segment. The results of Paola Confectii were not significant for the period beginning on the date of acquisition and ended on March 31, 2024 and would not have been either during fiscal 2024 if the acquisition had occurred as of the beginning of the fiscal year.
The PCML Vendors are employed as members of key management and continue to lead and maintain regular operations at Paola Confectii. The Earn-Out to the PCML Vendors and transactions with one of the PCML Vendors in connection with the acquisition for the lease of the manufacturing facility are related party transactions as they have been retained as employees of the Company. See “Note 20. Related Party Transactions” for more details.
Transactions during the year ended April 2, 2023
The Company and a former distributor of the Company's products in Japan, Sazaby League, Ltd. ("Sazaby League"), entered into an agreement (the "Joint Venture Agreement") to form a joint venture (the “Japan Joint Venture”) pursuant to which the Company acquired 50% of the issued and outstanding voting shares of the legal entity comprising the joint venture, Canada Goose Japan, K.K. (“CG Japan”), on April 4, 2022. CG Japan was established to market, distribute and sell Canada Goose products, and to operate retail stores and e-Commerce in Japan.
Prior to the establishment of CG Japan, the Company sold its products to Sazaby League. The majority of sales historically occurred in the first and second quarters and were recorded in the Wholesale operating segment. Subsequent to the transaction, the Company has consolidated the results of CG Japan and revenue and results of operations will be aligned to the respective operating segments and are expected to occur more in line with the seasonality of the Company's Wholesale and DTC segments.
Management performed an analysis under IFRS 10, Consolidated Financial Statements and since the Company has the power to direct the relevant activities of CG Japan, is exposed to variable returns, and can use its power to influence those returns, management determined that the Company has control over CG Japan for accounting purposes. In addition, management performed an analysis under IFRS 3, Business Combinations and has determined that the Company is the acquirer of CG Japan. Management determined that the assets and processes acquired comprised a business and therefore, accounted for the transaction as a business combination using the acquisition method of accounting. Under the acquisition method, assets and liabilities of the acquiree are recorded at their fair values.
The Company paid cash consideration to CG Japan of JPY250.0m ($2.6m) plus deferred contingent consideration to the non-controlling shareholder with an estimated fair value of JPY1,958.9m ($20.0m) resulting in total consideration of JPY2,208.9m ($22.6m). The deferred contingent consideration is payable if an agreed cumulative adjusted EBIT target is not reached through the period ended June 30, 2026. The fair value of the applicable contingent consideration is determined based on the estimated financial outcome and the resulting expected contingent consideration to be paid, discounted using an appropriate rate. As at April 4, 2022, the contingent consideration amount was recorded in other long-term liabilities. The amount of contingent consideration is remeasured at its fair value each reporting period, with changes in fair value recorded in the consolidated statements of income and comprehensive income.
The Company incurred $1.3m in transaction related costs which are included in SG&A expenses in the consolidated statements of income and consolidated statements of comprehensive income for the year ended April 2, 2023. For the year ended April 3, 2022, the Company incurred $0.7m in transaction related costs.
Assets acquired and liabilities assumed have been recorded based on the final valuation of their fair values at the date of acquisition as follows:
$
Assets acquired
Cash5.4
Inventories27.3
Property, plant and equipment1.2
Intangible assets14.9
Right-of-use assets3.3
Goodwill10.8
Other assets2.4
65.3
Liabilities assumed
Bank loan19.4
Lease liabilities3.2
Warranty provision0.3
22.9
Total identifiable net assets acquired42.4
Less: Deferred tax liability(8.1)
Less: Non-controlling interests(11.7)
Net assets acquired22.6
Consideration
Cash paid2.6
Contingent consideration20.0
Total purchase consideration22.6
Cash consideration paid(2.6)
Plus: Cash balance acquired5.4 
Net cash inflow on business combination2.8 
The determination of the fair value of assets acquired and liabilities assumed is based on estimates and certain assumptions with respect to the fair values of the assets acquired and liabilities assumed that were finalized as at April 2, 2023, within one year of the acquisition.
Goodwill is calculated as the difference between total consideration and the fair value of the net assets acquired and is attributable to expected synergies between CG Japan and the Company’s existing operations. Goodwill of $10.8m was recognized as the excess of the acquisition cost over the fair value of net identifiable assets at the date of acquisition. Goodwill recognized is not expected to be deductible for income tax purposes. Intangible assets of $14.9m relate to the fair value of the customer list and reacquired distribution rights of the Japan market, which will be amortized over a 10-year period.
The fair value of property, plant and equipment and right-of-use assets was based on management’s assessment of the acquired assets’ condition, as well as an evaluation of the current market value for such assets. In addition, the Company considered the length of time over which the economic benefit of these assets is expected to be realized and estimated the useful life of such assets as of the acquisition date. The fair value of inventories has been measured at net realizable value, less cost to sell.
CG Japan’s results are consolidated into the Company’s financial results effective April 4, 2022. For the year ended April 2, 2023, CG Japan contributed approximately $54.0m to the Company’s consolidated revenue and $1.0m to the Company’s operating income.
In connection with the business combination, the Joint Venture Agreement includes a put option that allows the non-controlling shareholder to sell its 50% interest to the Company within six months after certain circumstances constituting a "put option trigger" event occur. If the put option is not exercised during such six-month period, the put option will expire. The Company established a financial liability for the put option in respect of non-controlling interests. The fair value of the put option is classified as Level 3 within IFRS 13, Fair value measurement. As at April 4, 2022, the fair value of the put option held in Japanese yen by the non-controlling shareholder was recorded in other long-term liabilities in the amount of JPY2,076.4m ($21.2m).
The Company recorded the put option liability based on the present value of the amount expected to be paid to the non-controlling shareholder if exercised. Subsequently, the put option liability is adjusted to reflect changes in the present value of the amount that could be required to be paid at each reporting date, with fluctuations being recorded within the Company's consolidated statements of income, until it is exercised or expires.
v3.24.1.1.u2
Segment information
12 Months Ended
Mar. 31, 2024
Disclosure of operating segments [abstract]  
Segment information Segment information
The Company has three reportable operating segments: DTC, Wholesale, and Other. The Company measures each reportable operating segment’s performance based on revenue and segment operating income (loss), which is the profit metric utilized by the Company’s chief operating decision maker, the Chairman and Chief Executive Officer, for assessing the performance of operating segments. No single customer contributed 10 per cent or more to the Company’s revenue for the years ended March 31, 2024, April 2, 2023, and April 3, 2022.
As at March 31, 2024, the performance measure for our Other segment was revised to exclude corporate general and administrative expenses; these expenses are now presented as a reconciling item to the Company’s consolidated operating income. This change in segment reporting was made to improve the understanding of financial performance in the Other segment.
Corporate expenses comprises costs that do not occur through the DTC, Wholesale, or Other segments, including the cost of marketing expenditures to build brand awareness across all segments, management overhead costs in support of manufacturing operations, other corporate
costs, and foreign exchange gains and losses not specifically associated with segment operations.
The following table presents key performance information of the Company’s reportable operating segments:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
 $ $ $
Revenue
DTC950.7 807.3 740.4 
Wholesale312.3 373.8 348.5 
Other70.8 35.9 9.5 
Total segment revenue1,333.8 1,217.0 1,098.4 
Operating income (loss)ReclassifiedReclassified
DTC387.1 347.4 322.9 
Wholesale114.0 131.2 121.5 
Other14.0 10.5 4.1 
Total segment operating income515.1 489.1 448.5 
The following table reconciles the Company’s reportable total segment operating income to income before income taxes:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
 $ $ $
Total segment operating income515.1 489.1 448.5 
Corporate expenses(390.6)(341.5)(289.0)
Total operating income124.5 147.6 159.5 
Net interest, finance and other costs
48.8 54.1 41.8 
Income before incomes taxes
75.7 93.5 117.7 
The following table summarizes depreciation and amortization in SG&A expenses of each reportable operating segment and depreciation and amortization included in corporate expenses:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
$
$
$
Depreciation and amortization expense
DTC96.5 81.6 78.1 
Wholesale3.9 3.9 2.3 
Other— — — 
Total segment depreciation and amortization expense
100.4 85.5 80.4 
Corporate expenses15.8 14.9 8.3 
Total depreciation and amortization expense
116.2 100.4 88.7 
Geographic information
The Company determines the geographic location of revenue based on the location of its customers.
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
 $ $ $
Canada246.3 241.0 213.1 
United States324.6 340.2 305.9 
North America570.9 581.2 519.0 
Greater China1
422.2 287.3 288.8 
Asia Pacific (excluding Greater China1)
84.7 66.9 38.3 
Asia Pacific506.9 354.2 327.1 
EMEA2
256.0 281.6 252.3 
Total revenue1,333.8 1,217.0 1,098.4 
1.Greater China comprises Mainland China, Hong Kong, Macau, and Taiwan.
2.EMEA comprises Europe, the Middle East, Africa, and Latin America.
The Company’s non-current, non-financial assets (comprising of property, plant and equipment, intangible assets and right-of-use assets) are geographically located as follows:
Year ended
March 31,
2024
April 2,
2023
 $ $
Canada222.1 232.9 
United States140.7 111.7 
North America362.8 344.6 
Greater China1
63.6 73.6 
Asia Pacific (excluding Greater China1)
34.1 33.1 
Asia Pacific97.7 106.7 
EMEA2
126.2 131.6 
Non-current, non-financial assets586.7 582.9 
1.Greater China comprises Mainland China, Hong Kong, Macau, and Taiwan.
2.EMEA comprises Europe, the Middle East, Africa, and Latin America.
v3.24.1.1.u2
Income taxes
12 Months Ended
Mar. 31, 2024
Income taxes paid (refund) [abstract]  
Income taxes Income taxes
The components of the provision for income tax are as follows:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
Current income tax expense$$$
Current period15.4 44.0 35.6 
Adjustment in respect of prior periods9.5 (1.9)(0.4)
24.9 42.1 35.2 
Deferred income tax recovery
Origination and reversal of temporary differences(0.8)(18.5)(11.9)
Effect of change in income tax rates(0.2)(0.6)— 
Adjustment in respect of prior periods(6.3)1.6 (0.2)
(7.3)(17.5)(12.1)
Income tax expense17.6 24.6 23.1 
The effective income tax rates differ from the weighted average basic Canadian federal and provincial statutory income tax rates for the following reasons:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
$$$
Income before income taxes75.7 93.5 117.7 
Expected Statutory Rate25.5 %25.3 %25.4 %
Income tax at expected statutory rate19.3 23.7 29.8 
Non-deductible (taxable) items(0.1)0.8 (0.8)
Non-deductible stock option expense1.7 3.0 2.9 
Effect of foreign tax rates(10.3)(10.0)(14.6)
Non-deductible (taxable) remeasurement of contingent consideration and put option 1.4 2.4 — 
Non-deductible (taxable) foreign exchange loss (gain)0.9 1.4 0.2 
Change in tax rates(0.2)(0.4)0.1 
Change in deferred tax asset not recognized1.7 4.1 6.1 
Adjustments in respect of prior years 3.2 (0.4)(0.6)
Income tax expense17.6 24.6 23.1 
Pillar Two legislation has been enacted or substantively enacted locally in a number of jurisdictions in which the Company operates in, where they would be effective for financial year beginning on April 1, 2024. Based on a preliminary assessment, the Pillar Two effective tax rate in most of the jurisdictions in which the Company operates in, is above 15%. As a result, any impact of these rules is not expected to be material. However, the Company will continue to monitor and reassess the impact of the Pillar Two rules.
The change in the year in the components of deferred tax assets and liabilities are as follows:
Change in the year affecting
April 2,
2023
Net incomeForeign exchange translationOther comprehensive income (loss)March 31,
2024
$$$$$
Losses carried forward11.5 15.5 — — 27.0 
Employee future benefits0.1 — — 0.1 0.2 
Other liabilities1.9 5.0 0.8 — 7.7 
Inventory capitalization 6.8 (4.2)— — 2.6 
Capital lease 9.3 3.0 — — 12.3 
Tax relief from Swiss tax reform7.6 (5.9)— — 1.7 
Unrealized profit in inventory36.9 (1.6)0.1 — 35.4 
Provisions and other temporary differences7.6 0.4 — — 8.0 
Total deferred tax asset81.7 12.2 0.9 0.1 94.9 
Unrealized foreign exchange (3.1)0.7 — (0.3)(2.7)
Intangible assets(18.8)(0.8)— — (19.6)
Property, plant and equipment(8.7)(4.8)— — (13.5)
Total deferred tax liabilities(30.6)(4.9)— (0.3)(35.8)
Net deferred tax assets (liabilities)51.1 7.3 0.9 (0.2)59.1 
The change in deferred tax assets and liabilities as presented in the statement of financial position are as follows:
Changes in the year affecting
April 2,
2023
Net incomeForeign exchange translationOther comprehensive lossMarch 31,
2024
$$$$$
Deferred tax assets67.5 8.8 0.2 (0.2)76.3 
Deferred tax liabilities(16.4)(1.5)0.7 — (17.2)
51.1 7.3 0.9 (0.2)59.1 
Available deferred income tax assets related to capital losses, and Swiss tax relief in the amount of $0.5m and $31.8m, respectively, were not recognized as it is not probable that future taxable income will be available to the Company to utilize the benefits.
The corporate entities within the Company have the following tax-loss carry-forwards that are expected to expire in the following years, if not utilized.
$
2040 and prior 13.1 
20418.8 
20428.5 
20437.5 
20448.1 
46.0 
An additional $52.2m of operating losses can be carried forward indefinitely.
As at March 31, 2024, deferred income taxes have not been provided on $419.8m (April 2, 2023 - $417.7m, April 3, 2022 - $356.4m) of undistributed earnings of foreign subsidiaries, as the Company has concluded that such earnings should not give rise to additional tax liabilities upon repatriation or are indefinitely reinvested.
As at March 31, 2024, in addition to the amount charged to profit or loss and other comprehensive income, no tax recovery was recognized directly in equity related to excess tax deductions on share-based payments for stock options exercised (April 2, 2023 - $nil, April 3, 2022 - $nil). No tax expense was reversed out of equity related to reduction of expected tax deductions on issuance of RSU and PSU (April 2, 2023 - $nil and $nil, respectively, April 3, 2022 - $0.2m and $nil, respectively).
v3.24.1.1.u2
Earnings per share
12 Months Ended
Mar. 31, 2024
Earnings per share [abstract]  
Earnings per share Earnings per share
The following table presents details for the calculation of basic and diluted earnings per share:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
 $ $ $
Net income attributable to shareholders of the Company58.4 72.7 94.6 
Weighted average number of multiple and subordinate voting shares outstanding100,816,758 105,058,643 108,296,802 
Weighted average number of shares on exercise of stock options, RSUs and PSUs1
1,006,315 563,669 857,919 
Diluted weighted average number of multiple and subordinate voting shares outstanding101,823,073 105,622,312 109,154,721 
Earnings per share attributable to shareholders of the Company
Basic$0.58 $0.69 $0.87 
Diluted$0.57 $0.69 $0.87 
1    Subordinate voting shares issuable on exercise of stock options are not treated as dilutive if including them would decrease the loss per share, or if the weighted average daily closing share price for the period was greater than the exercise price. As at March 31, 2024, there were 3,904,366 shares (April 2, 2023 - 2,231,231 shares, April 3, 2022 - 1,475,545 shares) that were not taken into account in the calculation of diluted earnings per share because their effect was anti-dilutive.
v3.24.1.1.u2
Trade receivables
12 Months Ended
Mar. 31, 2024
Subclassifications of assets, liabilities and equities [abstract]  
Trade receivables Trade receivables
March 31,
2024
April 2,
2023
$$
Trade accounts receivable57.1 30.4 
Credit card receivables3.7 2.5 
Other receivables12.3 19.5 
73.1 52.4 
Less: expected credit loss and sales allowances(2.7)(1.5)
Trade receivables70.4 50.9 
The following are the continuities of the Company’s expected credit loss and sales allowances deducted from trade receivables:
March 31,
2024
April 2,
2023
Expected credit lossSales allowancesTotalExpected credit lossSales allowancesTotal
$$$$$$
Balance at the beginning of the year(0.4)(1.1)(1.5)(0.3)(0.8)(1.1)
Losses recognized(1.8)— (1.8)(0.1)(0.3)(0.4)
Amounts settled or written off during the year0.1 0.5 0.6 — — — 
Balance at the end of the year(2.1)(0.6)(2.7)(0.4)(1.1)(1.5)
v3.24.1.1.u2
Inventories
12 Months Ended
Mar. 31, 2024
Inventories [Abstract]  
Inventories Inventories
March 31,
2024
April 2,
2023
$$
Raw materials48.4 60.3 
Work in progress25.8 17.5 
Finished goods371.0 394.8 
Total inventories at the lower of cost and net realizable value445.2 472.6 
Inventories are written down to net realizable value when the cost of inventories is estimated to be unrecoverable due to obsolescence, damage, or declining rate of sale.
The breakdown of the provision for obsolescence is presented as follows:
March 31,
2024
April 2,
2023
$$
Raw material shrink reserves0.1 0.2 
Finished goods shrink reserves0.9 0.4 
Raw material obsolete inventory reserves22.1 20.5 
Finished goods obsolete inventory reserves37.7 22.1 
Provision for obsolescence60.8 43.2 
Amounts charged to cost of sales comprise the following:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
$$$
Cost of goods manufactured405.5 392.1 350.1 
Depreciation and amortization included in costs of sales10.9 9.7 14.7 
Cost of sales416.4 401.8 364.8 
v3.24.1.1.u2
Property, plant and equipment
12 Months Ended
Mar. 31, 2024
Property, plant and equipment [abstract]  
Property, plant and equipment Property, plant and equipment
The following table presents changes in the cost and the accumulated depreciation on the Company’s property, plant and equipment:
Plant equipmentComputer equipmentLeasehold improvementsShow displaysFurniture and fixturesIn progressTotal
Cost$$$$$$$
April 3, 202230.9 12.8 125.1 9.4 34.8 4.1 217.1 
Additions— 0.9 8.8 — 2.2 63.3 75.2 
Additions from business combinations (note 5)— — 0.9 — 0.3 — 1.2 
Disposals— (0.1)(1.0)— (0.1)— (1.2)
Transfers1.1 1.5 15.5 1.6 1.6 (21.3)— 
Impact of foreign currency translation— 0.2 2.1 0.4 1.0 0.4 4.1 
April 2, 202332.0 15.3 151.4 11.4 39.8 46.5 296.4 
Additions0.2 1.9 11.5 0.2 3.7 42.9 60.4 
Additions from business combinations (note 5)2.4 0.1 0.1 — — — 2.6 
Disposals(0.1)(0.3)(6.4)(1.0)(1.1)(0.1)(9.0)
Transfers2.9 4.4 70.4 (0.4)7.7 (85.0)— 
Impact of foreign currency translation(0.1)(0.1)(1.8)0.1 (0.4)(0.2)(2.5)
March 31, 202437.3 21.3 225.2 10.3 49.7 4.1 347.9 
Plant equipmentComputer equipmentLeasehold improvementsShow displaysFurniture and fixturesIn progressTotal
Accumulated depreciation$$$$$$$
April 3, 202212.1 9.3 53.9 7.3 20.3 — 102.9 
Depreciation3.2 2.7 23.1 1.1 7.3 — 37.4 
Disposals— (0.1)(1.0)— (0.1)— (1.2)
Impairment losses— — 0.2 — — — 0.2 
Impact of foreign currency translation— 0.2 (0.1)0.3 0.7 — 1.1 
April 2, 202315.3 12.1 76.1 8.7 28.2 — 140.4 
Depreciation3.7 3.4 30.2 1.2 6.9 — 45.4 
Disposals(0.1)(0.2)(6.4)(1.0)(1.0)— (8.7)
Impairment losses— — 0.2 — — — 0.2 
Impact of foreign currency translation— — (1.0)— (0.2)— (1.2)
March 31, 202418.9 15.3 99.1 8.9 33.9 — 176.1 
Net book value
April 2, 202316.7 3.2 75.3 2.7 11.6 46.5 156.0 
March 31, 202418.4 6.0 126.1 1.4 15.8 4.1 171.8 
Impairment losses for the years ended March 31, 2024 and April 2, 2023 were booked within the DTC segment as part of SG&A expenses in the statements of income.
v3.24.1.1.u2
Intangible assets
12 Months Ended
Mar. 31, 2024
Intangible assets other than goodwill [abstract]  
Intangible assets Intangible assets
Intangible assets comprise the following:
March 31,
2024
April 2,
2023
$$
Intangible assets with finite lives 18.3 19.3 
Intangible assets with indefinite lives:
Brand name116.5 115.5 
Domain name0.3 0.3 
135.1 135.1 
The following table presents the changes in cost and accumulated amortization of the Company’s intangible assets with finite lives:
Intangible assets with finite lives
SoftwareIntellectual propertyCustomer listsDistribution rightsTotal
Cost$$$$$
April 3, 20228.5 18.2 — — 26.7 
Additions1.8 0.1 — — 1.9 
Additions from business combinations (note 5)— — 7.7 7.2 14.9 
April 2, 202310.3 18.3 7.7 7.2 43.5 
Additions0.8 0.1 — — 0.9 
Additions from business combinations (note 5)— — 3.5 — 3.5 
Disposals(0.1)— — — (0.1)
Impact of foreign currency translation(0.1)0.1 (0.7)(0.9)(1.6)
March 31, 202410.9 18.5 10.5 6.3 46.2 
SoftwareIntellectual propertyCustomer listsDistribution rightsTotal
Accumulated amortization$$$$$
April 3, 20223.6 16.7 — — 20.3 
Amortization1.8 0.7 0.7 0.7 3.9 
April 2, 20235.4 17.4 0.7 0.7 24.2 
Amortization1.8 0.5 0.8 0.7 3.8 
Disposals(0.1)— — — (0.1)
Impact of foreign currency translation— — 0.1 (0.1)— 
March 31, 20247.1 17.9 1.6 1.3 27.9 
Net book value
April 2, 20234.9 0.9 7.0 6.5 19.3 
March 31, 20243.8 0.6 8.9 5.0 18.3 
Intellectual property consists of acquired technology, patents and trademarks.
Indefinite life intangible assets
Indefinite life intangible assets recorded by the Company are comprised of the Canada Goose, Baffin, and Paola Confectii brand names, as well as the Canada Goose and Baffin domain names associated with the Company’s websites. The Company expects to renew the registration of the brand names and domain names at each expiry date indefinitely, and expects these assets to generate economic benefit in perpetuity. As such, the Company assessed these intangibles to have indefinite useful lives.
The Company completed its annual impairment tests for the years ended March 31, 2024 and April 2, 2023 for indefinite life intangible assets and concluded that there was no impairment.
Key Assumptions
The key assumptions used to calculate the value-in-use (“VIU”) are consistent with the assumptions used for goodwill impairment testing (see "Note 14. Goodwill" for more details).
v3.24.1.1.u2
Leases
12 Months Ended
Mar. 31, 2024
Leases, Assets And Liabilities [Abstract]  
Leases Leases
Right-of-use assets
The following table presents changes in the cost and the accumulated depreciation of the Company’s right-of-use assets:
Retail storesManufacturing facilitiesOtherTotal
Cost$$$$
April 3, 2022296.3 36.7 17.4 350.4 
Additions82.8 8.2 39.6 130.6 
Additions from business combinations (note 5)1.5 — 1.8 3.3 
Lease modifications2.4 — — 2.4 
Derecognition on termination(1.8)— (1.0)(2.8)
Impact of foreign currency translation15.5 — 0.6 16.1 
April 2, 2023396.7 44.9 58.4 500.0 
Additions29.8 0.2 2.7 32.7 
Additions from business combinations (note 5)— 1.2 — 1.2 
Lease modifications31.9 — 1.8 33.7 
Derecognition on termination(5.1)(2.1)(1.8)(9.0)
Impact of foreign currency translation(3.0)— (0.2)(3.2)
March 31, 2024450.3 44.2 60.9 555.4 
Retail storesManufacturing facilitiesOtherTotal
Accumulated depreciation$$$$
April 3, 2022110.1 15.2 9.9 135.2 
Depreciation55.5 5.4 7.2 68.1 
Derecognition on termination(1.2)— (1.0)(2.2)
Impairment losses0.8 — — 0.8 
Impact of foreign currency translation5.9 — 0.4 6.3 
April 2, 2023171.1 20.6 16.5 208.2 
Depreciation63.8 5.5 7.3 76.6 
Derecognition on termination(5.1)(2.1)(1.8)(9.0)
Impairment losses1.0 — — 1.0 
Impact of foreign currency translation(1.1)— (0.1)(1.2)
March 31, 2024229.7 24.0 21.9 275.6 
Net book value
April 2, 2023225.6 24.3 41.9 291.8 
March 31, 2024220.6 20.2 39.0 279.8 
Impairment losses for the year ended March 31, 2024 and April 2, 2023 were booked within the DTC segment as part of SG&A expenses in the statements of income.
Lease liabilities
The following table presents the changes in the Company's lease liabilities:
Retail storesManufacturing facilitiesOtherTotal
$$$$
April 3, 2022217.2 24.8 8.7 250.7 
Additions82.1 8.2 39.6 129.9 
Additions from business combinations (note 5)1.5 — 1.7 3.2 
Lease modifications2.4 — — 2.4 
Derecognition on termination(0.7)— — (0.7)
Principal payments(54.5)(5.3)(2.4)(62.2)
Impact of foreign currency translation11.2 — 0.3 11.5 
April 2, 2023259.2 27.7 47.9 334.8 
Additions29.7 0.2 2.3 32.2 
Additions from business combinations (note 5)— 1.2 — 1.2 
Lease modifications31.9 — 1.8 33.7 
Principal payments(63.0)(5.3)(0.9)(69.2)
Impact of foreign currency translation(2.1)— (0.1)(2.2)
March 31, 2024255.7 23.8 51.0 330.5 
Lease liabilities are classified as current and non-current liabilities as follows:
Retail storesManufacturing facilitiesOtherTotal
$$$$
Current lease liabilities64.7 6.1 5.3 76.1 
Non-current lease liabilities194.5 21.6 42.6 258.7 
April 2, 2023259.2 27.7 47.9 334.8 
Current lease liabilities65.8 6.3 7.8 79.9 
Non-current lease liabilities189.9 17.5 43.2 250.6 
March 31, 2024255.7 23.8 51.0 330.5 
In the year ended March 31, 2024, $39.6m of lease payments were not included in the measurement of lease liabilities (April 2, 2023 - $23.5m, April 3, 2022 - $21.5m). The majority of these balances related to short-term leases and variable rent payments, net of rent concessions, which are expenses as incurred.
v3.24.1.1.u2
Goodwill
12 Months Ended
Mar. 31, 2024
Intangible assets and goodwill [abstract]  
Goodwill Goodwill
Goodwill arising from business combinations is as follows:
March 31,
2024
April 2,
2023
$$
Opening balance63.9 53.1 
Business combination (note 5)8.3 10.8 
Impact of foreign currency translation(1.4)— 
Goodwill70.8 63.9 
The Company has determined there to be 11 CGUs (April 2, 2023 - 10 CGUs) for which goodwill and indefinite life intangible assets are tested for impairment. The increase in CGUs from the comparative period is attributable to the recognition of goodwill from the Paola Confectii business combination which represents an additional CGU. No other changes were made to the existing CGUs from the previous year. The Company completed its annual impairment tests and concluded that there was no impairment in the years ended March 31, 2024 and April 2, 2023.
The following table outlines the goodwill allocation for the applicable CGUs for the current year:
March 31,
2024
April 2,
2023
$$
North America DTC - Retail11.7 11.7 
North America DTC - e-Commerce6.6 6.6 
North America Wholesale5.7 5.7 
Asia Pacific DTC - Retail9.8 9.8 
Asia Pacific DTC - e-Commerce2.6 2.6 
Asia Pacific Wholesale3.6 3.6 
EMEA1 DTC - Retail
4.3 4.3 
EMEA1 DTC - e-Commerce
2.8 2.8 
EMEA1 Wholesale
6.0 6.0 
Japan Joint Venture2
9.410.8
Paola Confectii8.3 — 
Goodwill70.8 63.9 
1EMEA comprises Europe, the Middle East, Africa, and Latin America.
2Goodwill for the Japan Joint Venture is JPY1,059.3m; year-over-year movement in the balance in Canadian Dollars is due to the impact of foreign exchange translation from JPY to CAD of $1.4m.
Key Assumptions
The key assumptions used to calculate the VIU are those regarding discount rate, revenue and gross margin growth rates, sales channel mix, and growth in SG&A expenses. These assumptions are considered to be Level 3 in the fair value hierarchy. The goodwill impairment tests resulted in excess of recoverable value over carrying value of at least 23.5% for each CGU. Because the VIU amount exceeds the CGUs’ asset carrying amount, the CGU is not impaired and the fair value less costs of disposition has not been calculated.
Cash flow projections were discounted using the Company’s weighted average cost of capital, determined to be 12.80% (April 2, 2023 - 12.67%) based on a risk-free rate, an equity risk premium adjusted for betas of comparable publicly traded companies, an unsystematic risk premium, country risk premium, specific risk premium, a cost of debt based on comparable corporate bond yields and the capital structure of the Company. Cash flow projections are based on management’s most recent forecasts over a five year period. A long term growth rate of 2% has been applied to cash flows beyond the forecasted period.
v3.24.1.1.u2
Accounts payables and accrued liabilities
12 Months Ended
Mar. 31, 2024
Subclassifications of assets, liabilities and equities [abstract]  
Accounts payables and accrued liabilities Accounts payables and accrued liabilities
Accounts payable and accrued liabilities consist of the following:
March 31,
2024
April 2,
2023
$$
Trade payables57.6 60.1 
Accrued liabilities73.5 82.4 
Employee benefits38.6 21.9 
Derivative financial instruments1.9 3.3 
ASPP liability (note 18)— 20.0 
Other payables6.1 7.9 
Accounts payable and accrued liabilities177.7 195.6 
v3.24.1.1.u2
Provisions
12 Months Ended
Mar. 31, 2024
Provisions [abstract]  
Provisions Provisions
Provisions consist primarily of amounts recorded with respect to customer warranty obligations, sales returns, and asset retirement obligations.
The provision for warranty claims represents the present value of management’s best estimate of the future outflow of economic resources that will be required to meet the Company’s obligations for warranties upon the sale of goods, which may include repair or replacement of previously sold products. The estimate has been made on the basis of historical warranty trends and may vary as a result of new materials, altered manufacturing processes, customer behaviour and expectations, or other events affecting product quality and production.
The sales contract provision relates to management’s estimated cost of the departure of certain third-party dealers and distributors.
Sales returns relate primarily to goods sold through the DTC segment which have a limited right of return (typically within 30 days), or exchange only, in certain jurisdictions.
Asset retirement obligations relate to legal obligations associated with the retirement of tangible long-lived assets, primarily for leasehold improvements that the Company is contractually obligated to remove at the end of the lease term. The Company recognizes the liability when such obligations are incurred. The fair value of the liability is estimated based on a number of assumptions requiring management’s judgment, including closing costs and inflation rates, and is accreted to its projected future value over time.
 WarrantySales returnsAsset retirement obligations Total
$$$$
April 3, 202229.2 12.9 7.7 49.8 
Additional provisions recognized7.6 10.8 4.1 22.5 
Reductions resulting from settlement(6.4)(7.5)— (13.9)
Release of provisions— (1.3)— (1.3)
Other— 0.7 0.3 1.0 
April 2, 202330.4 15.6 12.1 58.1 
Additional provisions recognized6.6 20.8 2.6 30.0 
Reductions resulting from settlement(6.8)(16.9)— (23.7)
Release of provisions— (0.7)(0.1)(0.8)
Other0.1 — (0.3)(0.2)
March 31, 202430.3 18.8 14.3 63.4 
Provisions are classified as current and non-current liabilities based on management’s expectation of the timing of settlement, as follows:
March 31,
2024
April 2,
2023
$$
Current provisions26.1 21.6 
Non-current provisions37.3 36.5 
Provisions63.4 58.1 
v3.24.1.1.u2
Borrowings
12 Months Ended
Mar. 31, 2024
Borrowings [abstract]  
Borrowings Borrowings
Amendments to borrowings
Effective June 30, 2023, LIBOR rates are no longer published for U.S Dollars. As a result, in the first quarter ended July 2, 2023, the Company transitioned facilities and contracts denominated in U.S dollars applying LIBOR to the Secured Overnight Financing Rate published by the Federal Reserve Bank of New York (“SOFR”). At this time, the Company entered into further amendments to its Revolving Facility (as defined below), Term Loan Facility (as defined below) and the interest rate swaps to transition to SOFR. In connection with the amendments, during the first quarter ended July 2, 2023, the Company also extended the maturity of the Revolving Facility to May 15, 2028 and incurred transaction costs of $0.7m, on the extension of the Revolving Facility, which are being amortized using the effective interest rate method over the new term to maturity. There were no further amendments to borrowings in the year ended March 31, 2024.
See "Note 22. Financial risk management objectives and policies" for more details on the amendments to the interest rate swaps.
Revolving Facility
The Company has an agreement with a syndicate of lenders for a senior secured asset-based revolving credit facility ("Revolving Facility") in the amount of $467.5m, with an increase in
commitments to $517.5m during the peak season (June 1 - November 30). The Revolving Facility matures on May 15, 2028. Amounts owing under the Revolving Facility may be borrowed, repaid and re-borrowed for general corporate purposes. The Company has pledged substantially all of its assets as collateral for the Revolving Facility. The Revolving Facility contains financial and non-financial covenants which could impact the Company’s ability to draw funds.
The Revolving Facility has multiple interest rate charge options that are based on the Canadian prime rate, Banker's Acceptance rate, the lenders' Alternate Base Rate, European Base Rate, SOFR rate, or EURIBOR rate plus an applicable margin, with interest payable the earlier of quarterly or at the end of the then current interest period (whichever is earlier).
As at March 31, 2024, the Company had repaid all amounts owing on the Revolving Facility (April 2, 2023 - $nil). As at March 31, 2024, no interest and administrative fees remain outstanding (April 2, 2023 - $nil). Deferred financing charges in the amounts of $1.0m (April 2, 2023 - $0.5m), were included in other long-term liabilities. As at and during the year ended March 31, 2024, the Company was in compliance with all covenants.
The Company had unused borrowing capacity available under the Revolving Facility of $203.7m as at March 31, 2024 (April 2, 2023 - $238.4m).
The revolving credit commitment also includes a letter of credit commitment in the amount of $25.0m, with a $5.0m sub-commitment for letters of credit issued in a currency other than Canadian dollars, U.S. dollars, euros or British pounds sterling, and a swingline commitment for $25.0m. As at March 31, 2024, the Company had letters of credit outstanding under the Revolving Facility of $1.5m (April 2, 2023 - $1.8m).
Term Loan
The Company has a senior secured loan agreement with a syndicate of lenders that is secured on a split collateral basis ("Term Loan") alongside the Revolving Facility. The Term Loan has an aggregate principal amount of USD300.0m, with quarterly repayments of USD0.75m on the principal amount and a maturity date of October 7, 2027. Moreover, the Term Loan has an interest rate of SOFR plus a term SOFR adjustment of 0.11448% with an applicable margin of 3.50% payable monthly in arrears. SOFR plus the term SOFR adjustment may not be less than 0.75%.
Voluntary prepayments of amounts owing under the Term Loan may be made at any time without premium or penalty but once repaid may not be reborrowed. As at March 31, 2024, the Company had USD290.3m (April 2, 2023 - USD293.3m) aggregate principal amount outstanding under the Term Loan. The Company has pledged substantially all of its assets as collateral for the Term Loan. The Term Loan contains financial and non-financial covenants which could impact the Company’s ability to draw funds. As at and during the year ended March 31, 2024, the Company was in compliance with all covenants.
As the Term Loan is denominated in U.S. dollars, the Company remeasures the outstanding balance plus accrued interest at each balance sheet date.
The amount outstanding with respect to the Term Loan is as follows:
March 31,
2024
April 2,
2023
$$
Term Loan393.1 396.3 
Unamortized portion of deferred transaction costs(0.6)(0.6)
Term Loan, net of unamortized deferred transaction costs392.5 395.7 
Mainland China Facilities
A subsidiary of the Company in Mainland China has two uncommitted loan facilities in the aggregate amount of RMB266.4m ($50.0m) ("Mainland China Facilities"). The term of each draw on the loans is one, three or six months or such other period as agreed upon and shall not exceed 12 months (including any extension or rollover). The interest rate on each facility is equal to loan prime rate of 1 year, minus a marginal rate between 0.35% and 0.45%, and payable at one, three or six months, depending on the term of each draw. Proceeds drawn on the Mainland China Facilities are being used to support working capital requirements and build up of inventory for peak season sales. As at March 31, 2024, the Company had no amounts owing on the Mainland China Facilities (April 2, 2023 - $9.8m (RMB50.0m)).
Japan Facility
A subsidiary of the Company in Japan has a loan facility in the aggregate amount of JPY4,000.0m ($35.8m) ("Japan Facility") with a floating interest rate of Japanese Bankers Association Tokyo Interbank Offered Rate (“JBA TIBOR”) plus an applicable margin of 0.30%. The term of the facility is 12 months and each draw on the facility is payable within the term. Proceeds drawn on the Japan Facility are being used to support build up of inventory for peak season sales. As at March 31, 2024, the Company had $5.4m (JPY600.0m) owing on the Japan Facility (April 2, 2023 - $13.7m (JPY1,350.0m)).
Short-term Borrowings
As at March 31, 2024, the Company has short-term borrowings in the amount of $9.4m. Short-term borrowings include $5.4m (April 2, 2023 - $13.7m) owing on the Japan Facility, and $4.0m (April 2, 2023 - $4.1m) for the current portion of the quarterly principal repayments on the Term Loan. For the year ended April 2, 2023, short-term borrowings included $9.8m on the Mainland China Facilities. Short-term borrowings are all due within the next 12 months.
Net interest, finance and other costs consist of the following:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
$$$
ReclassifiedReclassified
Interest expense
Mainland China Facilities0.9 0.5 0.4 
Japan Facility0.1 0.1 — 
Revolving Facility2.8 1.1 1.8 
Term Loan19.9 18.8 17.4 
Lease liabilities17.7 11.6 9.1 
Standby fees1.2 1.8 0.9 
Acceleration of unamortized costs on debt extinguishment— — 9.5 
Foreign exchange losses on Term Loan net of hedges2.1 12.1 2.8 
Fair value remeasurement on the put option liability (note 21)1.6 10.9 — 
Fair value remeasurement on the contingent consideration (note 21)2.8 (2.9)— 
Interest income(1.3)(0.9)(0.4)
Other costs1.0 1.0 0.3 
Net interest, finance and other costs48.8 54.1 41.8 
v3.24.1.1.u2
Shareholders' equity
12 Months Ended
Mar. 31, 2024
Share Capital, Reserves And Other Equity Interest [Abstract]  
Shareholders' equity Shareholders’ equity
The authorized and issued share capital of the Company are as follows:
Authorized
The authorized share capital of the Company consists of an unlimited number of subordinate voting shares without par value, an unlimited number of multiple voting shares without par value, and an unlimited number of preferred shares without par value, issuable in series.
Issued
Multiple voting shares - Holders of the multiple voting shares are entitled to 10 votes per multiple voting share. Multiple voting shares are convertible at any time at the option of the holder into one subordinate voting share. The multiple voting shares will automatically be converted into subordinate voting shares when they cease to be owned by one of the principal shareholders. In addition, the multiple voting shares of either of the principal shareholders will automatically be converted to subordinate voting shares at such time as the beneficial ownership of that shareholder falls below 15% of the outstanding subordinate voting shares and multiple voting shares outstanding, or additionally, in the case of DTR, when the current Chairman and Chief Executive Officer no longer serves as a director of the Company or in a senior management position.
Subordinate voting shares - Holders of the subordinate voting shares are entitled to one vote per subordinate voting share.
The rights of the subordinate voting shares and the multiple voting shares are substantially identical, except for voting and conversion. Subject to the prior rights of any preferred shares, the holders of subordinate and multiple voting shares participate equally in any dividends declared and share equally in any distribution of assets on liquidation, dissolution, or winding up.
Share capital transactions for the year ended March 31, 2024
Normal course issuer bid for Fiscal 2024
The Board of Directors has authorized the Company to initiate a normal course issuer bid, in accordance with the requirements of the Toronto Stock Exchange, to purchase up to 4,980,505 subordinate voting shares over the 12-month period from November 22, 2023 and ending no later than November 21, 2024 (the "Fiscal 2024 NCIB"). Purchased subordinate voting shares will be cancelled.
In connection with the Fiscal 2024 NCIB, the Company also entered an automatic share purchase plan (the “Fiscal 2024 ASPP”) under which a designated broker may purchase subordinate voting shares under the Fiscal 2024 NCIB during the regularly scheduled quarterly trading blackout periods of the Company. The repurchases made under the Fiscal 2024 ASPP will be made in accordance with certain purchasing parameters and will continue until the earlier of the date in which the Company has acquired the maximum limit of subordinate voting shares pursuant to the Fiscal 2024 ASPP or upon the date of expiry of the Fiscal 2024 NCIB.
During the year ended March 31, 2024, under the Fiscal 2024 NCIB, the Company purchased 3,586,124 subordinate voting shares for cancellation for total cash consideration of $56.9m. The amount to purchase the subordinate voting shares was charged to share capital, with the remaining $48.8m charged to retained earnings. Of the 3,586,124 subordinate voting shares purchased, 3,088,648 were purchased under the Fiscal 2024 ASPP for total cash consideration of $49.6m.
For the trading blackout period relating to the fiscal year ended March 31, 2024, the Company elected not to rely on the Fiscal 2024 ASPP. Therefore, there was no liability due to the designated broker as at March 31, 2024.
Normal course issuer bid for Fiscal 2023
The Board of Directors authorized the Company to initiate a normal course issuer bid, in accordance with the requirements of the Toronto Stock Exchange, to purchase and cancel up to 5,421,685 subordinate voting shares over the 12-month period from November 22, 2022 and concluded on November 21, 2023 (the “Fiscal 2023 NCIB”).
In connection with the Fiscal 2023 NCIB, the Company also entered an automatic share purchase plan (the “Fiscal 2023 ASPP”) under which a designated broker purchased subordinate voting shares under the Fiscal 2023 NCIB during the regularly scheduled quarterly trading blackout periods of the Company. This Fiscal 2023 ASPP terminated on November 21, 2023, along with the Fiscal 2023 NCIB, and the liability to the broker was fully settled at the end of the plan.
During the three fiscal quarters ended December 31, 2023, under the Fiscal 2023 NCIB until its expiration, the Company purchased 4,268,883 subordinate voting shares for cancellation for total cash consideration of $83.3m. The amount to purchase the subordinate voting shares has been charged to share capital, with the remaining $73.6m charged to retained earnings. Of the
4,268,883 subordinate voting shares purchased, 1,184,152 were purchased under the ASPP for total cash consideration of $25.3m.
Since the commencement of the Fiscal 2023 NCIB, the Company purchased 5,421,685, which represents the total authorized subordinate voting shares for cancellation for total cash consideration of $111.2m.
The transactions affecting the issued and outstanding share capital of the Company are described below:
Multiple voting sharesSubordinate voting sharesTotal
Number$Number$Number$
April 2, 202351,004,076 1.4 53,184,912 117.3 104,188,988 118.7 
Purchase of subordinate voting shares— — (7,855,007)(17.8)(7,855,007)(17.8)
Total share purchases— — (7,855,007)(17.8)(7,855,007)(17.8)
Exercise of stock options— — 64,058 0.2 64,058 0.2 
Settlement of RSUs— — 134,475 3.8 134,475 3.8 
Total share issuances— — 198,533 4.0 198,533 4.0 
March 31, 202451,004,076 1.4 45,528,438 103.5 96,532,514 104.9 
Share capital transactions for the year ended April 2, 2023
In connection with the Fiscal 2023 NCIB, during the year ended April 2, 2023, the Company purchased 1,152,802 subordinate voting shares for cancellation for total cash consideration of $26.7m. The amount to purchase the subordinate voting shares has been charged to share capital, with the remaining $25.4m charged to retained earnings. Of the 1,152,802 subordinate voting shares purchased, 821,622 were purchased under the Fiscal 2023 ASPP for total cash consideration of $20.0m.
A liability representing the maximum amount that the Company could be required to pay the designated broker under the Fiscal 2023 ASPP was $20.0m as at April 2, 2023. The amount was charged to contributed surplus.
The transactions affecting the issued and outstanding share capital of the Company are described below:
Multiple voting sharesSubordinate voting sharesTotal
Number$Number$Number$
April 3, 202251,004,076 1.4 54,190,432 117.1 105,194,508 118.5 
Purchase of subordinate voting shares— — (1,103,102)(2.4)(1,103,102)(2.4)
Purchase of subordinate voting shares held for cancellation— — (49,700)(0.1)(49,700)(0.1)
Total share purchases— — (1,152,802)(2.5)(1,152,802)(2.5)
Exercise of stock options— — 60,248 — 60,248 — 
Settlement of RSUs— — 87,034 2.7 87,034 2.7 
Total share issuances— — 147,282 2.7 147,282 2.7 
April 2, 202351,004,076 1.4 53,184,912 117.3 104,188,988 118.7 
Share capital transactions for the year ended April 3, 2022
The Company previously maintained another NCIB in relation to its subordinate voting shares. The Company was authorized to make purchases from August 20, 2021 to August 19, 2022, in accordance with the requirements of the TSX. The Board of Directors of the Company had authorized the Company to repurchase up to 5,943,239 subordinate voting shares, representing approximately 10% of the issued and outstanding subordinate voting shares as at August 6, 2021. Purchases were made during the validity of such NCIB by means of open market transactions on the TSX, the NYSE and one Canadian alternative trading system.
During the year ended April 3, 2022, the Company purchased 5,636,763 subordinate voting shares for cancellation for total cash consideration of $253.2m. The amount to purchase the subordinate voting shares has been charged to share capital, with the remaining $241.3m charged to retained earnings.
The transactions affecting the issued and outstanding share capital of the Company are described below:
Multiple voting sharesSubordinate voting sharesTotal
Number$Number$Number$
March 28, 202151,004,076 1.4 59,435,079 119.1 110,439,155 120.5 
Purchase of subordinate voting shares— — (5,636,763)(11.9)(5,636,763)(11.9)
Total share purchases— — (5,636,763)(11.9)(5,636,763)(11.9)
Exercise of stock options— — 342,148 8.5 342,148 8.5 
Settlement of RSUs— — 49,968 1.4 49,968 1.4 
Total share issuances— — 392,116 9.9 392,116 9.9 
April 3, 202251,004,076 1.4 54,190,432 117.1 105,194,508 118.5 
v3.24.1.1.u2
Share-based payments
12 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangements [Abstract]  
Share-based payments Share-based payments
Stock options
The Company has issued stock options to purchase subordinate voting shares under its incentive plans, prior to the public share offering on March 21, 2017, the Legacy Plan, and subsequently, the Omnibus Plan. All options are issued at an exercise price that is not less than market value at the time of grant and expire 10 years after the grant date.
Legacy Plan
Under the terms of the Legacy Plan, options were granted to certain executives of the Company which are exercisable to purchase subordinate voting shares. All Legacy Plan options have fully vested or been cancelled prior to the year ended March 31, 2024. No new options will be issued under the Legacy Plan.
Omnibus Plan
Under the terms of the Omnibus Plan, options are granted to certain employees of the Company which are exercisable to purchase subordinate voting shares. The options vest over four years contingent upon meeting the service conditions of the Omnibus Plan, 25% on each anniversary of the date of grant.
Stock option transactions are as follows:
Year ended
March 31,
2024
April 2,
2023
Weighted average exercise priceNumber of sharesWeighted average exercise priceNumber of shares
Options outstanding, beginning of period$36.58 4,055,199$42.99 2,722,690
Granted to purchase shares$19.77 1,278,211$24.63 1,580,506
Exercised$1.61 (64,058)$0.23 (60,248)
Cancelled$28.83 (660,575)$40.66 (187,749)
Options outstanding, end of period$33.51 4,608,777$36.58 4,055,199
The following table summarizes information about stock options outstanding and exercisable at March 31, 2024:
    Options Outstanding   Options Exercisable
Exercise price Number Weighted average remaining life in years Number Weighted average remaining life in years
$0.0215,434 0.015,434 0.0
$1.7944,307 0.844,307 0.8
$8.94122,221 2.8122,221 2.8
$14.292,565 9.6— 0.0
$16.21519,884 9.9— 0.0
$22.24611,798 9.1— 0.0
$23.6442,576 3.442,576 3.4
$23.7712,285 8.23,072 8.2
$24.641,169,619 7.9322,809 7.2
$30.7348,730 3.048,730 3.0
$31.7935,622 3.635,622 3.6
$33.97635,096 5.8462,427 5.6
$45.3433,708 4.033,708 4.0
$48.93541,197 6.9284,064 6.6
$50.00250,000 6.2187,500 6.2
$63.03359,157 4.8359,157 4.8
$83.53164,578 3.8164,578 3.8
4,608,7777.02,126,2055.3
Restricted share units
The Company has granted shares as part of the RSU program under the Omnibus Plan to employees of the Company. The RSUs are treated as equity instruments for accounting purposes. We expect that vested RSUs will be paid at settlement through the issuance of one subordinate voting share per RSU. The RSUs vest over a period of three years, a third on each anniversary of the date of grant.
RSUs transactions are as follows:
Year ended
March 31,
2024
April 2,
2023
Number of sharesNumber of shares
RSUs outstanding, beginning of period318,082 215,590 
Granted438,814 209,187 
Settled(134,475)(87,034)
Cancelled(141,903)(19,661)
RSUs outstanding, end of period480,518318,082
Performance share units
In May 2023, the Company implemented a PSU program under the Omnibus Plan. A PSU represents the right to receive a subordinate voting share settled by the issuance of shares at the vesting date. PSUs vest on the third anniversary of the award date and are earned only if certain performance targets are achieved. Shares issued per PSU at the vesting date can decrease or increase if minimum or maximum performance targets are achieved ranging from 0% to 200% of the PSU award granted. PSUs are treated as equity instruments for accounting purposes.
PSUs transactions are as follows:
Year ended
March 31,
2024
April 2,
2023
Number of sharesNumber of shares
PSUs outstanding, beginning of period— — 
Granted399,349 — 
Cancelled(56,424)— 
PSUs outstanding, end of period342,925
Shares reserved for issuance
As at March 31, 2024, subordinate voting shares, to a maximum of 5,310,387 shares, have been reserved for issuance under equity incentive plans to select employees of the Company, with vesting contingent upon meeting the service, performance goals and other conditions of the Omnibus Plan.
Accounting for share-based awards
For the year ended March 31, 2024, the Company recorded $10.4m as compensation expense for stock options, RSUs and PSUs (April 2, 2023 - $15.0m, April 3, 2022 - $14.0m). Share-based compensation expense is included in SG&A expenses.
The assumptions used to measure the fair value of options granted under the Black-Scholes option pricing model at the grant date were as follows:
Year ended
March 31,
2024
April 2,
2023
Weighted average stock price valuation$19.77 $24.63 
Weighted average exercise price$19.77 $24.63 
Risk-free interest rate4.09 %2.52 %
Expected life in years5.45.0
Expected dividend yield— %— %
Volatility40 %40 %
Weighted average fair value of options issued$6.82 $7.86 
RSU and PSU fair values are determined based on the market value of the subordinate voting shares at the time of grant. As at March 31, 2024, the weighted average fair value of RSUs was $21.37 (April 2, 2023 - $24.63). As at March 31, 2024, the weighted average fair value of PSUs was $22.21.
v3.24.1.1.u2
Related party transactions
12 Months Ended
Mar. 31, 2024
Related party transactions [abstract]  
Related party transactions Related party transactions
The Company enters into transactions from time to time with its principal shareholders and organizations affiliated with members of the Board of Directors by incurring expenses for business services. During the year ended March 31, 2024, the Company had transactions with related parties of $1.1m (April 2, 2023 - $1.3m, April 3, 2022 - $1.7m) from companies related to certain shareholders. Net balances owing to related parties as at March 31, 2024 were $0.2m (April 2, 2023 - $0.4m).
A lease liability due to the previous controlling shareholder of the acquired Baffin Inc. business (the "Baffin Vendor") for leased premises was $2.5m as at March 31, 2024 (April 2, 2023 - $3.1m). During the year ended March 31, 2024, the Company paid principal and interest on the lease liability, net of rent concessions, and other operating costs to entities affiliated with the Baffin Vendor totaling $1.6m (April 2, 2023 - $1.4m, April 3, 2022 - $1.4m). No amounts were owing to Baffin entities as at March 31, 2024 and April 2, 2023.
The joint venture between the Company and the Sazaby League (“Japan Joint Venture”), has lease liabilities due to the non-controlling shareholder, Sazaby League for leased premises. Lease liabilities were $1.9m as at March 31, 2024 (April 2, 2023 - $2.7m). During the year ended March 31, 2024, the Company incurred principal and interest on lease liabilities, royalty fees, and other operating costs to Sazaby League totalling $5.2m (April 2, 2023 - $5.9m, April 3, 2022 - $nil). Balances owing to Sazaby League as at March 31, 2024 were $0.3m (April 2, 2023 - $0.2m).
During the year ended March 31, 2024, the Japan Joint Venture sold inventory of $1.5m to companies wholly owned by Sazaby League (April 2, 2023 - $1.7m, April 3, 2022 - $nil). As at
March 31, 2024, the Japan Joint Venture recognized a trade receivable of $0.1m from these companies (April 2, 2023 - $0.1m).
Pursuant to the agreement entered between the Company and Sazaby League to form the Japan Joint Venture (“Joint Venture Agreement”), during the year ended April 2, 2023 the Company sold inventory of $11.9m to Sazaby League for repurchase by the Japan Joint Venture, and subsequently the Japan Joint Venture repurchased $11.9m of inventory from Sazaby League. These transactions were measured based on pricing established through the Joint Venture Agreement at market terms and were not recognized as sales transactions. There were no similar inventory transactions for the year ended March 31, 2024. The repurchase of inventory pursuant to this Joint Venture Agreement was completed during the fourth quarter ended April 2, 2023.
In connection with the business combination during the year ended March 31, 2024, the Company recognized $1.5m of remuneration costs related to the Earn-Out based on the estimated value of $7.4m for the payout. These costs have been included in other long-term liabilities on the statement of financial position, and reflects the amount owing to the PCML Vendors as at March 31, 2024.
A lease liability due to one of the PCML Vendors for leased premises was $1.2m as at March 31, 2024. During the year ended March 31, 2024, the Company paid principal and interest on the lease liability, to one of the PCML Vendors totalling less than $0.1m. No amounts were owing to one of the PCML Vendors as at March 31, 2024.
Terms and conditions of transactions with related parties
Transactions with related parties are conducted on terms pursuant to an approved agreement, or are approved by the Board of Directors.
Key management compensation
Key management consists of the Board of Directors, the Chairman and Chief Executive Officer and the executives who report directly to the Chairman and Chief Executive Officer.
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
$$$
Short term employee benefits10.8 10.1 12.5 
Long term employee benefits0.2 0.1 0.1 
Termination benefits1.0 — — 
Share-based compensation7.3 11.2 11.5 
Compensation expense19.3 21.4 24.1 
v3.24.1.1.u2
Financial instruments and fair values
12 Months Ended
Mar. 31, 2024
Financial Instruments And Fair Value Measurement [Abstract]  
Financial Instruments and Fair Values Financial instruments and fair values
The Company’s derivative financial assets and financial liabilities are measured at fair value at the end of each reporting period. The following table gives information about how the fair values of these financial assets and financial liabilities are determined, in particular, the valuation technique(s) and inputs used.
Financial assets/
financial liabilities
Fair value hierarchy
Valuation technique(s) and key input(s)
Foreign currency forward contractsLevel 2
Future cash flows are estimated based on forward exchange rates (from observable forward exchange rates at the end of the reporting period) and contract forward rates, discounted at a rate that reflects the credit risk of various counterparties.
Foreign currency and interest rate swap contractsLevel 2
Future cash flows are estimated based on forward exchange rates (from observable forward exchange and interest swap rates at the end of the reporting period) and contract forward rates, discounted at a rate that reflects the credit risk of various counterparties.
Revolving Facility, Term Loan and Japan Facility
Level 2
The fair value is based on the present value of contractual cash flows, discounted at the Company’s current incremental borrowing rate for similar types of borrowing arrangements or, where applicable, market rates.
Mainland China Facilities
Level 3The fair value is based on the present value of contractual cash flows, discounted at the Company’s current incremental borrowing rate for similar types of borrowing arrangements or, where applicable, market rates.
Put option liabilityLevel 3
The fair value is based on the present value of the amount expected to be paid to the non-controlling shareholder if the put option is exercised.
Contingent considerationLevel 3The fair value of the applicable contingent consideration is determined based on the estimated financial outcome and the resulting expected contingent consideration to be paid, discounted using an appropriate rate.
Earn-Out (note 5)Level 3The fair value is based on a pre-determined percentage of net equity value of Paola Confectii SRL, determined as a multiple of EBITDA and EBITDA margin for the fiscal year ending March 30, 2025, subject to a floor, less net debt adjustments.
The following table presents the fair values and fair value hierarchy of the Company’s financial instruments and excludes financial instruments carried at amortized cost that are short-term in nature, where fair value approximates carrying values:
March 31,
2024
April 2,
2023
Level 1Level 2Level 3Carrying valueFair valueLevel 1Level 2Level 3Carrying valueFair value
$$$$$$$$$$
Financial assets
Derivatives included in other current assets— 15.1 — 15.1 15.1 — 12.4 — 12.4 12.4 
Derivatives included in other long-term assets— 6.9 — 6.9 6.9 — 12.4 — 12.4 12.4 
Financial liabilities
Derivatives included in accounts payable and accrued liabilities— 1.9 — 1.9 1.9 — 3.3 — 3.3 3.3 
Mainland China Facilities— — — — — — — 9.8 9.8 9.8 
Japan Facility— 5.4 — 5.4 5.4 — 13.7 — 13.7 13.7 
Term Loan— 392.5 — 392.5 389.2 — 395.7 — 395.7 433.1 
Derivatives included in other long-term liabilities— 5.3 — 5.3 5.3 — 6.0 — 6.0 6.0 
Put option liability included in other long-term liabilities— — 29.4 29.4 29.4 — — 32.1 32.1 32.1 
Contingent consideration included in other long-term liabilities— — 17.7 17.7 17.7 — — 16.8 16.8 16.8 
Earn-Out included in other long-term liabilities (note 5)— — 1.5 1.5 1.5 — — — — — 
In connection with the Japan Joint Venture, for the year ended March 31, 2024, the Company recorded an increase of JPY327.0m ($0.9m, excluding translation losses of $1.9m) on the remeasurement of the contingent consideration. The Company recorded an increase of JPY129.3m (a decrease of $2.7m, excluding translation losses of $4.3m) on the remeasurement of the put option liability during the year ended March 31, 2024. The change in fair values of the contingent consideration and put option liability were driven by updated cash flow forecasts, progression through the 4-year and 10-year terms, respectively, and lower cost of equity in the market.
For the year ended April 2, 2023, the Company recorded a decrease of JPY301.2m ($3.2m, excluding translation losses of $0.3m) on the remeasurement of the contingent consideration. The Company recorded an increase of JPY1,079.9m ($10.9m, excluding translation gains of less than $0.1m) on the remeasurement of the put option liability during the year ended April 2, 2023.
v3.24.1.1.u2
Financial risk management objectives and policies
12 Months Ended
Mar. 31, 2024
Financial Risk Management [Abstract]  
Financial risk management objectives and policies Financial risk management objectives and policies
The Company’s primary risk management objective is to protect the Company’s assets and cash flow, in order to increase the Company’s enterprise value.
The Company is exposed to capital management risk, liquidity risk, credit risk, market risk, foreign exchange risk, and interest rate risk. The Company’s senior management and Board of Directors oversee the management of these risks. The Board of Directors reviews and agrees policies for managing each of these risks which are summarized below.
Capital management
The Company manages its capital and capital structure with the objectives of safeguarding sufficient working capital over the annual operating cycle and providing sufficient financial resources to grow operations to meet long-term consumer demand. The Board of Directors of the Company monitors the Company’s capital management on a regular basis. The Company will continually assess the adequacy of the Company’s capital structure and capacity and make adjustments within the context of the Company’s strategy, economic conditions, and risk characteristics of the business.
Liquidity risk
Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company’s approach to managing liquidity is to ensure, as far as possible, that it will always have sufficient liquidity to satisfy the requirements for business operations, capital expenditures, debt service and general corporate purposes, under normal and stressed conditions. The primary source of liquidity is funds generated by operating activities; the Company also relies on the Revolving Facility, the Mainland China Facilities, and Japan Facility as sources of funds for short term working capital needs. The Company continuously reviews both actual and forecasted cash flows to ensure that the Company has appropriate capital capacity.
The following table summarizes the amount of contractual undiscounted future cash flow requirements as at March 31, 2024:
20252026202720282029ThereafterTotal
$$$$$$$
Accounts payable and accrued liabilities177.7 — — — — — 177.7 
Japan Facility5.4 — — — — — 5.4 
Term Loan4.0 4.1 4.1 380.9 — — 393.1 
Interest commitments relating to borrowings1
35.2 35.2 35.2 17.5 — — 123.1 
Lease obligations92.0 75.8 66.3 42.1 32.5 81.6 390.3 
Pension obligation— — — — — 1.8 1.8 
Total contractual obligations314.3 115.1 105.6 440.5 32.5 83.4 1,091.4 
1    Interest commitments are calculated based on the loan balance and the interest rate payable on the Japan Facility and the Term Loan of 0.45% and 8.94% respectively, as at March 31, 2024.
As at March 31, 2024, we had additional liabilities which included provisions for warranty, sales returns, asset retirement obligations, deferred income tax liabilities, the Earn-Out to the PCML Vendors, the put option liability and the contingent consideration on the Japan Joint Venture.
These liabilities have not been included in the table above as the timing and amount of future payments are uncertain.
Letter of guarantee facility
On April 14, 2020, Canada Goose Inc. entered into a letter of guarantee facility in the amount of $10.0m. Within the facility, letters of guarantee are available for terms of up to 12 months from the date of issuance and will be charged a fee equal to 1.0% per annum calculated against the face amount and over the term of the guarantee. Amounts issued on the facility will be used to finance working capital requirements through letters of guarantee, standby letters of credit, performance bonds, counter guarantees, counter standby letters of credit, or similar credits. The Company immediately reimburses the issuing bank for amounts drawn on issued letters of guarantees. At March 31, 2024, the Company had $7.4m outstanding.
In addition, a subsidiary of the Company in Mainland China entered into letters of guarantee and as at March 31, 2024 the amount outstanding was $9.1m. Amounts will be used to support retail operations of such subsidiaries through letters of guarantee, standby letters of credit, performance bonds, counter guarantees, counter standby letters of credit, or similar credits.
Credit risk
Credit risk is the risk that a counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial loss.
Credit risk arises from the possibility that certain parties will be unable to discharge their obligations. The Company manages its credit risk through a combination of third party credit insurance and internal house risk. Credit insurance is provided by a third party for customers and is subject to continuous monitoring of the credit worthiness of the Company's customers. Insurance covers a specific amount of revenue, which may be less than the Company's total revenue with a specific customer. The Company has an agreement with a third party who has insured the risk of loss for up to 90% of trade accounts receivable from certain designated customers subject to a total deductible of $0.1m, to a maximum of $30.0m per year. As at March 31, 2024, trade accounts receivable totaling approximately $14.8m (April 2, 2023 - $10.3m) were insured subject to the policy cap. Complementary to the third party insurance, the Company establishes payment terms with customers to mitigate credit risk and continues to closely monitor its trade accounts receivable credit risk exposure.
Within CG Japan, the Company has an agreement with a third party who has insured the risk of trade accounts receivable for certain designated customers for a maximum of JPY540.0m per annum subject to a deductible of 10% and applicable only to accounts with receivables over JPY100k. As at March 31, 2024, trade accounts receivable totalling approximately $0.3m (JPY32.5m) were insured subject to the policy cap (April 2, 2023 - $0.7m (JPY72.8m)).
Customer deposits are received in advance from certain customers for seasonal orders to further mitigate credit risk, and applied to reduce accounts receivable when goods are shipped. As at March 31, 2024, customer deposits of $22.9m (April 2, 2023 - $0.2m) were included in accounts payable and accrued liabilities.
The aging of trade receivables was as follows:
Past due
TotalCurrent
< 30 days
31-60 days
> 61 days
 $ $ $ $ $
Trade accounts receivable57.1 33.5 10.0 5.1 8.5 
Credit card receivables3.7 3.7 — — — 
Other receivables12.3 11.8 0.3 — 0.2 
March 31, 202473.1 49.0 10.3 5.1 8.7 
Trade accounts receivable30.4 22.2 4.4 1.1 2.7 
Credit card receivables2.5 2.5 — — — 
Other receivables19.5 18.9 0.5 — 0.1 
April 2, 202352.4 43.6 4.9 1.1 2.8 
Trade accounts receivable factoring program
A subsidiary of the Company in Europe has an agreement to factor, on a limited recourse basis, certain of its trade accounts receivable up to a limit of EUR20.0m in exchange for advanced funding equal to 100% of the principal value of the invoice. Accepted currencies include euros, British pounds sterling, and Swiss francs. The Company is charged a fee of the applicable sterling overnight index average reference rate plus 1.15% per annum, based on the number of days between the purchase date and the invoice due date, which is lower than the Company’s average borrowing rate under its Revolving Facility. The program is utilized to provide sufficient liquidity to support its international operating cash needs. Upon transfer of the receivables, the Company receives cash proceeds and continues to service the receivables on behalf of the third-party financial institution. The program meets the derecognition requirements in accordance with IFRS 9, Financial Instruments as the Company transfers substantially all the risks and rewards of ownership upon the sale of a receivable. These proceeds are classified as cash flows from operating activities in the statement of cash flows.
For the year ended March 31, 2024, the Company received total cash proceeds from the sale of trade accounts receivable with carrying values of $46.3m which were derecognized from the Company's statement of financial position (April 2, 2023 - $45.7m). Fees of $0.4m were incurred during the year ended March 31, 2024 (April 2, 2023 - $0.3m) and included in net interest, finance and other costs in the statements of income. As at March 31, 2024, the outstanding amount of trade accounts receivable derecognized from the Company’s statement of financial position, but which the Company continued to service was $0.6m (April 2, 2023 - $1.1m). Subsequent to the year ended March 31, 2024, the Company has terminated its factoring program.
Market risk
Market risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market prices. Market prices comprise foreign exchange risk and interest rate risk.
Foreign exchange risk
Foreign exchange risk in operating cash flows
The Company’s consolidated financial statements are expressed in Canadian dollars, but a substantial portion of the Company’s revenues, purchases, and expenses are denominated in other currencies, primarily U.S. dollars, euros, British pounds sterling, Swiss francs, Chinese yuan, Hong Kong dollars and Japanese yen. The Company has entered into forward foreign exchange contracts to reduce the foreign exchange risk associated with revenues, purchases, and expenses denominated in these currencies. Certain forward foreign exchange contracts were designated at inception and accounted for as cash flow hedges.
Revenues and expenses of all foreign operations are translated into Canadian dollars at the foreign currency exchange rates that approximate the rates in effect at the dates when such items are recognized. As a result, we are exposed to foreign currency translation gains and losses. Appreciating foreign currencies relative to the Canadian dollar, to the extent they are not hedged, will positively impact operating income and net income by increasing our revenue, while depreciating foreign currencies relative to the Canadian dollar will have the opposite impact.
The Company recognized the following unrealized gains and losses in the fair value of derivatives designated as cash flow hedges in other comprehensive income:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
Net gainTax recoveryNet lossTax recoveryNet lossTax expense
$$$$$$
Forward foreign exchange contracts designated as cash flow hedges1.3 0.1 (3.7)0.9 (4.5)(0.1)
The Company reclassified the following losses and gains from other comprehensive income on derivatives designated as cash flow hedges to locations in the consolidated financial statements described below:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
Loss (gain) from other comprehensive income$$$
Forward foreign exchange contracts designated as cash flow hedges
Revenue1.8 5.5 3.9 
SG&A expenses(0.4)0.1 (0.4)
Inventory0.5 0.8 (0.9)
During the year ended March 31, 2024, an unrealized gain of $1.7m (April 2, 2023 - unrealized gain of $4.5m, April 3, 2022 - unrealized gain of $4.7m) on forward exchange contracts that were not treated as hedges was recognized in SG&A expenses in the statements of income.
Foreign currency forward exchange contracts outstanding as at March 31, 2024 related to operating cash flows were:
(in millions)Aggregate AmountsCurrency
Forward contract to purchase Canadian dollarsUSD62.1 U.S. dollars
89.3 euros
¥2,085.8 Japanese yen
Forward contract to sell Canadian dollarsUSD22.4 U.S. dollars
40.1 euros
Forward contract to purchase eurosCNY 525.4 Chinese yuan
£25.5 British pounds sterling
HKD32.9 Hong Kong dollars
CHF 0.1 Swiss francs
Forward contract to sell eurosCHF 3.3 Swiss francs
£1.5 British pounds sterling
CNY 9.2 Chinese yuan
HKD7.0 Hong Kong dollars
Foreign exchange risk on borrowings
The Company enters into derivative transactions to hedge a portion of its exposure to interest rate risk and foreign currency exchange risk related to principal and interest payments on the Term Loan denominated in U.S. dollars (see “Note 17. Borrowings”). The Company also entered into a five-year forward exchange contract by selling $368.5m and receiving USD270.0m as measured on the trade date, to fix the foreign exchange risk on a portion of the term loan borrowings.
The Company recognized the following unrealized losses and gains in the fair value of derivatives designed as hedging instruments in other comprehensive income:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
Net lossTax recoveryNet gainTax expenseNet gainTax expense
$$$$$$
Swaps designated as cash flow hedges(1.8)0.3 4.1 (0.8)13.2 (4.5)
The Company reclassified the following gains and losses from other comprehensive income on derivatives designated as hedging instruments to net interest, finance and other costs:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
(Gain) loss from other comprehensive income$$$
Swaps designated as cash flow hedges(2.0)0.5 0.9 
During the year ended March 31, 2024, an unrealized loss of $1.3m (April 2, 2023 - unrealized gain of $17.5m, April 3, 2022 - unrealized loss of $4.6m) in the fair value of the long-dated forward exchange contract related to a portion of the Term Loan balance has been recognized in net interest, finance and other costs in the consolidated statements of income.
Interest rate risk
The Company is exposed to interest rate risk related to the effect of interest rate changes on the borrowings outstanding under the Japan Facility, and the Term Loan, which currently bear interest rates at 0.45%, and 8.94%, respectively.
Interest rate risk on the Term Loan is partially mitigated by interest rate swap hedges. The Company entered into five-year interest rate swaps agreements terminating December 31, 2025 to pay fixing interest rate and receiving floating interest rates on notional debt of USD270.0m. Effective June 30, 2023, the floating interest benchmark reference rate contained within the swap agreements were amended from LIBOR to SOFR and the average fixed rates were reduced from 1.97% to 1.76%. These swap agreements fix the interest rate on the USD300.0m Term Loan. Following the amendment, the interest rate swaps continue to be designated and accounted for as cash flow hedges.
Based on the closing balance of outstanding borrowings, a 1.00% increase in the closing interest rate during the year ended March 31, 2024 would have increased interest expense on the Japan Facility and the Term Loan before hedging by $0.1m and $3.9m, respectively (April 2, 2023 - $0.3m, and $3.9m, respectively).
Until the third quarter ended December 31, 2023, the Company calculated interest rate sensitivity on debt facilities using the average balance of the facility and average interest rate in the reporting period. Following the third quarter, and applicable for the fourth quarter and fiscal year ended March 31, 2024, the Company calculated interest rate sensitivity on debt facilities using the closing balance of the facility and the closing interest rate. The Company believes this change provides more relevant information on interest rate sensitivity. The Company has recognized this change as a change in estimates and had adjusted the disclosure prospectively.
v3.24.1.1.u2
Selected cash flow information
12 Months Ended
Mar. 31, 2024
Cash Flow Information [Abstract]  
Selected cash flow information Selected cash flow information
Changes in non-cash operating items
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
$$$
Trade receivables(12.4)(4.6)(8.7)
Inventories27.2 (49.9)(60.7)
Other current assets2.8 (9.4)(3.4)
Accounts payable and accrued liabilities(9.5)(16.8)(8.5)
Provisions5.2 9.0 3.7 
Other(2.8)(3.7)(5.2)
Change in non-cash operating items10.5 (75.4)(82.8)
Changes in liabilities and equity arising from financing activities
Mainland China FacilitiesJapan FacilityRevolving FacilityTerm LoanLease liabilitiesShare capital
$$$$$$
April 2, 20239.8 13.7 (0.5)395.7 334.8 118.7 
Cash flows:
Mainland China Facilities borrowings(9.8)— — — — — 
Japan Facility borrowings— (8.3)— — — — 
Term Loan repayments— — — (4.0)— — 
Transactions costs on financing activities— — (0.1)(0.1)— — 
Normal course issuer bid purchase of subordinate voting shares— — — — — (140.2)
Principal payments on lease liabilities— — — — (69.2)— 
Issuance of shares— — — — — 0.1 
Additions from business combination— — — — 1.2 — 
Non-cash items:
Accrued transaction costs— — (0.7)— — — 
Amortization of deferred transaction costs— — 0.3 0.2 — — 
Unrealized foreign exchange loss (gain)— — — 0.7 (2.2)— 
Additions and amendments to lease liabilities (note 13)— — — — 65.9 — 
Share purchase charge to retained earnings (note 18)— — — — — 122.4 
Contributed surplus on share issuances (note 18)— — — — — 3.9 
March 31, 2024— 5.4 (1.0)392.5 330.5 104.9 
Mainland China Facilities
Japan FacilityRevolving Facility
Term Loan
Lease liabilitiesNet derivative asset on terminated contracts Share capital
$$$$$$$
April 3, 2022— — (0.9)370.0 250.7 (7.3)118.5 
Cash flows:
Cash inflow from business combination— 19.4 — — 3.2 — — 
Mainland China Facilities borrowings9.8 — — — — — — 
Japan Facility repayments— (5.7)— — — — — 
Term Loan repayments— — — (4.0)— — — 
Normal course issuer bid purchase of subordinate voting shares— — — — — — (26.7)
Principal payments on lease liabilities— — — — (62.2)— — 
Settlement of term loan derivative contracts — — — — — 8.6 — 
Non-cash items:
Amortization of deferred transaction costs — — 0.4 0.2 — — — 
Fair market valuation— — — — — (0.6)— 
Unrealized foreign exchange loss (gain)— — — 29.5 11.5 (0.7)— 
Additions and amendments to lease liabilities (note 13)— — — — 132.3 — — 
Derecognition on termination of lease liabilities (note 13)— — — — (0.7)— — 
Share purchase charge to retained earnings (note 18)— — — — — — 24.3 
Normal course issuer bid purchase of subordinate voting shares held for cancellation (note 18)— — — — — — (0.1)
Contributed surplus on share issuances (note 18)— — — — — — 2.7 
April 2, 20239.8 13.7 (0.5)395.7 334.8 — 118.7 
v3.24.1.1.u2
Subsequent Events
12 Months Ended
Mar. 31, 2024
Disclosure of non-adjusting events after reporting period [abstract]  
Subsequent Events Subsequent Events
Subsequent to the year ended March 31, 2024, the Company and Sazaby League amended the Joint Venture Agreement to extend the period by which the deferred contingent consideration is payable if an agreed cumulative adjusted EBIT target is not reached through the period ended June 30, 2026 to April 2, 2028.
Subsequent to the year ended March 31, 2024, the Company has terminated its trade receivables factoring program.
v3.24.1.1.u2
Schedule I - Condensed Financial Information of Canada Goose Holdings Inc.
12 Months Ended
Mar. 31, 2024
Consolidated And Separate Financial Statements [Abstract]  
Schedule I - Condensed Financial Information of Canada Goose Holdings Inc.
SCHEDULE I – CONDENSED FINANCIAL INFORMATION OF
CANADA GOOSE HOLDINGS INC.
(PARENT COMPANY)
All operating activities of Canada Goose Holdings Inc. (the “Parent Company”) are conducted by its subsidiaries. The Parent Company is a holding company and does not have any material assets or conduct business operations other than investments in its subsidiaries. The credit agreement of Canada Goose Inc., a wholly owned subsidiary of the Parent Company, contains provisions whereby Canada Goose Inc. has restrictions on the ability to pay dividends, loan funds and make other upstream distributions to the Parent Company.
These condensed parent company financial statements have been prepared using the same accounting principles and policies described in the notes to the consolidated financial statements. See the consolidated financial statements and notes presented above for additional information and disclosures with respect to these condensed financial statements.
Schedule I – Condensed Statements of Income
(in millions of Canadian dollars)
 
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
$$$
Equity in comprehensive income of subsidiary63.6 97.5 88.6 
Fee income from subsidiary6.9 10.2 10.8 
70.5 107.7 99.4 
Selling, general and administration expenses16.7 16.8 16.9 
Net interest, finance and other costs— 0.5 1.9 
Income before income taxes53.8 90.4 80.6 
Income tax recovery(2.5)(1.6)(2.0)
Net income56.3 92.0 82.6 
Attributable to:
Shareholders of the Company57.8 95.7 82.6 
Non-controlling interest(1.5)(3.7)— 
Net income56.3 92.0 82.6 
The accompanying notes to the condensed financial statements are an integral part of these financial statements.
Schedule I – Condensed Statements of Financial Position
(in millions of Canadian dollars)
 
 March 31,
2024
April 2,
2023
Reclassified
Assets$$
Current assets
Cash— 6.9 
Total current assets— 6.9 
Note receivable from subsidiary92.6 76.4 
Investment in subsidiary408.9 479.8 
Deferred income taxes13.4 10.9 
Total assets514.9 574.0 
Liabilities
Current liabilities
Accounts payable and accrued liabilities1.6 20.1 
Due to subsidiary60.4 44.3 
Total current liabilities62.0 64.4 
Other non-current liabilities29.4 32.1 
Total liabilities91.4 96.5 
Equity
Equity attributable to shareholders of the Company417.0 469.5 
Non-controlling interests6.5 8.0 
Total equity423.5 477.5 
Total liabilities and equity514.9 574.0 
The accompanying notes to the condensed financial statements are an integral part of these financial statements.
Schedule I – Condensed Statements of Changes in Equity
(in millions of Canadian dollars)
 
Share capitalContributed surplusRetained earnings Total attributable to shareholdersNon-controlling interestTotal
$$$$$$
Balance at March 28, 2021120.5 25.2 431.9 577.6 — 577.6 
Normal course issuer bid purchase of subordinate voting shares(11.9)— (241.3)(253.2)— (253.2)
Issuance of shares9.9 (2.8)— 7.1 — 7.1 
Net income— — 82.6 82.6 — 82.6 
Share-based payment— 14.0 — 14.0 — 14.0 
Deferred tax on share-based payment— (0.2)— (0.2)— (0.2)
Balance at April 3, 2022118.5 36.2 273.2 427.9 — 427.9 
Non-controlling interest on business combination— — — — 11.7 11.7 
Put option for non-controlling interest— — (21.2)(21.2)— (21.2)
Normal course issuer bid purchase of subordinate voting shares(2.4)— (24.3)(26.7)— (26.7)
Normal course issuer bid purchase of subordinate voting shares held for cancellation(0.1)— (1.1)(1.2)— (1.2)
Liability to broker under automatic share purchase plan— (20.0)— (20.0)— (20.0)
Issuance of shares2.7 (2.7)— — — — 
Net income— — 95.7 95.7 (3.7)92.0 
Share-based payment— 15.0 — 15.0 — 15.0 
Balance at April 2, 2023118.7 28.5 322.3 469.5 8.0 477.5 
Normal course issuer bid purchase of subordinate voting shares(17.8)— (122.4)(140.2)— (140.2)
Liability to broker under automatic share purchase plan— 20.0 — 20.0 — 20.0 
Issuance of shares4.0 (3.9)— 0.1 — 0.1 
Net income— — 57.8 57.8 (1.5)56.3 
Share-based payment— 9.8 — 9.8 — 9.8 
Balance at March 31, 2024104.9 54.4 257.7 417.0 6.5 423.5 
The accompanying notes to the condensed financial statements are an integral part of these financial statements.
Schedule I – Condensed Statements of Cash Flows
(in millions of Canadian dollars)
 
Year ended
 March 31,
2024
April 2,
2023
April 3,
2022
$$$
Operating activities
Net income56.3 92.0 82.6 
Items not affecting cash:
Equity in undistributed earnings of subsidiary(63.6)(97.5)(88.6)
Net interest expense— 0.5 1.9 
Income tax recovery(2.5)(1.6)(2.0)
Share-based compensation9.8 15.0 14.0 
— 8.4 7.9 
Changes in assets and liabilities1.7 (493.5)(20.2)
Intercompany accounts payable— 240.0 242.5 
Net cash from (used in) operating activities1.7 (245.1)230.2 
Investing activities
Dividend received131.5 198.4 — 
Investment in shares of subsidiary— 80.0 — 
Net cash from investing activities131.5 278.4 — 
Financing activities
Subordinate voting shares purchased and cancelled under NCIB(140.2)(26.7)(241.3)
Exercise of stock options0.1 — 7.1 
Net cash used in financing activities(140.1)(26.7)(234.2)
(Decrease) increase in cash(6.9)6.6 (4.0)
Cash, beginning of year6.9 0.3 4.3 
Cash, end of year— 6.9 0.3 
The accompanying notes to the condensed financial statements are an integral part of these financial statements.
Schedule I – Notes to the Condensed Financial Statements
(in millions of Canadian dollars)

1.BASIS OF PRESENTATION
The Parent Company is a holding company that conducts substantially all of its business operations through its subsidiaries. The Parent Company (a British Columbia corporation) was incorporated on November 21, 2013.
The Parent Company has accounted for the earnings of its subsidiaries under the equity method in these unconsolidated condensed financial statements.
Certain comparative figures have been reclassified to conform with the current year presentation.
2.TRANSACTIONS WITH SUBSIDIARIES
The Parent Company received cash dividends from its consolidated subsidiaries totaling $131.5m during the year ended March 31, 2024, $198.4m dividends were received for the year ended April 2, 2023, and no dividends were received for the year ended April 3, 2022.
3.COMMITMENTS AND CONTINGENCIES
The Parent Company has no material commitments or contingencies during the reported periods.
4.SHAREHOLDERS’ EQUITY
See the Annual Consolidated Financial Statements note 18 Shareholders’ equity during the year ended March 31, 2024.
v3.24.1.1.u2
Insider Trading Policies and Procedures
12 Months Ended
Mar. 31, 2024
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.24.1.1.u2
Material accounting policy information (Policies)
12 Months Ended
Mar. 31, 2024
Accounting Policies, Changes In Accounting Estimates And Errors [Abstract]  
Statement of compliance
Statement of compliance
The consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).
Operating segments
Operating segments
The Company classifies its business in three operating and reportable segments: Direct-to-Consumer (“DTC”), Wholesale, and Other. The DTC segment comprises sales through country-specific e-Commerce platforms available across numerous markets, which includes the newly launched recommerce platform Canada Goose Generations, currently available in the United States and Canada, and our Company-owned retail stores located in luxury shopping locations.
The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market. The Wholesale segment includes the introduction of travel retail in the second quarter of fiscal 2024.
The Other segment comprises revenue and costs that are not related to the Company’s DTC or Wholesale segments, such as sales to employees, friends and family sales, and results from the
newly acquired Paola Confectii business (see "Note 5. Business Combinations" for details and definitions).
Seasonality
Seasonality
Our business is seasonal, and we have historically realized a significant portion of our Wholesale revenue and operating income in the second and third quarters of the fiscal year and DTC revenue and operating income in the third and fourth quarters of the fiscal year. Thus, lower-than-expected revenue in these periods could have an adverse impact on our annual operating results.
Cash flows from operating activities are typically highest in the third and fourth quarters of the fiscal year due to revenue from the DTC segment and the collection of trade receivables from Wholesale revenue earlier in the year. Working capital requirements typically increase as inventory builds. Borrowings have historically increased in the first and second quarters and been repaid in the third quarter of the fiscal year.
Basis of presentation Basis of presentation
The consolidated financial statements are presented in Canadian dollars, the Company’s functional and presentation currency.
These consolidated financial statements have been prepared on the historical cost basis except for the following items, which are recorded at fair value:
financial instruments, including derivative financial instruments, at fair value in other comprehensive income and through profit or loss as described in “Note 21. Financial instruments and fair values” and
initial recognition of assets acquired and liabilities assumed in a business combination.
Certain comparative figures have been reclassified to conform with the current year presentation. Foreign exchange gains and losses related to the outstanding principal balance on the Term Loan, net of hedging, are reflected in the presentation of net interest, finance and other costs as outlined below (see “Note 17. Borrowings” for details and definitions); previously this was presented in SG&A expenses. This change was made to present all financing costs related to the Term Loan within the same financial statement caption in the consolidated statements of income. For the year ended April 2, 2023 and April 3, 2022, the Company reclassified foreign exchange losses of $12.1m and $2.8m, respectively. This reclassification did not impact net income, earnings per share, or the consolidated statements of financial position in the comparative year.
As at March 31, 2024, the Company amended the allocation basis for certain SG&A expenses between the operating segments to provide more relevant information on financial performance of each operating segment. The reclassification did not impact net income, earnings per share, or the consolidated statements of financial position in the comparative year. Comparative figures have been reclassified to conform with the current year presentation.
Principles of consolidation Principles of consolidation
The consolidated financial statements include the accounts of Canada Goose Holdings Inc. and its subsidiaries. All intercompany transactions and balances have been eliminated.
Foreign currency translation and transactions Foreign currency translation and transactions
The functional currency of each of the Company’s subsidiaries is the currency of the primary economic environment in which each entity operates. The assets and liabilities of subsidiaries whose functional currency is not the Canadian dollar are translated into the functional currency of the Company using the exchange rate at the reporting date. Revenues and expenses are translated at exchange rates prevailing at the transaction date. The resulting foreign exchange translation differences are recorded as a currency translation adjustment in other comprehensive income.
Foreign currency transactions are translated into the functional currency of each of the Company’s subsidiaries using the exchange rates prevailing at the date of the transactions or valuation when items are remeasured. Foreign exchange gains and losses resulting from the settlement of such transactions and from the changes at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the statements of income in SG&A expenses, except when included in other comprehensive income for qualifying cash flow and net investment hedges.
    Functional currency of subsidiary
Each entity within the Company determines its functional currency based on the primary economic environment in which the entity operates. Once an entity's functional currency is determined, it is not changed unless there is a change to the underlying transactions, events, and conditions that determine the entity's primary economic environment.
Revenue recognition Revenue recognition
Revenue comprises DTC, Wholesale and Other segment revenues. Revenue is measured at the amount of consideration to which the Company expects to be entitled in exchange for the sale of goods in the ordinary course of the Company’s activities. Revenue is presented net of sales tax, estimated returns, sales allowances, and discounts. The Company recognizes revenue when the Company has agreed terms with its customers, the contractual rights and payment terms have been identified, the contract has commercial substance, it is probable that consideration will be collected by the Company, and when control of the goods is transferred to the customer.
It is the Company’s policy to sell merchandise through the DTC channel with a limited right of return, typically within 30 days. Accumulated experience is used to estimate and provide for such returns.
Business combination Business combination
Acquisitions of businesses are accounted for using the acquisition method as of the acquisition date, which is the date when control is transferred to the Company. The consideration transferred in a business combination is measured at fair value, calculated as the sum of the acquisition date fair values of the assets transferred, liabilities incurred by the Company, and the equity interests issued by the Company in exchange for control of the acquiree. Transaction costs that the Company incurs in connection with a business combination are recognized in the statements of income as incurred.
Goodwill is measured as the excess of the sum of the fair value of the consideration transferred over the net of the acquisition date amounts of the identifiable assets acquired and the liabilities assumed.
When the consideration transferred in a business combination includes contingent consideration, the contingent consideration is measured at its acquisition date fair value. Contingent consideration is remeasured at subsequent reporting dates at its fair value, and the resulting gain or loss recognized in the statements of income.
Non-controlling interest Non-controlling interest
Non-controlling interest is measured based on the proportionate share of the acquiree's identifiable net assets. Transactions with non-controlling interests are treated as transactions with equity owners of the Company. Changes in the Company's ownership interest are accounted for as equity transactions.
Earnings per share Earnings per share
Basic earnings per share is calculated by dividing net income attributable to ordinary equity holders by the weighted average number of multiple and subordinate voting shares outstanding during the year.
Diluted earnings per share is calculated by dividing net income attributable to ordinary equity holders of the Company by the weighted average number of multiple and subordinate voting shares outstanding during the year plus the weighted average number of subordinate shares that would be issued on the exercise of stock options and settlement of restricted share units (“RSUs”) and performance share units (“PSUs”).
Income taxes Income taxes
Current and deferred income taxes are recognized in the statements of income, except when it relates to a business combination, or items recognized in equity or in other comprehensive income.
Current income tax
Current income tax is the expected income tax payable or receivable on the taxable income or loss for the period, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to income tax payable in respect of previous years.
Deferred income tax
Deferred income tax is provided using the liability method for temporary differences at the reporting date between the income tax bases of assets and liabilities and their carrying amounts for financial reporting purposes.
Deferred income tax is measured using enacted or substantively enacted income tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled. A deferred tax asset is recognized for unused income tax losses and credits to the extent that it is probable that future taxable income will be available against which they can be utilized.
The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable income will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are reassessed at each reporting date and are recognized to the extent that it has become probable that future taxable income will allow the deferred tax asset to be recovered.
Deferred income tax relating to items recognized outside profit or loss is recognized outside profit or loss. Deferred tax items are recognized in correlation to the underlying transaction either in other comprehensive income or directly in equity.
Deferred tax assets and deferred tax liabilities are offset if a legally enforceable right exists to set off current income tax assets against current income tax liabilities and the deferred tax relates to the same taxable entity and the same taxation authority.
Deferred income tax is provided on temporary differences arising on investments in subsidiaries, except where the timing of the reversal of the temporary difference is controlled by the Company and it is probable that the temporary difference will not reverse in the foreseeable future.
As disclosed in Note 4. Changes in accounting policies, the Company has applied the mandatory exception to recognizing and disclosing information about deferred tax assets and liabilities related to Pillar Two rules in accordance with amendments to IAS 12 Income Taxes.
Deferred income tax
Deferred income tax
Deferred income tax is provided using the liability method for temporary differences at the reporting date between the income tax bases of assets and liabilities and their carrying amounts for financial reporting purposes.
Deferred income tax is measured using enacted or substantively enacted income tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled. A deferred tax asset is recognized for unused income tax losses and credits to the extent that it is probable that future taxable income will be available against which they can be utilized.
The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable income will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are reassessed at each reporting date and are recognized to the extent that it has become probable that future taxable income will allow the deferred tax asset to be recovered.
Deferred income tax relating to items recognized outside profit or loss is recognized outside profit or loss. Deferred tax items are recognized in correlation to the underlying transaction either in other comprehensive income or directly in equity.
Deferred tax assets and deferred tax liabilities are offset if a legally enforceable right exists to set off current income tax assets against current income tax liabilities and the deferred tax relates to the same taxable entity and the same taxation authority.
Deferred income tax is provided on temporary differences arising on investments in subsidiaries, except where the timing of the reversal of the temporary difference is controlled by the Company and it is probable that the temporary difference will not reverse in the foreseeable future.
As disclosed in Note 4. Changes in accounting policies, the Company has applied the mandatory exception to recognizing and disclosing information about deferred tax assets and liabilities related to Pillar Two rules in accordance with amendments to IAS 12 Income Taxes.
Cash Cash
Cash consists of cash and cash equivalents, including cash on hand, deposits in banks, and short-term deposits with maturities of less than three months. The Company uses the indirect method of reporting cash flows from operating activities.
Trade receivables Trade receivables
Trade receivables, including credit card receivables, consist of amounts owing on product sales where we have extended credit to customers, and are initially recognized at fair value and subsequently measured at amortized cost using the effective interest method, less expected credit loss and sales allowances. The allowance for expected credit losses is recorded against trade receivables and is based on historical experience.
Inventories Inventories
Raw materials, work-in-process, and finished goods are valued at the lower of cost and net realizable value. Cost is determined using the weighted average cost method. The cost of work-in-process and finished goods inventories include the cost of raw materials and an applicable share of the cost of labour and fixed and variable production overhead costs, including the depreciation of property, plant and equipment used in the production of finished goods, design costs, and other costs incurred to bring the inventories to their present location and condition.
The Company estimates net realizable value as the amount at which inventories are expected to be sold, taking into consideration fluctuations in selling prices due to seasonality, less estimated costs necessary to complete the sale.
Inventories are written down to net realizable value when the cost of inventories is estimated to be unrecoverable due to obsolescence, damage, or declining selling prices. Inventory is adjusted to reflect estimated loss (“shrinkage”) incurred since the last inventory count. Shrinkage is based on historical experience. When circumstances that previously caused inventories to be written down below cost no longer exist or when there is clear evidence of an increase in realizable value, the amount of the write-down previously recorded is reversed.
Storage costs, indirect administrative overhead and certain selling costs related to inventories are expensed in the period that these costs are incurred.
Property, plant and equipment Property, plant and equipment
Property, plant and equipment is stated at cost, net of accumulated depreciation and any accumulated impairment losses. Cost includes expenditures that are directly attributable to the acquisition of the asset, including costs incurred to prepare the asset for its intended use and capitalized borrowing costs, when the recognition criteria are met. The commencement date for capitalization of costs occurs when the Company first incurs expenditures for the qualifying assets and undertakes the required activities to prepare the assets for their intended use.
Property, plant and equipment assets are depreciated on a straight-line basis over their estimated useful lives when the assets are available for use. When significant parts of a fixed asset have different useful lives, they are accounted for as separate components and depreciated separately. Depreciation methods and useful lives are reviewed annually and are adjusted for prospectively, if appropriate. Estimated useful lives are as follows:
Asset CategoryEstimated Useful Life
Plant equipment (except moulds)10 years
Footwear moulds5 years
Computer equipment3 years
Leasehold improvementsLesser of the lease term or useful life of the asset
Show displays5 years
Furniture and fixtures
5 to 10 years
An item of property, plant and equipment and any significant part initially recognized is derecognized upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising on derecognition of the asset, calculated as the difference between the net disposal proceeds and the carrying amount of the asset, is included in the statements of income when the asset is derecognized.
The cost of repairs and maintenance of property, plant and equipment is expensed as incurred and recognized in the statements of income.
Property, plant and equipment are reviewed at the end of each reporting period to determine whether there is any indication of impairment. If any such indication exists, the asset is then tested for impairment by comparing its recoverable amount to its carrying value. Impairment losses are recorded in the statements of income.
Intangible assets Intangible assets
Intangible assets acquired separately are measured on initial recognition at cost. The cost of an intangible asset acquired in a business combination is its fair value as at the date of acquisition. Following initial recognition, intangible assets with finite lives are carried at cost less any accumulated amortization and any accumulated impairment losses.
The useful lives of intangible assets are assessed as either finite or indefinite.
Asset CategoryEstimated Useful Life
Brand nameIndefinite
Domain nameIndefinite
Software
5 to 7 years
Intellectual property
1 to 8 years
Customer lists (Canada Goose)10 years
Customer lists (Paola Confectii SRL)4 years
Distribution rights10 years
In connection with the acquisition of the business of Paola Confectii SRL during fiscal 2024 (See “Note 5. Business combinations” for more details), identifiable intangible assets acquired consist of the customer list and brand.
Intangible assets with indefinite useful lives consists of the Canada Goose, Baffin, and Paola Confectii SRL brand names, as well as the Canada Goose and Baffin domain names, which were acquired as part of an acquisition and were recorded at their estimated fair value. The brand names and domain name are considered to have an indefinite life based on a history of revenue and cash flow performance, and the intent and ability of the Company to support the brand with spending to maintain its value for the foreseeable future. The brand names and domain name are tested at least annually for impairment, at the cash-generating unit (“CGU”) level. The assessment of indefinite life is reviewed annually to determine whether the indefinite life assessment continues to be supportable. If not, the change in the useful life assessment from indefinite to finite is made on a prospective basis.
Intangible assets with finite lives are amortized over the useful economic life on a straight-line basis. The amortization period and the amortization method for an intangible
asset with a finite useful life are reviewed at least at the end of each reporting period. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate, and treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in the statements of income over the asset’s estimated useful life.
An intangible asset is derecognized on disposal or when no future economic benefits are expected from its use. Gains or losses arising from the derecognition of an intangible asset are measured as the difference between the net disposal proceeds and the carrying amount of the asset and are included in the statements of income when the asset is derecognized.
Intangible assets are reviewed at the end of each reporting period to determine whether there is any indication of impairment. If any such indication exists, the asset is then tested for impairment by comparing its recoverable amount to its carrying value. Any resulting impairment loss is recorded in the statements of income.
Leases Leases
The Company recognizes a right-of-use asset and a lease liability based on the present value of the future lease payments at the commencement date. The commencement date is when the lessor makes the leased asset available for use by the Company, typically the possession date. The discount rate used in the present value calculation for lease payments is the incremental borrowing rate, if the rate implicit in the lease is not readily determinable, for each leased asset or portfolio of leased assets with similar characteristics by reference to the Company’s creditworthiness, the security, term and value of the underlying leased asset, and the economic environment in which the leased asset operates. The lease term is determined as the non-cancellable periods of a lease, together with periods covered by a renewal option if the Company is reasonably certain to exercise that option and a termination option if the Company is reasonably certain not to exercise that option.
Leases of low-value assets and short-term leases are not included in the calculation of lease liabilities. These lease expenses are recognized in cost of sales or SG&A expenses on a straight-line or other systematic basis.
    Lease liabilities
Lease liabilities are measured at the present value of future lease payments, discounted using the Company’s incremental borrowing rates, and include the fixed payments, variable lease payments that depend on an index or a rate, less any lease incentives receivable. Subsequent to initial measurement, the Company measures lease liabilities at amortized cost using the effective interest rate method. Lease liabilities are remeasured when there are changes to the lease payments, lease term, assessment of an option to purchase the underlying asset, expected residual value guarantee, or future lease payments due to a change in the index or rate tied to the payment.
    Right-of-use assets
Right-of-use assets are measured at the initial amount of the lease liabilities, lease payments made at or before the commencement date less any lease incentives received, initial direct costs, if any, and decommissioning costs to restore the site to the
condition required by the terms and conditions of the lease, and net of accumulated impairment losses. Subsequent to initial measurement, the Company applies the cost model to the right-of-use assets and measures the asset at cost less any accumulated depreciation, accumulated impairment losses in accordance with IAS 36, Impairment of Assets and any remeasurements of the lease liabilities. Assets are depreciated from the commencement date on a straight-line basis over the earlier of the end of the assets’ useful lives or the end of the lease terms.
Right-of-use assets are reviewed at the end of each reporting period to determine whether there is any indication of impairment. If any such indication exists, the asset is then tested for impairment by comparing its recoverable amount to its carrying value. Impairment losses are recorded in the statements of income.
Goodwill Goodwill
Goodwill represents the difference between the purchase price of an acquired business and the Company’s share of the net identifiable assets acquired and liabilities assumed and any contingent liabilities assumed. It is initially recorded at cost and subsequently measured at cost less any accumulated impairment losses.
For the purpose of impairment testing, goodwill acquired in a business combination is, from the acquisition date, allocated to CGUs based on the lowest level within the entity in which the goodwill is monitored for internal management purposes. The allocation is made to the CGUs that are expected to benefit from the business combination in which the goodwill arose. Any potential impairment of goodwill is identified by comparing the recoverable amount of a CGU to its carrying value. An impairment loss is recognized if the carrying amount of CGU exceeds its recoverable amount. Any loss identified is first applied to reduce the carrying amount of goodwill allocated to the CGU, and then to reduce the carrying amounts of the remaining assets in the CGU on a pro-rata basis. The Company tests goodwill for impairment annually at the reporting date.
The recoverable amount of a CGU is the higher of the estimated fair value less costs of disposal or value-in-use of the CGU. In assessing the recoverable amount, the estimated future cash flows are discounted using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset.
The Company has determined that there are 12 CGUs, 11 for which goodwill contributes to the cash flows (April 2, 2023 - 11 CGUs, 10 for which goodwill contributed to the cash flows). The increase in CGUs from the comparative period is attributable to the Paola Confectii acquisition which represents an additional CGU. No other changes were made to the existing CGUs from the previous year. See “Note 5. Business combinations” for more details.
Provisions Provisions
Provisions are recognized when the Company has a present obligation, legal or constructive, as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation, and a reliable estimate can be made of the amount of the obligation. Where the Company expects some or all of a provision to be reimbursed, for example under an insurance contract, the reimbursement is recognized as a separate asset but only when the reimbursement is virtually certain. The expense relating to any provision is presented in the statements of income net of any reimbursement. If the effect of the time value of money is material, provisions are discounted using a current pre-tax rate that reflects, where appropriate, the risks specific to the liability. Where discounting is used, the increase in the provision due to the passage of time is recognized in the statements of income.
The provision for warranty returns relates to the Company’s obligation for defective goods sold to customers that have yet to be returned for exchange or repair. Accruals for warranty returns are estimated on the basis of historical returns and are recorded so as to allocate them to the same period the corresponding revenue is recognized.
Fair values Fair values
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:
in the principal market for the asset or liability, or
in the absence of a principal market, in the most advantageous market for the asset or liability.
The Company uses valuation techniques that it believes are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs. All assets and liabilities for which fair value is measured or disclosed in the financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:
Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
Level 2: inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly or indirectly.
Level 3: unobservable inputs for the asset or liability. Unobservable inputs are used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.
For the purpose of fair value disclosures, the Company determines classes of assets and liabilities on the basis of the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy as explained above.
There was no change in the valuation techniques applied to financial instruments during all periods presented. The following table describes the valuation techniques used in the determination of the fair values of financial instruments:
Type
Valuation Approach
Cash, trade receivables, accounts payable and accrued liabilities
The carrying amount approximates fair value due to the short term maturity of these instruments.
Derivatives (included in other current assets, other long-term assets, accounts payable and accrued liabilities or other long-term liabilities)

Specific valuation techniques used to value derivative financial instruments include:
- quoted market prices or dealer quotes for similar instruments;
- observable market information as well as valuations determined by external valuators with experience in the financial markets.
Revolving Facility, Term Loan, Mainland China Facilities, and Japan Facility
The fair value is based on the present value of contractual cash flows, discounted at the Company’s current incremental borrowing rate for similar types of borrowing arrangements or, where applicable, market rates.
Put option liability
The fair value is based on the present value of the amount expected to be paid to the non-controlling shareholder if the put option is exercised. Subsequent changes in the present value of the amount that could be required to be paid at each reporting date are recorded with the statements of income until the put option is exercised or expires.
Contingent considerationThe fair value of the applicable contingent consideration is determined based on the estimated financial outcome and the resulting expected contingent consideration to be paid, discounted using an appropriate rate. Subsequent changes in the fair value is recognized in the statements of income.
Earn-Out included in other long-term liabilities
The fair value is based on a pre-determined percentage of net equity value of Paola Confectii SRL, determined as a multiple of EBITDA and EBITDA margin for the fiscal year ending March 30, 2025, subject to a floor, less net debt adjustments. Subsequent changes in the fair value are recognized in the statements of income.
Financial instruments Financial instruments
Financial assets and financial liabilities are recognized when the Company becomes a party to the contractual provisions of the financial instrument.
Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issuance of financial assets and financial liabilities (other than financial assets and financial liabilities classified at fair value through profit or loss) are added to, or deducted from, the fair value of the financial
assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities classified at fair value through profit or loss are recognized immediately in profit or loss.
Financial assets and financial liabilities are measured subsequently as described below.
i)Non-derivative financial assets
Non-derivative financial assets include cash and trade receivables which are measured at amortized cost. The Company initially recognizes receivables and deposits on the date that they are originated. The Company derecognizes a financial asset when the contractual rights to the cash flows from the asset expire, or it transfers the rights to receive the contractual cash flows on the financial asset in a transaction in which substantially all the risks and rewards of ownership of the financial asset are transferred.
ii)Non-derivative financial liabilities
Non-derivative financial liabilities include accounts payable, accrued liabilities, the Revolving Facility (as defined below), the Term Loan (as defined below), the Mainland China Facilities (as defined below), and the Japan Facility (as defined below). The Company initially recognizes debt instruments on the date that they are originated. All other financial liabilities are recognized initially on the trade date on which the Company becomes a party to the contractual provisions of the instrument. Financial liabilities are recognized initially at fair value less any directly attributable transaction costs. Subsequent to initial recognition, these financial liabilities are measured at amortized cost using the effective interest method. The Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expire.
In respect of non-controlling interests, a financial liability is recognized for the put option based on the present value of the amount expected to be paid to the non-controlling shareholder if exercised. Subsequently, the put option liability is adjusted to reflect changes in the present value of the amount that could be required to be paid at each reporting date, with fluctuations being recorded within the statements of income, until it is exercised or expires. The put option is measured at fair value through profit or loss.
iii)Derivative financial instruments
Derivatives are initially recognized at fair value on the date a derivative contract is entered into and are subsequently remeasured to their fair value at each reporting date. The method of recognizing the resulting gain or loss depends on whether the derivative is designated and effective as a hedging instrument. When a derivative financial instrument, including an embedded derivative, is not designated and effective in a qualifying hedge relationship, all changes in its fair value are recognized immediately in the statements of income; attributable transaction costs are recognized in the statements of income as incurred. The Company does not use derivatives for trading or speculative purposes.
Embedded derivatives are separated from a host contract and accounted for separately if the economic characteristics and risks of the host contract and the embedded derivative are not closely related.
iv)Hedge accounting
The Company is exposed to the risk of currency fluctuations and has entered into currency derivative contracts to hedge its exposure on the basis of planned transactions. Where hedge accounting is applied, the criteria are documented at the inception of the hedge and updated at each reporting date. The Company documents the relationship between hedging instruments and hedged items, as well as its risk management objectives and strategy for undertaking the hedging transactions. The Company also documents its assessment, at hedge inception and on an ongoing basis, of whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flows of hedged items.
The fair value of a hedging derivative is classified as a current asset or liability when the maturity of the hedged item is less than 12 months, and as a non-current asset or liability when the maturity of the hedged item is more than 12 months.
The effective portion of changes in the fair value of derivatives that are designated and qualify as cash flow hedges is recognized, net of tax, in other comprehensive income. The gain or loss relating to the ineffective portion is recognized immediately in the statements of income. Amounts accumulated in other comprehensive income are transferred to the statements of income in the periods when the hedged item affects net income. When a forecasted transaction that is hedged results in the recognition of a non-financial asset or liability, such as inventory, the amounts are included in the measurement of the cost of the related asset or liability. The deferred amounts are ultimately recognized in the statements of income.
Hedges of net investments are accounted for similarly to cash flow hedges, with unrealized gains and losses recognized, net of tax, in other comprehensive income. Amounts included in other comprehensive income are transferred to the statements of income in the period when the foreign operation is disposed of or sold.
Share-based payments Share-based payments
Share-based payments are valued based on the grant date fair value of these awards and the Company records compensation expense over the corresponding service period. The fair value of the share-based payments is determined using acceptable valuation techniques.
The Company has issued stock options to purchase subordinate voting shares, RSUs, and PSUs under its equity incentive plans, prior to the public offering on March 21, 2017 (the “Legacy Plan”) and subsequently (the “Omnibus Plan”). All Legacy Plan options have fully vested or been cancelled prior to the year ended March 31, 2024. Under the terms of the Omnibus Plan, options are granted to certain executives of the Company with vesting, generally over four years, contingent upon meeting the service conditions of the Omnibus Plan. The compensation expense related to the options, RSUs, and PSUs is recognized ratably over the requisite service period, provided it is probable that the
vesting conditions will be achieved and the occurrence of the exit event, if applicable, is probable.
v3.24.1.1.u2
Material accounting policy information (Tables)
12 Months Ended
Mar. 31, 2024
Accounting Policies, Changes In Accounting Estimates And Errors [Abstract]  
Schedule of Useful Lives of Property, Plant and Equipment Estimated useful lives are as follows:
Asset CategoryEstimated Useful Life
Plant equipment (except moulds)10 years
Footwear moulds5 years
Computer equipment3 years
Leasehold improvementsLesser of the lease term or useful life of the asset
Show displays5 years
Furniture and fixtures
5 to 10 years
The following table presents changes in the cost and the accumulated depreciation on the Company’s property, plant and equipment:
Plant equipmentComputer equipmentLeasehold improvementsShow displaysFurniture and fixturesIn progressTotal
Cost$$$$$$$
April 3, 202230.9 12.8 125.1 9.4 34.8 4.1 217.1 
Additions— 0.9 8.8 — 2.2 63.3 75.2 
Additions from business combinations (note 5)— — 0.9 — 0.3 — 1.2 
Disposals— (0.1)(1.0)— (0.1)— (1.2)
Transfers1.1 1.5 15.5 1.6 1.6 (21.3)— 
Impact of foreign currency translation— 0.2 2.1 0.4 1.0 0.4 4.1 
April 2, 202332.0 15.3 151.4 11.4 39.8 46.5 296.4 
Additions0.2 1.9 11.5 0.2 3.7 42.9 60.4 
Additions from business combinations (note 5)2.4 0.1 0.1 — — — 2.6 
Disposals(0.1)(0.3)(6.4)(1.0)(1.1)(0.1)(9.0)
Transfers2.9 4.4 70.4 (0.4)7.7 (85.0)— 
Impact of foreign currency translation(0.1)(0.1)(1.8)0.1 (0.4)(0.2)(2.5)
March 31, 202437.3 21.3 225.2 10.3 49.7 4.1 347.9 
Plant equipmentComputer equipmentLeasehold improvementsShow displaysFurniture and fixturesIn progressTotal
Accumulated depreciation$$$$$$$
April 3, 202212.1 9.3 53.9 7.3 20.3 — 102.9 
Depreciation3.2 2.7 23.1 1.1 7.3 — 37.4 
Disposals— (0.1)(1.0)— (0.1)— (1.2)
Impairment losses— — 0.2 — — — 0.2 
Impact of foreign currency translation— 0.2 (0.1)0.3 0.7 — 1.1 
April 2, 202315.3 12.1 76.1 8.7 28.2 — 140.4 
Depreciation3.7 3.4 30.2 1.2 6.9 — 45.4 
Disposals(0.1)(0.2)(6.4)(1.0)(1.0)— (8.7)
Impairment losses— — 0.2 — — — 0.2 
Impact of foreign currency translation— — (1.0)— (0.2)— (1.2)
March 31, 202418.9 15.3 99.1 8.9 33.9 — 176.1 
Net book value
April 2, 202316.7 3.2 75.3 2.7 11.6 46.5 156.0 
March 31, 202418.4 6.0 126.1 1.4 15.8 4.1 171.8 
Schedule of Useful Lives of Intangible Assets
The useful lives of intangible assets are assessed as either finite or indefinite.
Asset CategoryEstimated Useful Life
Brand nameIndefinite
Domain nameIndefinite
Software
5 to 7 years
Intellectual property
1 to 8 years
Customer lists (Canada Goose)10 years
Customer lists (Paola Confectii SRL)4 years
Distribution rights10 years
Intangible assets comprise the following:
March 31,
2024
April 2,
2023
$$
Intangible assets with finite lives 18.3 19.3 
Intangible assets with indefinite lives:
Brand name116.5 115.5 
Domain name0.3 0.3 
135.1 135.1 
The following table presents the changes in cost and accumulated amortization of the Company’s intangible assets with finite lives:
Intangible assets with finite lives
SoftwareIntellectual propertyCustomer listsDistribution rightsTotal
Cost$$$$$
April 3, 20228.5 18.2 — — 26.7 
Additions1.8 0.1 — — 1.9 
Additions from business combinations (note 5)— — 7.7 7.2 14.9 
April 2, 202310.3 18.3 7.7 7.2 43.5 
Additions0.8 0.1 — — 0.9 
Additions from business combinations (note 5)— — 3.5 — 3.5 
Disposals(0.1)— — — (0.1)
Impact of foreign currency translation(0.1)0.1 (0.7)(0.9)(1.6)
March 31, 202410.9 18.5 10.5 6.3 46.2 
SoftwareIntellectual propertyCustomer listsDistribution rightsTotal
Accumulated amortization$$$$$
April 3, 20223.6 16.7 — — 20.3 
Amortization1.8 0.7 0.7 0.7 3.9 
April 2, 20235.4 17.4 0.7 0.7 24.2 
Amortization1.8 0.5 0.8 0.7 3.8 
Disposals(0.1)— — — (0.1)
Impact of foreign currency translation— — 0.1 (0.1)— 
March 31, 20247.1 17.9 1.6 1.3 27.9 
Net book value
April 2, 20234.9 0.9 7.0 6.5 19.3 
March 31, 20243.8 0.6 8.9 5.0 18.3 
Schedule of Valuation Techniques Used in Determining Fair Value of Financial Instruments The following table describes the valuation techniques used in the determination of the fair values of financial instruments:
Type
Valuation Approach
Cash, trade receivables, accounts payable and accrued liabilities
The carrying amount approximates fair value due to the short term maturity of these instruments.
Derivatives (included in other current assets, other long-term assets, accounts payable and accrued liabilities or other long-term liabilities)

Specific valuation techniques used to value derivative financial instruments include:
- quoted market prices or dealer quotes for similar instruments;
- observable market information as well as valuations determined by external valuators with experience in the financial markets.
Revolving Facility, Term Loan, Mainland China Facilities, and Japan Facility
The fair value is based on the present value of contractual cash flows, discounted at the Company’s current incremental borrowing rate for similar types of borrowing arrangements or, where applicable, market rates.
Put option liability
The fair value is based on the present value of the amount expected to be paid to the non-controlling shareholder if the put option is exercised. Subsequent changes in the present value of the amount that could be required to be paid at each reporting date are recorded with the statements of income until the put option is exercised or expires.
Contingent considerationThe fair value of the applicable contingent consideration is determined based on the estimated financial outcome and the resulting expected contingent consideration to be paid, discounted using an appropriate rate. Subsequent changes in the fair value is recognized in the statements of income.
Earn-Out included in other long-term liabilities
The fair value is based on a pre-determined percentage of net equity value of Paola Confectii SRL, determined as a multiple of EBITDA and EBITDA margin for the fiscal year ending March 30, 2025, subject to a floor, less net debt adjustments. Subsequent changes in the fair value are recognized in the statements of income.
v3.24.1.1.u2
Business combinations (Tables)
12 Months Ended
Mar. 31, 2024
Disclosure of detailed information about business combination [abstract]  
Schedule of Assets and Liabilities Assumed in Business Combination
The aggregate purchase consideration for the business combination is as follows:
$
Cash16.4
Working capital adjustments(0.5)
Total purchase consideration15.9
Assets acquired and liabilities assumed have been recorded at the date of acquisition as follows:
$
Assets acquired
Trade receivables7.2
Inventories1.6
Prepaid expenses0.1
Property, plant and equipment2.6
Intangible assets
Customer list3.5
Brand1.0
Right-of-use assets1.2
Goodwill8.3
Accounts payable and accrued liabilities(8.4)
Lease liability(1.2)
Total assets acquired, net of liabilities assumed15.9
Assets acquired and liabilities assumed have been recorded based on the final valuation of their fair values at the date of acquisition as follows:
$
Assets acquired
Cash5.4
Inventories27.3
Property, plant and equipment1.2
Intangible assets14.9
Right-of-use assets3.3
Goodwill10.8
Other assets2.4
65.3
Liabilities assumed
Bank loan19.4
Lease liabilities3.2
Warranty provision0.3
22.9
Total identifiable net assets acquired42.4
Less: Deferred tax liability(8.1)
Less: Non-controlling interests(11.7)
Net assets acquired22.6
Consideration
Cash paid2.6
Contingent consideration20.0
Total purchase consideration22.6
Cash consideration paid(2.6)
Plus: Cash balance acquired5.4 
Net cash inflow on business combination2.8 
v3.24.1.1.u2
Segment information (Tables)
12 Months Ended
Mar. 31, 2024
Disclosure of operating segments [abstract]  
Schedule of Operating Segments
The following table presents key performance information of the Company’s reportable operating segments:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
 $ $ $
Revenue
DTC950.7 807.3 740.4 
Wholesale312.3 373.8 348.5 
Other70.8 35.9 9.5 
Total segment revenue1,333.8 1,217.0 1,098.4 
Operating income (loss)ReclassifiedReclassified
DTC387.1 347.4 322.9 
Wholesale114.0 131.2 121.5 
Other14.0 10.5 4.1 
Total segment operating income515.1 489.1 448.5 
The following table reconciles the Company’s reportable total segment operating income to income before income taxes:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
 $ $ $
Total segment operating income515.1 489.1 448.5 
Corporate expenses(390.6)(341.5)(289.0)
Total operating income124.5 147.6 159.5 
Net interest, finance and other costs
48.8 54.1 41.8 
Income before incomes taxes
75.7 93.5 117.7 
The following table summarizes depreciation and amortization in SG&A expenses of each reportable operating segment and depreciation and amortization included in corporate expenses:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
$
$
$
Depreciation and amortization expense
DTC96.5 81.6 78.1 
Wholesale3.9 3.9 2.3 
Other— — — 
Total segment depreciation and amortization expense
100.4 85.5 80.4 
Corporate expenses15.8 14.9 8.3 
Total depreciation and amortization expense
116.2 100.4 88.7 
Schedule of Geographical Areas
The Company determines the geographic location of revenue based on the location of its customers.
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
 $ $ $
Canada246.3 241.0 213.1 
United States324.6 340.2 305.9 
North America570.9 581.2 519.0 
Greater China1
422.2 287.3 288.8 
Asia Pacific (excluding Greater China1)
84.7 66.9 38.3 
Asia Pacific506.9 354.2 327.1 
EMEA2
256.0 281.6 252.3 
Total revenue1,333.8 1,217.0 1,098.4 
1.Greater China comprises Mainland China, Hong Kong, Macau, and Taiwan.
2.EMEA comprises Europe, the Middle East, Africa, and Latin America.
The Company’s non-current, non-financial assets (comprising of property, plant and equipment, intangible assets and right-of-use assets) are geographically located as follows:
Year ended
March 31,
2024
April 2,
2023
 $ $
Canada222.1 232.9 
United States140.7 111.7 
North America362.8 344.6 
Greater China1
63.6 73.6 
Asia Pacific (excluding Greater China1)
34.1 33.1 
Asia Pacific97.7 106.7 
EMEA2
126.2 131.6 
Non-current, non-financial assets586.7 582.9 
1.Greater China comprises Mainland China, Hong Kong, Macau, and Taiwan.
2.EMEA comprises Europe, the Middle East, Africa, and Latin America.
v3.24.1.1.u2
Income taxes (Tables)
12 Months Ended
Mar. 31, 2024
Income taxes paid (refund) [abstract]  
Schedule of Major Components of Tax Expense (Income)
The components of the provision for income tax are as follows:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
Current income tax expense$$$
Current period15.4 44.0 35.6 
Adjustment in respect of prior periods9.5 (1.9)(0.4)
24.9 42.1 35.2 
Deferred income tax recovery
Origination and reversal of temporary differences(0.8)(18.5)(11.9)
Effect of change in income tax rates(0.2)(0.6)— 
Adjustment in respect of prior periods(6.3)1.6 (0.2)
(7.3)(17.5)(12.1)
Income tax expense17.6 24.6 23.1 
Schedule of Effective Income Tax Rate Reconciliation
The effective income tax rates differ from the weighted average basic Canadian federal and provincial statutory income tax rates for the following reasons:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
$$$
Income before income taxes75.7 93.5 117.7 
Expected Statutory Rate25.5 %25.3 %25.4 %
Income tax at expected statutory rate19.3 23.7 29.8 
Non-deductible (taxable) items(0.1)0.8 (0.8)
Non-deductible stock option expense1.7 3.0 2.9 
Effect of foreign tax rates(10.3)(10.0)(14.6)
Non-deductible (taxable) remeasurement of contingent consideration and put option 1.4 2.4 — 
Non-deductible (taxable) foreign exchange loss (gain)0.9 1.4 0.2 
Change in tax rates(0.2)(0.4)0.1 
Change in deferred tax asset not recognized1.7 4.1 6.1 
Adjustments in respect of prior years 3.2 (0.4)(0.6)
Income tax expense17.6 24.6 23.1 
Schedule of Components and Changes in Deferred Tax Assets and Liabilities
The change in the year in the components of deferred tax assets and liabilities are as follows:
Change in the year affecting
April 2,
2023
Net incomeForeign exchange translationOther comprehensive income (loss)March 31,
2024
$$$$$
Losses carried forward11.5 15.5 — — 27.0 
Employee future benefits0.1 — — 0.1 0.2 
Other liabilities1.9 5.0 0.8 — 7.7 
Inventory capitalization 6.8 (4.2)— — 2.6 
Capital lease 9.3 3.0 — — 12.3 
Tax relief from Swiss tax reform7.6 (5.9)— — 1.7 
Unrealized profit in inventory36.9 (1.6)0.1 — 35.4 
Provisions and other temporary differences7.6 0.4 — — 8.0 
Total deferred tax asset81.7 12.2 0.9 0.1 94.9 
Unrealized foreign exchange (3.1)0.7 — (0.3)(2.7)
Intangible assets(18.8)(0.8)— — (19.6)
Property, plant and equipment(8.7)(4.8)— — (13.5)
Total deferred tax liabilities(30.6)(4.9)— (0.3)(35.8)
Net deferred tax assets (liabilities)51.1 7.3 0.9 (0.2)59.1 
The change in deferred tax assets and liabilities as presented in the statement of financial position are as follows:
Changes in the year affecting
April 2,
2023
Net incomeForeign exchange translationOther comprehensive lossMarch 31,
2024
$$$$$
Deferred tax assets67.5 8.8 0.2 (0.2)76.3 
Deferred tax liabilities(16.4)(1.5)0.7 — (17.2)
51.1 7.3 0.9 (0.2)59.1 
Schedule of Tax Loss Carryforwards
The corporate entities within the Company have the following tax-loss carry-forwards that are expected to expire in the following years, if not utilized.
$
2040 and prior 13.1 
20418.8 
20428.5 
20437.5 
20448.1 
46.0 
v3.24.1.1.u2
Earnings per share (Tables)
12 Months Ended
Mar. 31, 2024
Earnings per share [abstract]  
Schedule of Earnings per Share
The following table presents details for the calculation of basic and diluted earnings per share:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
 $ $ $
Net income attributable to shareholders of the Company58.4 72.7 94.6 
Weighted average number of multiple and subordinate voting shares outstanding100,816,758 105,058,643 108,296,802 
Weighted average number of shares on exercise of stock options, RSUs and PSUs1
1,006,315 563,669 857,919 
Diluted weighted average number of multiple and subordinate voting shares outstanding101,823,073 105,622,312 109,154,721 
Earnings per share attributable to shareholders of the Company
Basic$0.58 $0.69 $0.87 
Diluted$0.57 $0.69 $0.87 
1    Subordinate voting shares issuable on exercise of stock options are not treated as dilutive if including them would decrease the loss per share, or if the weighted average daily closing share price for the period was greater than the exercise price. As at March 31, 2024, there were 3,904,366 shares (April 2, 2023 - 2,231,231 shares, April 3, 2022 - 1,475,545 shares) that were not taken into account in the calculation of diluted earnings per share because their effect was anti-dilutive.
v3.24.1.1.u2
Trade receivables (Tables)
12 Months Ended
Mar. 31, 2024
Subclassifications of assets, liabilities and equities [abstract]  
Schedule of Net Trade Receivables
March 31,
2024
April 2,
2023
$$
Trade accounts receivable57.1 30.4 
Credit card receivables3.7 2.5 
Other receivables12.3 19.5 
73.1 52.4 
Less: expected credit loss and sales allowances(2.7)(1.5)
Trade receivables70.4 50.9 
Schedule of Allowance for Expected Credit Losses and Sales Allowances
The following are the continuities of the Company’s expected credit loss and sales allowances deducted from trade receivables:
March 31,
2024
April 2,
2023
Expected credit lossSales allowancesTotalExpected credit lossSales allowancesTotal
$$$$$$
Balance at the beginning of the year(0.4)(1.1)(1.5)(0.3)(0.8)(1.1)
Losses recognized(1.8)— (1.8)(0.1)(0.3)(0.4)
Amounts settled or written off during the year0.1 0.5 0.6 — — — 
Balance at the end of the year(2.1)(0.6)(2.7)(0.4)(1.1)(1.5)
v3.24.1.1.u2
Inventories (Tables)
12 Months Ended
Mar. 31, 2024
Inventories [Abstract]  
Schedule of Inventories
March 31,
2024
April 2,
2023
$$
Raw materials48.4 60.3 
Work in progress25.8 17.5 
Finished goods371.0 394.8 
Total inventories at the lower of cost and net realizable value445.2 472.6 
Schedule of Breakdown of Provision for Obsolescence
The breakdown of the provision for obsolescence is presented as follows:
March 31,
2024
April 2,
2023
$$
Raw material shrink reserves0.1 0.2 
Finished goods shrink reserves0.9 0.4 
Raw material obsolete inventory reserves22.1 20.5 
Finished goods obsolete inventory reserves37.7 22.1 
Provision for obsolescence60.8 43.2 
Schedule of Cost of Sales
Amounts charged to cost of sales comprise the following:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
$$$
Cost of goods manufactured405.5 392.1 350.1 
Depreciation and amortization included in costs of sales10.9 9.7 14.7 
Cost of sales416.4 401.8 364.8 
v3.24.1.1.u2
Property, plant and equipment (Tables)
12 Months Ended
Mar. 31, 2024
Property, plant and equipment [abstract]  
Schedule of Property, Plant and Equipment Estimated useful lives are as follows:
Asset CategoryEstimated Useful Life
Plant equipment (except moulds)10 years
Footwear moulds5 years
Computer equipment3 years
Leasehold improvementsLesser of the lease term or useful life of the asset
Show displays5 years
Furniture and fixtures
5 to 10 years
The following table presents changes in the cost and the accumulated depreciation on the Company’s property, plant and equipment:
Plant equipmentComputer equipmentLeasehold improvementsShow displaysFurniture and fixturesIn progressTotal
Cost$$$$$$$
April 3, 202230.9 12.8 125.1 9.4 34.8 4.1 217.1 
Additions— 0.9 8.8 — 2.2 63.3 75.2 
Additions from business combinations (note 5)— — 0.9 — 0.3 — 1.2 
Disposals— (0.1)(1.0)— (0.1)— (1.2)
Transfers1.1 1.5 15.5 1.6 1.6 (21.3)— 
Impact of foreign currency translation— 0.2 2.1 0.4 1.0 0.4 4.1 
April 2, 202332.0 15.3 151.4 11.4 39.8 46.5 296.4 
Additions0.2 1.9 11.5 0.2 3.7 42.9 60.4 
Additions from business combinations (note 5)2.4 0.1 0.1 — — — 2.6 
Disposals(0.1)(0.3)(6.4)(1.0)(1.1)(0.1)(9.0)
Transfers2.9 4.4 70.4 (0.4)7.7 (85.0)— 
Impact of foreign currency translation(0.1)(0.1)(1.8)0.1 (0.4)(0.2)(2.5)
March 31, 202437.3 21.3 225.2 10.3 49.7 4.1 347.9 
Plant equipmentComputer equipmentLeasehold improvementsShow displaysFurniture and fixturesIn progressTotal
Accumulated depreciation$$$$$$$
April 3, 202212.1 9.3 53.9 7.3 20.3 — 102.9 
Depreciation3.2 2.7 23.1 1.1 7.3 — 37.4 
Disposals— (0.1)(1.0)— (0.1)— (1.2)
Impairment losses— — 0.2 — — — 0.2 
Impact of foreign currency translation— 0.2 (0.1)0.3 0.7 — 1.1 
April 2, 202315.3 12.1 76.1 8.7 28.2 — 140.4 
Depreciation3.7 3.4 30.2 1.2 6.9 — 45.4 
Disposals(0.1)(0.2)(6.4)(1.0)(1.0)— (8.7)
Impairment losses— — 0.2 — — — 0.2 
Impact of foreign currency translation— — (1.0)— (0.2)— (1.2)
March 31, 202418.9 15.3 99.1 8.9 33.9 — 176.1 
Net book value
April 2, 202316.7 3.2 75.3 2.7 11.6 46.5 156.0 
March 31, 202418.4 6.0 126.1 1.4 15.8 4.1 171.8 
v3.24.1.1.u2
Intangible assets (Tables)
12 Months Ended
Mar. 31, 2024
Intangible assets other than goodwill [abstract]  
Schedule of Intangible Assets and Changes of Intangible Assets with Finite Lives
The useful lives of intangible assets are assessed as either finite or indefinite.
Asset CategoryEstimated Useful Life
Brand nameIndefinite
Domain nameIndefinite
Software
5 to 7 years
Intellectual property
1 to 8 years
Customer lists (Canada Goose)10 years
Customer lists (Paola Confectii SRL)4 years
Distribution rights10 years
Intangible assets comprise the following:
March 31,
2024
April 2,
2023
$$
Intangible assets with finite lives 18.3 19.3 
Intangible assets with indefinite lives:
Brand name116.5 115.5 
Domain name0.3 0.3 
135.1 135.1 
The following table presents the changes in cost and accumulated amortization of the Company’s intangible assets with finite lives:
Intangible assets with finite lives
SoftwareIntellectual propertyCustomer listsDistribution rightsTotal
Cost$$$$$
April 3, 20228.5 18.2 — — 26.7 
Additions1.8 0.1 — — 1.9 
Additions from business combinations (note 5)— — 7.7 7.2 14.9 
April 2, 202310.3 18.3 7.7 7.2 43.5 
Additions0.8 0.1 — — 0.9 
Additions from business combinations (note 5)— — 3.5 — 3.5 
Disposals(0.1)— — — (0.1)
Impact of foreign currency translation(0.1)0.1 (0.7)(0.9)(1.6)
March 31, 202410.9 18.5 10.5 6.3 46.2 
SoftwareIntellectual propertyCustomer listsDistribution rightsTotal
Accumulated amortization$$$$$
April 3, 20223.6 16.7 — — 20.3 
Amortization1.8 0.7 0.7 0.7 3.9 
April 2, 20235.4 17.4 0.7 0.7 24.2 
Amortization1.8 0.5 0.8 0.7 3.8 
Disposals(0.1)— — — (0.1)
Impact of foreign currency translation— — 0.1 (0.1)— 
March 31, 20247.1 17.9 1.6 1.3 27.9 
Net book value
April 2, 20234.9 0.9 7.0 6.5 19.3 
March 31, 20243.8 0.6 8.9 5.0 18.3 
v3.24.1.1.u2
Leases (Tables)
12 Months Ended
Mar. 31, 2024
Leases, Assets And Liabilities [Abstract]  
Schedule of Changes in Right-of-Use Assets
The following table presents changes in the cost and the accumulated depreciation of the Company’s right-of-use assets:
Retail storesManufacturing facilitiesOtherTotal
Cost$$$$
April 3, 2022296.3 36.7 17.4 350.4 
Additions82.8 8.2 39.6 130.6 
Additions from business combinations (note 5)1.5 — 1.8 3.3 
Lease modifications2.4 — — 2.4 
Derecognition on termination(1.8)— (1.0)(2.8)
Impact of foreign currency translation15.5 — 0.6 16.1 
April 2, 2023396.7 44.9 58.4 500.0 
Additions29.8 0.2 2.7 32.7 
Additions from business combinations (note 5)— 1.2 — 1.2 
Lease modifications31.9 — 1.8 33.7 
Derecognition on termination(5.1)(2.1)(1.8)(9.0)
Impact of foreign currency translation(3.0)— (0.2)(3.2)
March 31, 2024450.3 44.2 60.9 555.4 
Retail storesManufacturing facilitiesOtherTotal
Accumulated depreciation$$$$
April 3, 2022110.1 15.2 9.9 135.2 
Depreciation55.5 5.4 7.2 68.1 
Derecognition on termination(1.2)— (1.0)(2.2)
Impairment losses0.8 — — 0.8 
Impact of foreign currency translation5.9 — 0.4 6.3 
April 2, 2023171.1 20.6 16.5 208.2 
Depreciation63.8 5.5 7.3 76.6 
Derecognition on termination(5.1)(2.1)(1.8)(9.0)
Impairment losses1.0 — — 1.0 
Impact of foreign currency translation(1.1)— (0.1)(1.2)
March 31, 2024229.7 24.0 21.9 275.6 
Net book value
April 2, 2023225.6 24.3 41.9 291.8 
March 31, 2024220.6 20.2 39.0 279.8 
Schedule of Changes in and Classification of Lease Liabilities
The following table presents the changes in the Company's lease liabilities:
Retail storesManufacturing facilitiesOtherTotal
$$$$
April 3, 2022217.2 24.8 8.7 250.7 
Additions82.1 8.2 39.6 129.9 
Additions from business combinations (note 5)1.5 — 1.7 3.2 
Lease modifications2.4 — — 2.4 
Derecognition on termination(0.7)— — (0.7)
Principal payments(54.5)(5.3)(2.4)(62.2)
Impact of foreign currency translation11.2 — 0.3 11.5 
April 2, 2023259.2 27.7 47.9 334.8 
Additions29.7 0.2 2.3 32.2 
Additions from business combinations (note 5)— 1.2 — 1.2 
Lease modifications31.9 — 1.8 33.7 
Principal payments(63.0)(5.3)(0.9)(69.2)
Impact of foreign currency translation(2.1)— (0.1)(2.2)
March 31, 2024255.7 23.8 51.0 330.5 
Lease liabilities are classified as current and non-current liabilities as follows:
Retail storesManufacturing facilitiesOtherTotal
$$$$
Current lease liabilities64.7 6.1 5.3 76.1 
Non-current lease liabilities194.5 21.6 42.6 258.7 
April 2, 2023259.2 27.7 47.9 334.8 
Current lease liabilities65.8 6.3 7.8 79.9 
Non-current lease liabilities189.9 17.5 43.2 250.6 
March 31, 2024255.7 23.8 51.0 330.5 
v3.24.1.1.u2
Goodwill (Tables)
12 Months Ended
Mar. 31, 2024
Intangible assets and goodwill [abstract]  
Schedule of Changes in Goodwill
Goodwill arising from business combinations is as follows:
March 31,
2024
April 2,
2023
$$
Opening balance63.9 53.1 
Business combination (note 5)8.3 10.8 
Impact of foreign currency translation(1.4)— 
Goodwill70.8 63.9 
Disclosure of Goodwill Allocation by Cash-Generating Units
The following table outlines the goodwill allocation for the applicable CGUs for the current year:
March 31,
2024
April 2,
2023
$$
North America DTC - Retail11.7 11.7 
North America DTC - e-Commerce6.6 6.6 
North America Wholesale5.7 5.7 
Asia Pacific DTC - Retail9.8 9.8 
Asia Pacific DTC - e-Commerce2.6 2.6 
Asia Pacific Wholesale3.6 3.6 
EMEA1 DTC - Retail
4.3 4.3 
EMEA1 DTC - e-Commerce
2.8 2.8 
EMEA1 Wholesale
6.0 6.0 
Japan Joint Venture2
9.410.8
Paola Confectii8.3 — 
Goodwill70.8 63.9 
1EMEA comprises Europe, the Middle East, Africa, and Latin America.
2Goodwill for the Japan Joint Venture is JPY1,059.3m; year-over-year movement in the balance in Canadian Dollars is due to the impact of foreign exchange translation from JPY to CAD of $1.4m.
v3.24.1.1.u2
Accounts payables and accrued liabilities (Tables)
12 Months Ended
Mar. 31, 2024
Subclassifications of assets, liabilities and equities [abstract]  
Schedule of Accounts Payable and Accrued Liabilities
Accounts payable and accrued liabilities consist of the following:
March 31,
2024
April 2,
2023
$$
Trade payables57.6 60.1 
Accrued liabilities73.5 82.4 
Employee benefits38.6 21.9 
Derivative financial instruments1.9 3.3 
ASPP liability (note 18)— 20.0 
Other payables6.1 7.9 
Accounts payable and accrued liabilities177.7 195.6 
v3.24.1.1.u2
Provisions (Tables)
12 Months Ended
Mar. 31, 2024
Provisions [abstract]  
Schedule of Reconciliation of Provisions
 WarrantySales returnsAsset retirement obligations Total
$$$$
April 3, 202229.2 12.9 7.7 49.8 
Additional provisions recognized7.6 10.8 4.1 22.5 
Reductions resulting from settlement(6.4)(7.5)— (13.9)
Release of provisions— (1.3)— (1.3)
Other— 0.7 0.3 1.0 
April 2, 202330.4 15.6 12.1 58.1 
Additional provisions recognized6.6 20.8 2.6 30.0 
Reductions resulting from settlement(6.8)(16.9)— (23.7)
Release of provisions— (0.7)(0.1)(0.8)
Other0.1 — (0.3)(0.2)
March 31, 202430.3 18.8 14.3 63.4 
Schedule of Current and Non-Current Provisions
Provisions are classified as current and non-current liabilities based on management’s expectation of the timing of settlement, as follows:
March 31,
2024
April 2,
2023
$$
Current provisions26.1 21.6 
Non-current provisions37.3 36.5 
Provisions63.4 58.1 
v3.24.1.1.u2
Borrowings (Tables)
12 Months Ended
Mar. 31, 2024
Borrowings [abstract]  
Schedule of Term Loan
The amount outstanding with respect to the Term Loan is as follows:
March 31,
2024
April 2,
2023
$$
Term Loan393.1 396.3 
Unamortized portion of deferred transaction costs(0.6)(0.6)
Term Loan, net of unamortized deferred transaction costs392.5 395.7 
Schedule of Net Interest and Other Finance Costs
Net interest, finance and other costs consist of the following:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
$$$
ReclassifiedReclassified
Interest expense
Mainland China Facilities0.9 0.5 0.4 
Japan Facility0.1 0.1 — 
Revolving Facility2.8 1.1 1.8 
Term Loan19.9 18.8 17.4 
Lease liabilities17.7 11.6 9.1 
Standby fees1.2 1.8 0.9 
Acceleration of unamortized costs on debt extinguishment— — 9.5 
Foreign exchange losses on Term Loan net of hedges2.1 12.1 2.8 
Fair value remeasurement on the put option liability (note 21)1.6 10.9 — 
Fair value remeasurement on the contingent consideration (note 21)2.8 (2.9)— 
Interest income(1.3)(0.9)(0.4)
Other costs1.0 1.0 0.3 
Net interest, finance and other costs48.8 54.1 41.8 
v3.24.1.1.u2
Shareholders' equity (Tables)
12 Months Ended
Mar. 31, 2024
Share Capital, Reserves And Other Equity Interest [Abstract]  
Schedule of Transactions Affecting Issued and Outstanding Share Capital
The transactions affecting the issued and outstanding share capital of the Company are described below:
Multiple voting sharesSubordinate voting sharesTotal
Number$Number$Number$
April 2, 202351,004,076 1.4 53,184,912 117.3 104,188,988 118.7 
Purchase of subordinate voting shares— — (7,855,007)(17.8)(7,855,007)(17.8)
Total share purchases— — (7,855,007)(17.8)(7,855,007)(17.8)
Exercise of stock options— — 64,058 0.2 64,058 0.2 
Settlement of RSUs— — 134,475 3.8 134,475 3.8 
Total share issuances— — 198,533 4.0 198,533 4.0 
March 31, 202451,004,076 1.4 45,528,438 103.5 96,532,514 104.9 
The transactions affecting the issued and outstanding share capital of the Company are described below:
Multiple voting sharesSubordinate voting sharesTotal
Number$Number$Number$
April 3, 202251,004,076 1.4 54,190,432 117.1 105,194,508 118.5 
Purchase of subordinate voting shares— — (1,103,102)(2.4)(1,103,102)(2.4)
Purchase of subordinate voting shares held for cancellation— — (49,700)(0.1)(49,700)(0.1)
Total share purchases— — (1,152,802)(2.5)(1,152,802)(2.5)
Exercise of stock options— — 60,248 — 60,248 — 
Settlement of RSUs— — 87,034 2.7 87,034 2.7 
Total share issuances— — 147,282 2.7 147,282 2.7 
April 2, 202351,004,076 1.4 53,184,912 117.3 104,188,988 118.7 
The transactions affecting the issued and outstanding share capital of the Company are described below:
Multiple voting sharesSubordinate voting sharesTotal
Number$Number$Number$
March 28, 202151,004,076 1.4 59,435,079 119.1 110,439,155 120.5 
Purchase of subordinate voting shares— — (5,636,763)(11.9)(5,636,763)(11.9)
Total share purchases— — (5,636,763)(11.9)(5,636,763)(11.9)
Exercise of stock options— — 342,148 8.5 342,148 8.5 
Settlement of RSUs— — 49,968 1.4 49,968 1.4 
Total share issuances— — 392,116 9.9 392,116 9.9 
April 3, 202251,004,076 1.4 54,190,432 117.1 105,194,508 118.5 
v3.24.1.1.u2
Share-based payments (Tables)
12 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangements [Abstract]  
Schedule of Stock Option, RSU and PSU Transactions
Stock option transactions are as follows:
Year ended
March 31,
2024
April 2,
2023
Weighted average exercise priceNumber of sharesWeighted average exercise priceNumber of shares
Options outstanding, beginning of period$36.58 4,055,199$42.99 2,722,690
Granted to purchase shares$19.77 1,278,211$24.63 1,580,506
Exercised$1.61 (64,058)$0.23 (60,248)
Cancelled$28.83 (660,575)$40.66 (187,749)
Options outstanding, end of period$33.51 4,608,777$36.58 4,055,199
RSUs transactions are as follows:
Year ended
March 31,
2024
April 2,
2023
Number of sharesNumber of shares
RSUs outstanding, beginning of period318,082 215,590 
Granted438,814 209,187 
Settled(134,475)(87,034)
Cancelled(141,903)(19,661)
RSUs outstanding, end of period480,518318,082
PSUs transactions are as follows:
Year ended
March 31,
2024
April 2,
2023
Number of sharesNumber of shares
PSUs outstanding, beginning of period— — 
Granted399,349 — 
Cancelled(56,424)— 
PSUs outstanding, end of period342,925
Schedule of Stock Options Outstanding and Exercisable
The following table summarizes information about stock options outstanding and exercisable at March 31, 2024:
    Options Outstanding   Options Exercisable
Exercise price Number Weighted average remaining life in years Number Weighted average remaining life in years
$0.0215,434 0.015,434 0.0
$1.7944,307 0.844,307 0.8
$8.94122,221 2.8122,221 2.8
$14.292,565 9.6— 0.0
$16.21519,884 9.9— 0.0
$22.24611,798 9.1— 0.0
$23.6442,576 3.442,576 3.4
$23.7712,285 8.23,072 8.2
$24.641,169,619 7.9322,809 7.2
$30.7348,730 3.048,730 3.0
$31.7935,622 3.635,622 3.6
$33.97635,096 5.8462,427 5.6
$45.3433,708 4.033,708 4.0
$48.93541,197 6.9284,064 6.6
$50.00250,000 6.2187,500 6.2
$63.03359,157 4.8359,157 4.8
$83.53164,578 3.8164,578 3.8
4,608,7777.02,126,2055.3
Schedule of Assumptions Used to Measure Fair Value of Options Granted
The assumptions used to measure the fair value of options granted under the Black-Scholes option pricing model at the grant date were as follows:
Year ended
March 31,
2024
April 2,
2023
Weighted average stock price valuation$19.77 $24.63 
Weighted average exercise price$19.77 $24.63 
Risk-free interest rate4.09 %2.52 %
Expected life in years5.45.0
Expected dividend yield— %— %
Volatility40 %40 %
Weighted average fair value of options issued$6.82 $7.86 
v3.24.1.1.u2
Related party transactions (Tables)
12 Months Ended
Mar. 31, 2024
Related party transactions [abstract]  
Schedule of Transactions between Related Parties
Key management consists of the Board of Directors, the Chairman and Chief Executive Officer and the executives who report directly to the Chairman and Chief Executive Officer.
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
$$$
Short term employee benefits10.8 10.1 12.5 
Long term employee benefits0.2 0.1 0.1 
Termination benefits1.0 — — 
Share-based compensation7.3 11.2 11.5 
Compensation expense19.3 21.4 24.1 
v3.24.1.1.u2
Financial instruments and fair values (Tables)
12 Months Ended
Mar. 31, 2024
Financial Instruments And Fair Value Measurement [Abstract]  
Schedule of Fair Value Measurement The following table gives information about how the fair values of these financial assets and financial liabilities are determined, in particular, the valuation technique(s) and inputs used.
Financial assets/
financial liabilities
Fair value hierarchy
Valuation technique(s) and key input(s)
Foreign currency forward contractsLevel 2
Future cash flows are estimated based on forward exchange rates (from observable forward exchange rates at the end of the reporting period) and contract forward rates, discounted at a rate that reflects the credit risk of various counterparties.
Foreign currency and interest rate swap contractsLevel 2
Future cash flows are estimated based on forward exchange rates (from observable forward exchange and interest swap rates at the end of the reporting period) and contract forward rates, discounted at a rate that reflects the credit risk of various counterparties.
Revolving Facility, Term Loan and Japan Facility
Level 2
The fair value is based on the present value of contractual cash flows, discounted at the Company’s current incremental borrowing rate for similar types of borrowing arrangements or, where applicable, market rates.
Mainland China Facilities
Level 3The fair value is based on the present value of contractual cash flows, discounted at the Company’s current incremental borrowing rate for similar types of borrowing arrangements or, where applicable, market rates.
Put option liabilityLevel 3
The fair value is based on the present value of the amount expected to be paid to the non-controlling shareholder if the put option is exercised.
Contingent considerationLevel 3The fair value of the applicable contingent consideration is determined based on the estimated financial outcome and the resulting expected contingent consideration to be paid, discounted using an appropriate rate.
Earn-Out (note 5)Level 3The fair value is based on a pre-determined percentage of net equity value of Paola Confectii SRL, determined as a multiple of EBITDA and EBITDA margin for the fiscal year ending March 30, 2025, subject to a floor, less net debt adjustments.
Schedule of Fair Value Measurement of Assets
The following table presents the fair values and fair value hierarchy of the Company’s financial instruments and excludes financial instruments carried at amortized cost that are short-term in nature, where fair value approximates carrying values:
March 31,
2024
April 2,
2023
Level 1Level 2Level 3Carrying valueFair valueLevel 1Level 2Level 3Carrying valueFair value
$$$$$$$$$$
Financial assets
Derivatives included in other current assets— 15.1 — 15.1 15.1 — 12.4 — 12.4 12.4 
Derivatives included in other long-term assets— 6.9 — 6.9 6.9 — 12.4 — 12.4 12.4 
Financial liabilities
Derivatives included in accounts payable and accrued liabilities— 1.9 — 1.9 1.9 — 3.3 — 3.3 3.3 
Mainland China Facilities— — — — — — — 9.8 9.8 9.8 
Japan Facility— 5.4 — 5.4 5.4 — 13.7 — 13.7 13.7 
Term Loan— 392.5 — 392.5 389.2 — 395.7 — 395.7 433.1 
Derivatives included in other long-term liabilities— 5.3 — 5.3 5.3 — 6.0 — 6.0 6.0 
Put option liability included in other long-term liabilities— — 29.4 29.4 29.4 — — 32.1 32.1 32.1 
Contingent consideration included in other long-term liabilities— — 17.7 17.7 17.7 — — 16.8 16.8 16.8 
Earn-Out included in other long-term liabilities (note 5)— — 1.5 1.5 1.5 — — — — — 
Schedule of Fair Value Measurement of Liabilities
The following table presents the fair values and fair value hierarchy of the Company’s financial instruments and excludes financial instruments carried at amortized cost that are short-term in nature, where fair value approximates carrying values:
March 31,
2024
April 2,
2023
Level 1Level 2Level 3Carrying valueFair valueLevel 1Level 2Level 3Carrying valueFair value
$$$$$$$$$$
Financial assets
Derivatives included in other current assets— 15.1 — 15.1 15.1 — 12.4 — 12.4 12.4 
Derivatives included in other long-term assets— 6.9 — 6.9 6.9 — 12.4 — 12.4 12.4 
Financial liabilities
Derivatives included in accounts payable and accrued liabilities— 1.9 — 1.9 1.9 — 3.3 — 3.3 3.3 
Mainland China Facilities— — — — — — — 9.8 9.8 9.8 
Japan Facility— 5.4 — 5.4 5.4 — 13.7 — 13.7 13.7 
Term Loan— 392.5 — 392.5 389.2 — 395.7 — 395.7 433.1 
Derivatives included in other long-term liabilities— 5.3 — 5.3 5.3 — 6.0 — 6.0 6.0 
Put option liability included in other long-term liabilities— — 29.4 29.4 29.4 — — 32.1 32.1 32.1 
Contingent consideration included in other long-term liabilities— — 17.7 17.7 17.7 — — 16.8 16.8 16.8 
Earn-Out included in other long-term liabilities (note 5)— — 1.5 1.5 1.5 — — — — — 
v3.24.1.1.u2
Financial risk management objectives and policies (Tables)
12 Months Ended
Mar. 31, 2024
Financial Risk Management [Abstract]  
Schedule of Contractual Undiscounted Future Cash Flow Requirements
The following table summarizes the amount of contractual undiscounted future cash flow requirements as at March 31, 2024:
20252026202720282029ThereafterTotal
$$$$$$$
Accounts payable and accrued liabilities177.7 — — — — — 177.7 
Japan Facility5.4 — — — — — 5.4 
Term Loan4.0 4.1 4.1 380.9 — — 393.1 
Interest commitments relating to borrowings1
35.2 35.2 35.2 17.5 — — 123.1 
Lease obligations92.0 75.8 66.3 42.1 32.5 81.6 390.3 
Pension obligation— — — — — 1.8 1.8 
Total contractual obligations314.3 115.1 105.6 440.5 32.5 83.4 1,091.4 
1    Interest commitments are calculated based on the loan balance and the interest rate payable on the Japan Facility and the Term Loan of 0.45% and 8.94% respectively, as at March 31, 2024.
Schedule of Aging of Trade Receivables
The aging of trade receivables was as follows:
Past due
TotalCurrent
< 30 days
31-60 days
> 61 days
 $ $ $ $ $
Trade accounts receivable57.1 33.5 10.0 5.1 8.5 
Credit card receivables3.7 3.7 — — — 
Other receivables12.3 11.8 0.3 — 0.2 
March 31, 202473.1 49.0 10.3 5.1 8.7 
Trade accounts receivable30.4 22.2 4.4 1.1 2.7 
Credit card receivables2.5 2.5 — — — 
Other receivables19.5 18.9 0.5 — 0.1 
April 2, 202352.4 43.6 4.9 1.1 2.8 
Schedule of Unrealized Gains (Losses) in Fair Value of Derivatives in Other Comprehensive Income
The Company recognized the following unrealized gains and losses in the fair value of derivatives designated as cash flow hedges in other comprehensive income:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
Net gainTax recoveryNet lossTax recoveryNet lossTax expense
$$$$$$
Forward foreign exchange contracts designated as cash flow hedges1.3 0.1 (3.7)0.9 (4.5)(0.1)
The Company recognized the following unrealized losses and gains in the fair value of derivatives designed as hedging instruments in other comprehensive income:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
Net lossTax recoveryNet gainTax expenseNet gainTax expense
$$$$$$
Swaps designated as cash flow hedges(1.8)0.3 4.1 (0.8)13.2 (4.5)
Schedule of Losses (Gains) Reclassified from Other Comprehensive Income on Derivatives to the Consolidated Financial Statements
The Company reclassified the following losses and gains from other comprehensive income on derivatives designated as cash flow hedges to locations in the consolidated financial statements described below:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
Loss (gain) from other comprehensive income$$$
Forward foreign exchange contracts designated as cash flow hedges
Revenue1.8 5.5 3.9 
SG&A expenses(0.4)0.1 (0.4)
Inventory0.5 0.8 (0.9)
The Company reclassified the following gains and losses from other comprehensive income on derivatives designated as hedging instruments to net interest, finance and other costs:
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
(Gain) loss from other comprehensive income$$$
Swaps designated as cash flow hedges(2.0)0.5 0.9 
Schedule of Foreign Currency Forward Exchange Contracts
Foreign currency forward exchange contracts outstanding as at March 31, 2024 related to operating cash flows were:
(in millions)Aggregate AmountsCurrency
Forward contract to purchase Canadian dollarsUSD62.1 U.S. dollars
89.3 euros
¥2,085.8 Japanese yen
Forward contract to sell Canadian dollarsUSD22.4 U.S. dollars
40.1 euros
Forward contract to purchase eurosCNY 525.4 Chinese yuan
£25.5 British pounds sterling
HKD32.9 Hong Kong dollars
CHF 0.1 Swiss francs
Forward contract to sell eurosCHF 3.3 Swiss francs
£1.5 British pounds sterling
CNY 9.2 Chinese yuan
HKD7.0 Hong Kong dollars
v3.24.1.1.u2
Selected cash flow information (Tables)
12 Months Ended
Mar. 31, 2024
Cash Flow Information [Abstract]  
Schedule of Changes in Non-Cash Operating Items
Changes in non-cash operating items
Year ended
March 31,
2024
April 2,
2023
April 3,
2022
$$$
Trade receivables(12.4)(4.6)(8.7)
Inventories27.2 (49.9)(60.7)
Other current assets2.8 (9.4)(3.4)
Accounts payable and accrued liabilities(9.5)(16.8)(8.5)
Provisions5.2 9.0 3.7 
Other(2.8)(3.7)(5.2)
Change in non-cash operating items10.5 (75.4)(82.8)
Schedule of Changes in Liabilities and Equity Arising from Financing Activities
Changes in liabilities and equity arising from financing activities
Mainland China FacilitiesJapan FacilityRevolving FacilityTerm LoanLease liabilitiesShare capital
$$$$$$
April 2, 20239.8 13.7 (0.5)395.7 334.8 118.7 
Cash flows:
Mainland China Facilities borrowings(9.8)— — — — — 
Japan Facility borrowings— (8.3)— — — — 
Term Loan repayments— — — (4.0)— — 
Transactions costs on financing activities— — (0.1)(0.1)— — 
Normal course issuer bid purchase of subordinate voting shares— — — — — (140.2)
Principal payments on lease liabilities— — — — (69.2)— 
Issuance of shares— — — — — 0.1 
Additions from business combination— — — — 1.2 — 
Non-cash items:
Accrued transaction costs— — (0.7)— — — 
Amortization of deferred transaction costs— — 0.3 0.2 — — 
Unrealized foreign exchange loss (gain)— — — 0.7 (2.2)— 
Additions and amendments to lease liabilities (note 13)— — — — 65.9 — 
Share purchase charge to retained earnings (note 18)— — — — — 122.4 
Contributed surplus on share issuances (note 18)— — — — — 3.9 
March 31, 2024— 5.4 (1.0)392.5 330.5 104.9 
Mainland China Facilities
Japan FacilityRevolving Facility
Term Loan
Lease liabilitiesNet derivative asset on terminated contracts Share capital
$$$$$$$
April 3, 2022— — (0.9)370.0 250.7 (7.3)118.5 
Cash flows:
Cash inflow from business combination— 19.4 — — 3.2 — — 
Mainland China Facilities borrowings9.8 — — — — — — 
Japan Facility repayments— (5.7)— — — — — 
Term Loan repayments— — — (4.0)— — — 
Normal course issuer bid purchase of subordinate voting shares— — — — — — (26.7)
Principal payments on lease liabilities— — — — (62.2)— — 
Settlement of term loan derivative contracts — — — — — 8.6 — 
Non-cash items:
Amortization of deferred transaction costs — — 0.4 0.2 — — — 
Fair market valuation— — — — — (0.6)— 
Unrealized foreign exchange loss (gain)— — — 29.5 11.5 (0.7)— 
Additions and amendments to lease liabilities (note 13)— — — — 132.3 — — 
Derecognition on termination of lease liabilities (note 13)— — — — (0.7)— — 
Share purchase charge to retained earnings (note 18)— — — — — — 24.3 
Normal course issuer bid purchase of subordinate voting shares held for cancellation (note 18)— — — — — — (0.1)
Contributed surplus on share issuances (note 18)— — — — — — 2.7 
April 2, 20239.8 13.7 (0.5)395.7 334.8 — 118.7 
v3.24.1.1.u2
The Company (Details)
12 Months Ended
Mar. 31, 2024
segment
Corporate information and statement of IFRS compliance [abstract]  
Proportion of total outstanding shares owned by principal shareholder 52.80%
Proportion of voting shares owned by principal shareholder 91.80%
Proportion of total outstanding shares owned by public markets 47.20%
Proportion of voting shares owned by public markets 8.20%
Number of operating segments 3
Number of reportable segments 3
v3.24.1.1.u2
Material accounting policy information - Basis of Presentation (Details) - CAD ($)
$ in Millions
12 Months Ended
Apr. 02, 2023
Apr. 03, 2022
Accounting Policies, Changes In Accounting Estimates And Errors [Abstract]    
Foreign exchange loss $ 12.1 $ 2.8
v3.24.1.1.u2
Material accounting policy information - Revenue Recognition (Details)
12 Months Ended
Mar. 31, 2024
Disclosure of disaggregation of revenue from contracts with customers [line items]  
Revenue recognition, return period 30 days
DTC  
Disclosure of disaggregation of revenue from contracts with customers [line items]  
Revenue recognition, return period 30 days
v3.24.1.1.u2
Material accounting policy information - Schedule of Useful Lives of Property, Plant and Equipment (Details)
12 Months Ended
Mar. 31, 2024
Plant equipment (except moulds)  
Disclosure of detailed information about property, plant and equipment [line items]  
Estimated Useful Life 10 years
Footwear moulds  
Disclosure of detailed information about property, plant and equipment [line items]  
Estimated Useful Life 5 years
Computer equipment  
Disclosure of detailed information about property, plant and equipment [line items]  
Estimated Useful Life 3 years
Show displays  
Disclosure of detailed information about property, plant and equipment [line items]  
Estimated Useful Life 5 years
Furniture and fixtures | Minimum  
Disclosure of detailed information about property, plant and equipment [line items]  
Estimated Useful Life 5 years
Furniture and fixtures | Maximum  
Disclosure of detailed information about property, plant and equipment [line items]  
Estimated Useful Life 10 years
v3.24.1.1.u2
Material accounting policy information - Schedule of Useful Lives of Intangible Assets (Details)
12 Months Ended
Mar. 31, 2024
Software | Minimum  
Disclosure of intangible assets with indefinite useful life [line items]  
Useful life measured as period of time, intangible assets other than goodwill 5 years
Software | Maximum  
Disclosure of intangible assets with indefinite useful life [line items]  
Useful life measured as period of time, intangible assets other than goodwill 7 years
Intellectual property | Minimum  
Disclosure of intangible assets with indefinite useful life [line items]  
Useful life measured as period of time, intangible assets other than goodwill 1 year
Intellectual property | Maximum  
Disclosure of intangible assets with indefinite useful life [line items]  
Useful life measured as period of time, intangible assets other than goodwill 8 years
Customer Lists  
Disclosure of intangible assets with indefinite useful life [line items]  
Useful life measured as period of time, intangible assets other than goodwill 10 years
Customer Lists | Paola Confectii  
Disclosure of intangible assets with indefinite useful life [line items]  
Useful life measured as period of time, intangible assets other than goodwill 4 years
Distribution rights  
Disclosure of intangible assets with indefinite useful life [line items]  
Useful life measured as period of time, intangible assets other than goodwill 10 years
v3.24.1.1.u2
Material accounting policy information - Goodwill (Details) - cashGeneratingUnit
Mar. 31, 2024
Apr. 02, 2023
Accounting Policies, Changes In Accounting Estimates And Errors [Abstract]    
Number of cash generating units 12 11
Number of cash generating units that contribute to cash flows 11 10
v3.24.1.1.u2
Material accounting policy information - Share-Based Payments (Details)
12 Months Ended
Mar. 31, 2024
Performance-based options  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Vesting period 4 years
v3.24.1.1.u2
Significant accounting judgments, estimates, and assumptions (Details) - cashGeneratingUnit
Mar. 31, 2024
Apr. 02, 2023
Accounting Policies, Changes In Accounting Estimates And Errors [Abstract]    
Number of cash generating units that contribute to cash flows 11 10
v3.24.1.1.u2
Business combinations - Narrative (Details)
¥ in Millions, $ in Millions
12 Months Ended
Nov. 01, 2023
CAD ($)
Apr. 04, 2022
CAD ($)
Mar. 31, 2024
CAD ($)
Apr. 02, 2023
CAD ($)
Apr. 03, 2022
CAD ($)
Apr. 04, 2022
JPY (¥)
Disclosure of detailed information about business combination [line items]            
Goodwill     $ 70.8 $ 63.9 $ 53.1  
Net cash inflow on business combination     (15.9) 2.8 0.0  
Paola Confectii            
Disclosure of detailed information about business combination [line items]            
Total purchase consideration $ 16.4          
Acquisition-related costs     0.8      
Goodwill 8.3          
Total purchase consideration $ 15.9          
Contingent liabilities recognised in business combination     $ 7.4      
Contingent liabilities recognised in business combination, period     2 years      
Paola Confectii | Customer-related intangible assets            
Disclosure of detailed information about business combination [line items]            
Useful life measured as period of time, intangible assets other than goodwill 4 years          
Intangible assets $ 3.5          
Paola Confectii | Brand name            
Disclosure of detailed information about business combination [line items]            
Intangible assets $ 1.0          
Canada Goose Japan, K.K.            
Disclosure of detailed information about business combination [line items]            
Percentage of voting equity interests acquired   50.00%       50.00%
Cash transferred   $ (2.6)       ¥ (250.0)
Contingent consideration recognised as of acquisition date   20.0       1,958.9
Total purchase consideration   22.6       2,208.9
Acquisition-related costs       1.3 $ 0.7  
Goodwill   10.8   $ 10.8    
Useful life measured as period of time, intangible assets other than goodwill       10 years    
Revenue of acquiree since acquisition date       $ 54.0    
Profit (loss) of acquiree since acquisition date       $ 1.0    
Proportion of ownership interests held by non-controlling interests       50.00%    
Put option, period       6 months    
Put option for non-controlling interest   21.2       ¥ 2,076.4
Net cash inflow on business combination   2.8        
Intangible assets   $ 14.9   $ 14.9    
v3.24.1.1.u2
Business combinations - Schedule of Assets and Liabilities Acquired Paola Confectii (Details) - CAD ($)
$ in Millions
Nov. 01, 2023
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Disclosure of detailed information about business combination [line items]        
Goodwill   $ 70.8 $ 63.9 $ 53.1
Paola Confectii        
Disclosure of detailed information about business combination [line items]        
Total purchase consideration $ 16.4      
Working capital adjustments (0.5)      
Total purchase consideration 15.9      
Trade receivables 7.2      
Inventories 1.6      
Prepaid expenses 0.1      
Property, plant and equipment 2.6      
Contingent liabilities recognised in business combination, period   2 years    
Right-of-use assets 1.2      
Goodwill 8.3      
Accounts payable and accrued liabilities (8.4)      
Lease liabilities (1.2)      
Total identifiable net assets acquired 15.9      
Paola Confectii | Customer-related intangible assets        
Disclosure of detailed information about business combination [line items]        
Intangible assets 3.5      
Paola Confectii | Brand        
Disclosure of detailed information about business combination [line items]        
Intangible assets $ 1.0      
v3.24.1.1.u2
Business combinations - Schedule of Assets and Liabilities Assumed in Sazaby League Business Combination (Details)
¥ in Millions, $ in Millions
12 Months Ended
Apr. 04, 2022
CAD ($)
Mar. 31, 2024
CAD ($)
Apr. 02, 2023
CAD ($)
Apr. 03, 2022
CAD ($)
Apr. 04, 2022
JPY (¥)
Assets acquired          
Goodwill   $ 70.8 $ 63.9 $ 53.1  
Consideration          
Net cash (outflow) inflow from business combination   $ (15.9) 2.8 $ 0.0  
Canada Goose Japan, K.K.          
Assets acquired          
Cash $ 5.4        
Inventories 27.3        
Property, plant and equipment 1.2        
Intangible assets 14.9   14.9    
Right-of-use assets 3.3        
Goodwill 10.8   $ 10.8    
Other assets 2.4        
Assets acquired 65.3        
Liabilities assumed          
Bank loan 19.4        
Lease liabilities 3.2        
Warranty provision 0.3        
Liabilities assumed 22.9        
Total identifiable net assets acquired 42.4        
Less: Deferred tax liability (8.1)        
Less: Non-controlling interests (11.7)        
Net assets acquired 22.6        
Consideration          
Cash transferred 2.6       ¥ 250.0
Contingent consideration recognised as of acquisition date 20.0       1,958.9
Total purchase consideration 22.6       ¥ 2,208.9
Net cash (outflow) inflow from business combination $ 2.8        
v3.24.1.1.u2
Segment information - Narrative (Details)
12 Months Ended
Mar. 31, 2024
segment
Disclosure of operating segments [abstract]  
Number of reportable segments 3
v3.24.1.1.u2
Segment information - Schedule of Operating Segments (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Disclosure of operating segments [line items]      
Revenue $ 1,333.8 $ 1,217.0 $ 1,098.4
Operating income 124.5 147.6 159.5
Net interest, finance and other costs 48.8 54.1 41.8
Income before income taxes 75.7 93.5 117.7
Depreciation and amortisation expense 116.2 100.4 88.7
Operating segments      
Disclosure of operating segments [line items]      
Operating income 515.1 489.1 448.5
Depreciation and amortisation expense 100.4 85.5 80.4
Corporate expenses      
Disclosure of operating segments [line items]      
Operating income (390.6) (341.5) (289.0)
Depreciation and amortisation expense 15.8 14.9 8.3
DTC      
Disclosure of operating segments [line items]      
Revenue 950.7 807.3 740.4
DTC | Operating segments      
Disclosure of operating segments [line items]      
Operating income 387.1 347.4 322.9
Depreciation and amortisation expense 96.5 81.6 78.1
Wholesale      
Disclosure of operating segments [line items]      
Revenue 312.3 373.8 348.5
Wholesale | Operating segments      
Disclosure of operating segments [line items]      
Operating income 114.0 131.2 121.5
Depreciation and amortisation expense 3.9 3.9 2.3
Other      
Disclosure of operating segments [line items]      
Revenue 70.8 35.9 9.5
Other | Operating segments      
Disclosure of operating segments [line items]      
Operating income 14.0 10.5 4.1
Depreciation and amortisation expense $ 0.0 $ 0.0 $ 0.0
v3.24.1.1.u2
Segment information - Schedule of Geographical Areas (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Disclosure of geographical areas [line items]      
Revenue $ 1,333.8 $ 1,217.0 $ 1,098.4
Other non-current non-financial assets 586.7 582.9  
North America      
Disclosure of geographical areas [line items]      
Revenue 570.9 581.2 519.0
Other non-current non-financial assets 362.8 344.6  
Canada      
Disclosure of geographical areas [line items]      
Revenue 246.3 241.0 213.1
Other non-current non-financial assets 222.1 232.9  
United States      
Disclosure of geographical areas [line items]      
Revenue 324.6 340.2 305.9
Other non-current non-financial assets 140.7 111.7  
Asia Pacific      
Disclosure of geographical areas [line items]      
Revenue 506.9 354.2 327.1
Other non-current non-financial assets 97.7 106.7  
Greater China      
Disclosure of geographical areas [line items]      
Revenue 422.2 287.3 288.8
Other non-current non-financial assets 63.6 73.6  
Asia Pacific (excluding Greater China)      
Disclosure of geographical areas [line items]      
Revenue 84.7 66.9 38.3
Other non-current non-financial assets 34.1 33.1  
EMEA      
Disclosure of geographical areas [line items]      
Revenue 256.0 281.6 $ 252.3
Other non-current non-financial assets $ 126.2 $ 131.6  
v3.24.1.1.u2
Income taxes - Schedule of Major Components of Tax Expense (Income) (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Current income tax expense      
Current period $ 15.4 $ 44.0 $ 35.6
Adjustment in respect of prior periods 9.5 (1.9) (0.4)
Current income tax expense 24.9 42.1 35.2
Deferred income tax recovery      
Origination and reversal of temporary differences (0.8) (18.5) (11.9)
Effect of change in income tax rates (0.2) (0.6) 0.0
Adjustment in respect of prior periods (6.3) 1.6 (0.2)
Deferred income tax recovery (7.3) (17.5) (12.1)
Income tax expense $ 17.6 $ 24.6 $ 23.1
v3.24.1.1.u2
Income taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Income taxes paid (refund) [abstract]      
Income before income taxes $ 75.7 $ 93.5 $ 117.7
Reconciliation of average effective tax rate and applicable tax rate [abstract]      
Expected Statutory Rate 25.50% 25.30% 25.40%
Income tax at expected statutory rate $ 19.3 $ 23.7 $ 29.8
Non-deductible (taxable) items (0.1) 0.8 (0.8)
Non-deductible stock option expense 1.7 3.0 2.9
Effect of foreign tax rates (10.3) (10.0) (14.6)
Non-deductible (taxable) remeasurement of contingent consideration and put option 1.4 2.4 0.0
Non-deductible (taxable) foreign exchange loss (gain) 0.9 1.4 0.2
Change in tax rates (0.2) (0.4) 0.1
Change in deferred tax asset not recognized 1.7 4.1 6.1
Adjustment in respect of prior periods 3.2 (0.4) (0.6)
Income tax expense $ 17.6 $ 24.6 $ 23.1
Effective tax rate that most jurisdictions are above 15.00%    
v3.24.1.1.u2
Income taxes - Schedule of Components of Deferred Tax Assets and Liabilities (Details)
$ in Millions
12 Months Ended
Mar. 31, 2024
CAD ($)
Changes in deferred tax liability (asset) [abstract]  
Deferred tax assets, beginning balance $ 67.5
Deferred tax liabilities, beginning balance (16.4)
Net deferred tax assets, beginning balance 51.1
Change in the year affecting net income 7.3
Change in the year affecting foreign exchange translation 0.9
Change in the year affecting other comprehensive (loss) income (0.2)
Deferred tax assets, ending balance 76.3
Deferred tax liabilities, ending balance (17.2)
Net deferred tax assets, ending balance 59.1
Total deferred tax asset  
Changes in deferred tax liability (asset) [abstract]  
Deferred tax assets, beginning balance 81.7
Change in the year affecting net income 12.2
Change in the year affecting foreign exchange translation 0.9
Change in the year affecting other comprehensive (loss) income 0.1
Deferred tax assets, ending balance 94.9
Losses carried forward  
Changes in deferred tax liability (asset) [abstract]  
Deferred tax assets, beginning balance 11.5
Change in the year affecting net income 15.5
Change in the year affecting foreign exchange translation 0.0
Change in the year affecting other comprehensive (loss) income 0.0
Deferred tax assets, ending balance 27.0
Employee future benefits  
Changes in deferred tax liability (asset) [abstract]  
Deferred tax assets, beginning balance 0.1
Change in the year affecting net income 0.0
Change in the year affecting foreign exchange translation 0.0
Change in the year affecting other comprehensive (loss) income 0.1
Deferred tax assets, ending balance 0.2
Other liabilities  
Changes in deferred tax liability (asset) [abstract]  
Deferred tax assets, beginning balance 1.9
Change in the year affecting net income 5.0
Change in the year affecting foreign exchange translation 0.8
Change in the year affecting other comprehensive (loss) income 0.0
Deferred tax assets, ending balance 7.7
Inventory capitalization  
Changes in deferred tax liability (asset) [abstract]  
Deferred tax assets, beginning balance 6.8
Change in the year affecting net income (4.2)
Change in the year affecting foreign exchange translation 0.0
Change in the year affecting other comprehensive (loss) income 0.0
Deferred tax assets, ending balance 2.6
Capital lease  
Changes in deferred tax liability (asset) [abstract]  
Deferred tax assets, beginning balance 9.3
Change in the year affecting net income 3.0
Change in the year affecting foreign exchange translation 0.0
Change in the year affecting other comprehensive (loss) income 0.0
Deferred tax assets, ending balance 12.3
Tax relief from Swiss tax reform  
Changes in deferred tax liability (asset) [abstract]  
Deferred tax assets, beginning balance 7.6
Change in the year affecting net income (5.9)
Change in the year affecting foreign exchange translation 0.0
Change in the year affecting other comprehensive (loss) income 0.0
Deferred tax assets, ending balance 1.7
Unrealized profit in inventory  
Changes in deferred tax liability (asset) [abstract]  
Deferred tax assets, beginning balance 36.9
Change in the year affecting net income (1.6)
Change in the year affecting foreign exchange translation 0.1
Change in the year affecting other comprehensive (loss) income 0.0
Deferred tax assets, ending balance 35.4
Provisions and other temporary differences  
Changes in deferred tax liability (asset) [abstract]  
Deferred tax assets, beginning balance 7.6
Change in the year affecting net income 0.4
Change in the year affecting foreign exchange translation 0.0
Change in the year affecting other comprehensive (loss) income 0.0
Deferred tax assets, ending balance 8.0
Total deferred tax liabilities  
Changes in deferred tax liability (asset) [abstract]  
Deferred tax liabilities, beginning balance (30.6)
Change in the year affecting net income (4.9)
Change in the year affecting foreign exchange translation 0.0
Change in the year affecting other comprehensive (loss) income (0.3)
Deferred tax liabilities, ending balance (35.8)
Unrealized foreign exchange  
Changes in deferred tax liability (asset) [abstract]  
Deferred tax liabilities, beginning balance (3.1)
Change in the year affecting net income 0.7
Change in the year affecting foreign exchange translation 0.0
Change in the year affecting other comprehensive (loss) income (0.3)
Deferred tax liabilities, ending balance (2.7)
Intangible assets  
Changes in deferred tax liability (asset) [abstract]  
Deferred tax liabilities, beginning balance (18.8)
Change in the year affecting net income (0.8)
Change in the year affecting foreign exchange translation 0.0
Change in the year affecting other comprehensive (loss) income 0.0
Deferred tax liabilities, ending balance (19.6)
Property, plant and equipment  
Changes in deferred tax liability (asset) [abstract]  
Deferred tax liabilities, beginning balance (8.7)
Change in the year affecting net income (4.8)
Change in the year affecting foreign exchange translation 0.0
Change in the year affecting other comprehensive (loss) income 0.0
Deferred tax liabilities, ending balance $ (13.5)
v3.24.1.1.u2
Income taxes - Schedule of Changes in Deferred Tax Assets and Liabilities (Details)
$ in Millions
12 Months Ended
Mar. 31, 2024
CAD ($)
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]  
Deferred tax assets, beginning balance $ 67.5
Deferred tax liabilities, beginning balance (16.4)
Net deferred tax assets, beginning balance 51.1
Change in the year affecting net income 7.3
Change in the year affecting foreign exchange translation 0.9
Change in the year affecting other comprehensive income (0.2)
Deferred tax assets, ending balance 76.3
Deferred tax liabilities, ending balance (17.2)
Net deferred tax assets, ending balance 59.1
Deferred tax assets  
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]  
Change in the year affecting net income 8.8
Change in the year affecting foreign exchange translation 0.2
Change in the year affecting other comprehensive income (0.2)
Deferred tax liabilities  
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]  
Change in the year affecting net income (1.5)
Change in the year affecting foreign exchange translation 0.7
Change in the year affecting other comprehensive income $ 0.0
v3.24.1.1.u2
Income taxes - Narrative (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Unremitted earnings from foreign subsidiaries $ 419.8 $ 417.7 $ 356.4
Deferred tax on share-based payment     0.2
Stock options      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Deferred tax on share-based payment 0.0 0.0 0.0
RSU      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Deferred tax on share-based payment 0.0 0.0 0.2
PSU      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Deferred tax on share-based payment 0.0 $ 0.0 $ 0.0
Capital losses      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Decrease in deferred tax asset 0.5    
Tax relief from Swiss tax reform      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Decrease in deferred tax asset $ 31.8    
v3.24.1.1.u2
Income taxes - Schedule of Tax Loss Carryforwards (Details)
$ in Millions
Mar. 31, 2024
CAD ($)
Tax Loss Carry Forwards [Line Items]  
Unused tax losses for which no deferred tax asset recognised $ 46.0
2040 and prior  
Tax Loss Carry Forwards [Line Items]  
Unused tax losses for which no deferred tax asset recognised 13.1
2041  
Tax Loss Carry Forwards [Line Items]  
Unused tax losses for which no deferred tax asset recognised 8.8
2042  
Tax Loss Carry Forwards [Line Items]  
Unused tax losses for which no deferred tax asset recognised 8.5
2043  
Tax Loss Carry Forwards [Line Items]  
Unused tax losses for which no deferred tax asset recognised 7.5
2044  
Tax Loss Carry Forwards [Line Items]  
Unused tax losses for which no deferred tax asset recognised 8.1
Carry forward indefinitely  
Tax Loss Carry Forwards [Line Items]  
Unused tax losses for which no deferred tax asset recognised $ 52.2
v3.24.1.1.u2
Earnings per share (Details) - CAD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Earnings per share [abstract]      
Net income attributable to shareholders of the Company $ 58.4 $ 72.7 $ 94.6
Weighted average number of multiple and subordinate voting shares outstanding (in shares) 100,816,758 105,058,643 108,296,802
Weighted average number of shares on exercise of stock options and RSUs (in shares) 1,006,315 563,669 857,919
Diluted weighted average number of multiple and subordinate voting shares outstanding (in shares) 101,823,073 105,622,312 109,154,721
Basic (in CAD per share) $ 0.58 $ 0.69 $ 0.87
Diluted (in CAD per share) $ 0.57 $ 0.69 $ 0.87
Share options      
Earnings per share [line items]      
Number of instruments that are antidilutive in period presented (in shares) 3,904,366 2,231,231 1,475,545
v3.24.1.1.u2
Trade receivables - Schedule of Net Trade Receivables (Details) - CAD ($)
$ in Millions
Mar. 31, 2024
Apr. 02, 2023
Subclassifications of assets, liabilities and equities [abstract]    
Trade accounts receivable $ 57.1 $ 30.4
Credit card receivables 3.7 2.5
Other receivables 12.3 19.5
Current receivables 73.1 52.4
Less: expected credit loss and sales allowances (2.7) (1.5)
Trade receivables $ 70.4 $ 50.9
v3.24.1.1.u2
Trade receivables - Schedule of Allowance for Expected Credit Losses and Sales Allowances (Details) - Accumulated impairment - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Trade And Other Current Receivables [Line Items]    
Financial assets at beginning of period $ (1.5) $ (1.1)
Losses recognized (1.8) (0.4)
Amounts settled or written off during the year 0.6 0.0
Financial assets at end of period (2.7) (1.5)
Expected credit loss    
Trade And Other Current Receivables [Line Items]    
Financial assets at beginning of period (0.4) (0.3)
Losses recognized (1.8) (0.1)
Amounts settled or written off during the year 0.1 0.0
Financial assets at end of period (2.1) (0.4)
Sales allowances    
Trade And Other Current Receivables [Line Items]    
Financial assets at beginning of period (1.1) (0.8)
Losses recognized 0.0 (0.3)
Amounts settled or written off during the year 0.5 0.0
Financial assets at end of period $ (0.6) $ (1.1)
v3.24.1.1.u2
Inventories - Schedule of Inventories (Details) - CAD ($)
$ in Millions
Mar. 31, 2024
Apr. 02, 2023
Inventories [Abstract]    
Raw materials $ 48.4 $ 60.3
Work in progress 25.8 17.5
Finished goods 371.0 394.8
Total inventories at the lower of cost and net realizable value $ 445.2 $ 472.6
v3.24.1.1.u2
Inventories - Narrative (Details) - CAD ($)
$ in Millions
Mar. 31, 2024
Apr. 02, 2023
Inventories [Abstract]    
Provisions for obsolescence and inventory shrinkage $ 60.8 $ 43.2
v3.24.1.1.u2
Inventories - Schedule of Breakdown of Provision for Obsolescence (Details) - CAD ($)
$ in Millions
Mar. 31, 2024
Apr. 02, 2023
Inventories [Abstract]    
Raw material shrink reserves $ 0.1 $ 0.2
Finished goods shrink reserves 0.9 0.4
Raw material obsolete inventory reserves 22.1 20.5
Finished goods obsolete inventory reserves 37.7 22.1
Provision for obsolescence $ 60.8 $ 43.2
v3.24.1.1.u2
Inventories - Schedule of Cost of Sales (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Inventories [Abstract]      
Cost of goods manufactured $ 405.5 $ 392.1 $ 350.1
Depreciation and amortization included in costs of sales 10.9 9.7 14.7
Total cost of sales $ 416.4 $ 401.8 $ 364.8
v3.24.1.1.u2
Property, plant and equipment (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance $ 156.0  
Property, plant and equipment, ending balance 171.8 $ 156.0
Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance 296.4 217.1
Additions 60.4 75.2
Additions from business combinations (note 5) 2.6 1.2
Disposals 9.0 1.2
Transfers 0.0 0.0
Impact of foreign currency translation (2.5) 4.1
Property, plant and equipment, ending balance 347.9 296.4
Accumulated depreciation    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance (140.4) (102.9)
Depreciation 45.4 37.4
Disposals (8.7) (1.2)
Impairment losses 0.2 0.2
Impact of foreign currency translation (1.2) 1.1
Property, plant and equipment, ending balance (176.1) (140.4)
Plant equipment    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance 16.7  
Property, plant and equipment, ending balance 18.4 16.7
Plant equipment | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance 32.0 30.9
Additions 0.2 0.0
Additions from business combinations (note 5) 2.4 0.0
Disposals 0.1 0.0
Transfers 2.9 1.1
Impact of foreign currency translation (0.1) 0.0
Property, plant and equipment, ending balance 37.3 32.0
Plant equipment | Accumulated depreciation    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance (15.3) (12.1)
Depreciation 3.7 3.2
Disposals (0.1) 0.0
Impairment losses 0.0 0.0
Impact of foreign currency translation 0.0 0.0
Property, plant and equipment, ending balance (18.9) (15.3)
Computer equipment    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance 3.2  
Property, plant and equipment, ending balance 6.0 3.2
Computer equipment | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance 15.3 12.8
Additions 1.9 0.9
Additions from business combinations (note 5) 0.1 0.0
Disposals 0.3 0.1
Transfers 4.4 1.5
Impact of foreign currency translation (0.1) 0.2
Property, plant and equipment, ending balance 21.3 15.3
Computer equipment | Accumulated depreciation    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance (12.1) (9.3)
Depreciation 3.4 2.7
Disposals (0.2) (0.1)
Impairment losses 0.0 0.0
Impact of foreign currency translation 0.0 0.2
Property, plant and equipment, ending balance (15.3) (12.1)
Leasehold improvements    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance 75.3  
Property, plant and equipment, ending balance 126.1 75.3
Leasehold improvements | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance 151.4 125.1
Additions 11.5 8.8
Additions from business combinations (note 5) 0.1 0.9
Disposals 6.4 1.0
Transfers 70.4 15.5
Impact of foreign currency translation (1.8) 2.1
Property, plant and equipment, ending balance 225.2 151.4
Leasehold improvements | Accumulated depreciation    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance (76.1) (53.9)
Depreciation 30.2 23.1
Disposals (6.4) (1.0)
Impairment losses 0.2 0.2
Impact of foreign currency translation (1.0) (0.1)
Property, plant and equipment, ending balance (99.1) (76.1)
Show displays    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance 2.7  
Property, plant and equipment, ending balance 1.4 2.7
Show displays | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance 11.4 9.4
Additions 0.2 0.0
Additions from business combinations (note 5) 0.0 0.0
Disposals 1.0 0.0
Transfers (0.4) 1.6
Impact of foreign currency translation 0.1 0.4
Property, plant and equipment, ending balance 10.3 11.4
Show displays | Accumulated depreciation    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance (8.7) (7.3)
Depreciation 1.2 1.1
Disposals (1.0) 0.0
Impairment losses 0.0 0.0
Impact of foreign currency translation 0.0 0.3
Property, plant and equipment, ending balance (8.9) (8.7)
Furniture and fixtures    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance 11.6  
Property, plant and equipment, ending balance 15.8 11.6
Furniture and fixtures | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance 39.8 34.8
Additions 3.7 2.2
Additions from business combinations (note 5) 0.0 0.3
Disposals 1.1 0.1
Transfers 7.7 1.6
Impact of foreign currency translation (0.4) 1.0
Property, plant and equipment, ending balance 49.7 39.8
Furniture and fixtures | Accumulated depreciation    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance (28.2) (20.3)
Depreciation 6.9 7.3
Disposals (1.0) (0.1)
Impairment losses 0.0 0.0
Impact of foreign currency translation (0.2) 0.7
Property, plant and equipment, ending balance (33.9) (28.2)
In progress    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance 46.5  
Property, plant and equipment, ending balance 4.1 46.5
In progress | Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance 46.5 4.1
Additions 42.9 63.3
Additions from business combinations (note 5) 0.0 0.0
Disposals 0.1 0.0
Transfers (85.0) (21.3)
Impact of foreign currency translation (0.2) 0.4
Property, plant and equipment, ending balance 4.1 46.5
In progress | Accumulated depreciation    
Reconciliation of changes in property, plant and equipment [abstract]    
Property, plant and equipment, beginning balance 0.0 0.0
Depreciation 0.0 0.0
Disposals 0.0 0.0
Impairment losses 0.0 0.0
Impact of foreign currency translation 0.0 0.0
Property, plant and equipment, ending balance $ 0.0 $ 0.0
v3.24.1.1.u2
Intangible assets - Schedule of Intangible Assets (Details) - CAD ($)
$ in Millions
Mar. 31, 2024
Apr. 02, 2023
Disclosure of detailed information about intangible assets [line items]    
Intangible assets $ 135.1 $ 135.1
Intangible assets with finite lives    
Disclosure of detailed information about intangible assets [line items]    
Intangible assets 18.3 19.3
Intangible assets with indefinite lives: | Brand name    
Disclosure of detailed information about intangible assets [line items]    
Intangible assets 116.5 115.5
Intangible assets with indefinite lives: | Domain name    
Disclosure of detailed information about intangible assets [line items]    
Intangible assets $ 0.3 $ 0.3
v3.24.1.1.u2
Intangible assets - Schedule of Changes in Intangible Assets with Finite Lives (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Reconciliation of changes in intangible assets other than goodwill [abstract]    
Intangible assets, beginning balance $ 135.1  
Intangible assets, ending balance 135.1 $ 135.1
Intangible assets with finite lives    
Reconciliation of changes in intangible assets other than goodwill [abstract]    
Intangible assets, beginning balance 19.3  
Intangible assets, ending balance 18.3 19.3
Intangible assets with finite lives | Cost    
Reconciliation of changes in intangible assets other than goodwill [abstract]    
Intangible assets, beginning balance 43.5 26.7
Additions 0.9 1.9
Additions from business combinations (note 5) 3.5 14.9
Disposals 0.1  
Impact of foreign currency translation (1.6)  
Intangible assets, ending balance 46.2 43.5
Intangible assets with finite lives | Accumulated amortization    
Reconciliation of changes in intangible assets other than goodwill [abstract]    
Intangible assets, beginning balance (24.2) (20.3)
Amortization 3.8 3.9
Disposals (0.1)  
Impact of foreign currency translation 0.0  
Intangible assets, ending balance (27.9) (24.2)
Intangible assets with finite lives | Software    
Reconciliation of changes in intangible assets other than goodwill [abstract]    
Intangible assets, beginning balance 4.9  
Intangible assets, ending balance 3.8 4.9
Intangible assets with finite lives | Software | Cost    
Reconciliation of changes in intangible assets other than goodwill [abstract]    
Intangible assets, beginning balance 10.3 8.5
Additions 0.8 1.8
Additions from business combinations (note 5) 0.0 0.0
Disposals 0.1  
Impact of foreign currency translation (0.1)  
Intangible assets, ending balance 10.9 10.3
Intangible assets with finite lives | Software | Accumulated amortization    
Reconciliation of changes in intangible assets other than goodwill [abstract]    
Intangible assets, beginning balance (5.4) (3.6)
Amortization 1.8 1.8
Disposals (0.1)  
Impact of foreign currency translation 0.0  
Intangible assets, ending balance (7.1) (5.4)
Intangible assets with finite lives | Intellectual property    
Reconciliation of changes in intangible assets other than goodwill [abstract]    
Intangible assets, beginning balance 0.9  
Intangible assets, ending balance 0.6 0.9
Intangible assets with finite lives | Intellectual property | Cost    
Reconciliation of changes in intangible assets other than goodwill [abstract]    
Intangible assets, beginning balance 18.3 18.2
Additions 0.1 0.1
Additions from business combinations (note 5) 0.0 0.0
Disposals 0.0  
Impact of foreign currency translation 0.1  
Intangible assets, ending balance 18.5 18.3
Intangible assets with finite lives | Intellectual property | Accumulated amortization    
Reconciliation of changes in intangible assets other than goodwill [abstract]    
Intangible assets, beginning balance (17.4) (16.7)
Amortization 0.5 0.7
Disposals 0.0  
Impact of foreign currency translation 0.0  
Intangible assets, ending balance (17.9) (17.4)
Intangible assets with finite lives | Customer-related intangible assets    
Reconciliation of changes in intangible assets other than goodwill [abstract]    
Intangible assets, beginning balance 7.0  
Intangible assets, ending balance 8.9 7.0
Intangible assets with finite lives | Customer-related intangible assets | Cost    
Reconciliation of changes in intangible assets other than goodwill [abstract]    
Intangible assets, beginning balance 7.7 0.0
Additions 0.0 0.0
Additions from business combinations (note 5) 3.5 7.7
Disposals 0.0  
Impact of foreign currency translation (0.7)  
Intangible assets, ending balance 10.5 7.7
Intangible assets with finite lives | Customer-related intangible assets | Accumulated amortization    
Reconciliation of changes in intangible assets other than goodwill [abstract]    
Intangible assets, beginning balance (0.7) 0.0
Amortization 0.8 0.7
Disposals 0.0  
Impact of foreign currency translation 0.1  
Intangible assets, ending balance (1.6) (0.7)
Intangible assets with finite lives | Distribution rights    
Reconciliation of changes in intangible assets other than goodwill [abstract]    
Intangible assets, beginning balance 6.5  
Intangible assets, ending balance 5.0 6.5
Intangible assets with finite lives | Distribution rights | Cost    
Reconciliation of changes in intangible assets other than goodwill [abstract]    
Intangible assets, beginning balance 7.2 0.0
Additions 0.0 0.0
Additions from business combinations (note 5) 0.0 7.2
Disposals 0.0  
Impact of foreign currency translation (0.9)  
Intangible assets, ending balance 6.3 7.2
Intangible assets with finite lives | Distribution rights | Accumulated amortization    
Reconciliation of changes in intangible assets other than goodwill [abstract]    
Intangible assets, beginning balance (0.7) 0.0
Amortization 0.7 0.7
Disposals 0.0  
Impact of foreign currency translation (0.1)  
Intangible assets, ending balance $ (1.3) $ (0.7)
v3.24.1.1.u2
Intangible assets - Narrative (Details) - CAD ($)
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Intangible assets other than goodwill [abstract]    
Impairment loss on intangible assets $ 0 $ 0
v3.24.1.1.u2
Leases - Schedule of Changes in Right-of-Use Assets (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Right-of-use assets    
Right-of-use assets, beginning balance $ 291.8  
Right-of-use assets, ending balance 279.8 $ 291.8
Retail stores    
Right-of-use assets    
Right-of-use assets, beginning balance 225.6  
Right-of-use assets, ending balance 220.6 225.6
Manufacturing facilities    
Right-of-use assets    
Right-of-use assets, beginning balance 24.3  
Right-of-use assets, ending balance 20.2 24.3
Other    
Right-of-use assets    
Right-of-use assets, beginning balance 41.9  
Right-of-use assets, ending balance 39.0 41.9
Cost    
Right-of-use assets    
Right-of-use assets, beginning balance 500.0 350.4
Additions 32.7 130.6
Additions from business combinations (note 5) 1.2 3.3
Lease modifications 33.7 2.4
Derecognition on termination (9.0) (2.8)
Impact of foreign currency translation (3.2) 16.1
Right-of-use assets, ending balance 555.4 500.0
Cost | Retail stores    
Right-of-use assets    
Right-of-use assets, beginning balance 396.7 296.3
Additions 29.8 82.8
Additions from business combinations (note 5) 0.0 1.5
Lease modifications 31.9 2.4
Derecognition on termination (5.1) (1.8)
Impact of foreign currency translation (3.0) 15.5
Right-of-use assets, ending balance 450.3 396.7
Cost | Manufacturing facilities    
Right-of-use assets    
Right-of-use assets, beginning balance 44.9 36.7
Additions 0.2 8.2
Additions from business combinations (note 5) 1.2 0.0
Lease modifications 0.0 0.0
Derecognition on termination (2.1) 0.0
Impact of foreign currency translation 0.0 0.0
Right-of-use assets, ending balance 44.2 44.9
Cost | Other    
Right-of-use assets    
Right-of-use assets, beginning balance 58.4 17.4
Additions 2.7 39.6
Additions from business combinations (note 5) 0.0 1.8
Lease modifications 1.8 0.0
Derecognition on termination (1.8) (1.0)
Impact of foreign currency translation (0.2) 0.6
Right-of-use assets, ending balance 60.9 58.4
Accumulated depreciation    
Right-of-use assets    
Right-of-use assets, beginning balance (208.2) (135.2)
Depreciation 76.6 68.1
Derecognition on termination (9.0) (2.2)
Impairment losses 1.0 0.8
Impact of foreign currency translation (1.2) 6.3
Right-of-use assets, ending balance (275.6) (208.2)
Accumulated depreciation | Retail stores    
Right-of-use assets    
Right-of-use assets, beginning balance (171.1) (110.1)
Depreciation 63.8 55.5
Derecognition on termination (5.1) (1.2)
Impairment losses 1.0 0.8
Impact of foreign currency translation (1.1) 5.9
Right-of-use assets, ending balance (229.7) (171.1)
Accumulated depreciation | Manufacturing facilities    
Right-of-use assets    
Right-of-use assets, beginning balance (20.6) (15.2)
Depreciation 5.5 5.4
Derecognition on termination (2.1) 0.0
Impairment losses 0.0 0.0
Impact of foreign currency translation 0.0 0.0
Right-of-use assets, ending balance (24.0) (20.6)
Accumulated depreciation | Other    
Right-of-use assets    
Right-of-use assets, beginning balance (16.5) (9.9)
Depreciation 7.3 7.2
Derecognition on termination (1.8) (1.0)
Impairment losses 0.0 0.0
Impact of foreign currency translation (0.1) 0.4
Right-of-use assets, ending balance $ (21.9) $ (16.5)
v3.24.1.1.u2
Leases - Schedule of Changes in Lease Liabilities (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Lease liabilities    
Lease liabilities, beginning balance $ 334.8 $ 250.7
Additions 32.2 129.9
Additions from business combinations (note 5) 1.2 3.2
Lease modifications 33.7 2.4
Derecognition on termination   (0.7)
Principal payments (69.2) (62.2)
Impact of foreign currency translation (2.2) 11.5
Lease liabilities, ending balance 330.5 334.8
Retail stores    
Lease liabilities    
Lease liabilities, beginning balance 259.2 217.2
Additions 29.7 82.1
Additions from business combinations (note 5) 0.0 1.5
Lease modifications 31.9 2.4
Derecognition on termination   (0.7)
Principal payments (63.0) (54.5)
Impact of foreign currency translation (2.1) 11.2
Lease liabilities, ending balance 255.7 259.2
Manufacturing facilities    
Lease liabilities    
Lease liabilities, beginning balance 27.7 24.8
Additions 0.2 8.2
Additions from business combinations (note 5) 1.2 0.0
Lease modifications 0.0 0.0
Derecognition on termination   0.0
Principal payments (5.3) (5.3)
Impact of foreign currency translation 0.0 0.0
Lease liabilities, ending balance 23.8 27.7
Other    
Lease liabilities    
Lease liabilities, beginning balance 47.9 8.7
Additions 2.3 39.6
Additions from business combinations (note 5) 0.0 1.7
Lease modifications 1.8 0.0
Derecognition on termination   0.0
Principal payments (0.9) (2.4)
Impact of foreign currency translation (0.1) 0.3
Lease liabilities, ending balance $ 51.0 $ 47.9
v3.24.1.1.u2
Leases - Schedule of Classification of Lease Liabilities (Details) - CAD ($)
$ in Millions
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Schedule of Detailed Information About Lease Liabilities [Line Items]      
Current lease liabilities $ 79.9 $ 76.1  
Non-current lease liabilities 250.6 258.7  
Lease liabilities 330.5 334.8 $ 250.7
Retail stores      
Schedule of Detailed Information About Lease Liabilities [Line Items]      
Current lease liabilities 65.8 64.7  
Non-current lease liabilities 189.9 194.5  
Lease liabilities 255.7 259.2 217.2
Manufacturing facilities      
Schedule of Detailed Information About Lease Liabilities [Line Items]      
Current lease liabilities 6.3 6.1  
Non-current lease liabilities 17.5 21.6  
Lease liabilities 23.8 27.7 24.8
Other      
Schedule of Detailed Information About Lease Liabilities [Line Items]      
Current lease liabilities 7.8 5.3  
Non-current lease liabilities 43.2 42.6  
Lease liabilities $ 51.0 $ 47.9 $ 8.7
v3.24.1.1.u2
Leases - Narrative (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Leases, Assets And Liabilities [Abstract]      
Lease payments not included in the measurement of lease liabilities $ 39.6 $ 23.5 $ 21.5
v3.24.1.1.u2
Goodwill - Schedule of Changes in Goodwill (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Reconciliation of changes in goodwill [abstract]    
Goodwill at beginning of period $ 63.9 $ 53.1
Business combination (note 5) 8.3 10.8
Increase (decrease) through net exchange differences, goodwill (1.4) 0.0
Goodwill at end of period $ 70.8 $ 63.9
v3.24.1.1.u2
Goodwill - Narrative (Details)
$ in Millions
12 Months Ended
Mar. 31, 2024
CAD ($)
cashGeneratingUnit
Apr. 02, 2023
CAD ($)
cashGeneratingUnit
Disclosure of reconciliation of changes in goodwill [line items]    
Number of cash generating units that contribute to cash flows | cashGeneratingUnit 11 10
Impairment loss recognised in profit or loss, goodwill | $ $ 0.0 $ 0.0
Excess of recoverable value over carrying value per CGU 23.50%  
Discount rate applied to cash flow projections 12.80% 12.67%
Cash flow projections, period 5 years  
Growth rate used to extrapolate cash flow projections 2.00%  
v3.24.1.1.u2
Goodwill - Disclosure of Goodwill Allocation by Cash-Generating Units (Details)
¥ in Millions, $ in Millions
12 Months Ended
Mar. 31, 2024
CAD ($)
Apr. 02, 2023
CAD ($)
Mar. 31, 2024
JPY (¥)
Apr. 03, 2022
CAD ($)
Disclosure of information for cash-generating units [line items]        
Goodwill $ 70.8 $ 63.9   $ 53.1
Increase (decrease) through net exchange differences, goodwill (1.4) 0.0    
North America DTC - Retail        
Disclosure of information for cash-generating units [line items]        
Goodwill 11.7 11.7    
North America DTC - e-Commerce        
Disclosure of information for cash-generating units [line items]        
Goodwill 6.6 6.6    
North America Wholesale        
Disclosure of information for cash-generating units [line items]        
Goodwill 5.7 5.7    
Asia Pacific DTC - Retail        
Disclosure of information for cash-generating units [line items]        
Goodwill 9.8 9.8    
Asia Pacific DTC - e-Commerce        
Disclosure of information for cash-generating units [line items]        
Goodwill 2.6 2.6    
Asia Pacific Wholesale        
Disclosure of information for cash-generating units [line items]        
Goodwill 3.6 3.6    
EMEA DTC - Retail        
Disclosure of information for cash-generating units [line items]        
Goodwill 4.3 4.3    
EMEA DTC - e-Commerce        
Disclosure of information for cash-generating units [line items]        
Goodwill 2.8 2.8    
EMEA Wholesale        
Disclosure of information for cash-generating units [line items]        
Goodwill 6.0 6.0    
Japan Joint Venture        
Disclosure of information for cash-generating units [line items]        
Goodwill 9.4 10.8 ¥ 1,059.3  
Increase (decrease) through net exchange differences, goodwill 1.4      
Paola Confectii        
Disclosure of information for cash-generating units [line items]        
Goodwill $ 8.3 $ 0.0    
v3.24.1.1.u2
Accounts payables and accrued liabilities (Details) - CAD ($)
$ in Millions
Mar. 31, 2024
Apr. 02, 2023
Subclassifications of assets, liabilities and equities [abstract]    
Trade payables $ 57.6 $ 60.1
Accrued liabilities 73.5 82.4
Employee benefits 38.6 21.9
Derivative financial instruments 1.9 3.3
ASPP liability (note 18) 0.0 20.0
Other payables 6.1 7.9
Accounts payable and accrued liabilities $ 177.7 $ 195.6
v3.24.1.1.u2
Provisions - Narrative (Details)
12 Months Ended
Mar. 31, 2024
Provisions [abstract]  
Revenue recognition, return period 30 days
v3.24.1.1.u2
Provisions - Schedule of Reconciliation of Provisions (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Reconciliation of changes in other provisions [abstract]    
Provisions, beginning balance $ 58.1 $ 49.8
Additional provisions recognized 30.0 22.5
Reductions resulting from settlement (23.7) (13.9)
Release of provisions (0.8) (1.3)
Other (0.2) 1.0
Provisions, ending balance 63.4 58.1
Warranty    
Reconciliation of changes in other provisions [abstract]    
Provisions, beginning balance 30.4 29.2
Additional provisions recognized 6.6 7.6
Reductions resulting from settlement (6.8) (6.4)
Release of provisions 0.0 0.0
Other 0.1 0.0
Provisions, ending balance 30.3 30.4
Sales returns    
Reconciliation of changes in other provisions [abstract]    
Provisions, beginning balance 15.6 12.9
Additional provisions recognized 20.8 10.8
Reductions resulting from settlement (16.9) (7.5)
Release of provisions (0.7) (1.3)
Other 0.0 0.7
Provisions, ending balance 18.8 15.6
Asset retirement obligations    
Reconciliation of changes in other provisions [abstract]    
Provisions, beginning balance 12.1 7.7
Additional provisions recognized 2.6 4.1
Reductions resulting from settlement 0.0 0.0
Release of provisions (0.1) 0.0
Other (0.3) 0.3
Provisions, ending balance $ 14.3 $ 12.1
v3.24.1.1.u2
Provisions - Schedule of Current and Non-Current Provisions (Details) - CAD ($)
$ in Millions
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Provisions [abstract]      
Current provisions $ 26.1 $ 21.6  
Non-current provisions 37.3 36.5  
Provisions $ 63.4 $ 58.1 $ 49.8
v3.24.1.1.u2
Borrowings - Amendments to borrowings (Details)
$ in Millions
Jul. 02, 2023
CAD ($)
Deferred financing costs netting | The Revolving Facility  
Disclosure of detailed information about borrowings [line items]  
Borrowings $ (0.7)
v3.24.1.1.u2
Borrowings - Revolving Facility (Details) - The Revolving Facility - CAD ($)
Mar. 31, 2024
Apr. 02, 2023
Feb. 24, 2020
Disclosure of detailed information about borrowings [line items]      
Line of credit facility, maximum borrowing capacity     $ 467,500,000
Line of credit facility, increase in credit facility commitments     $ 517,500,000
Line of credit facility, repayment   $ 0  
Line of credit facility, interest and administrative fees, outstanding $ 0 0  
Line of credit facility, unused borrowing capacity 203,700,000 238,400,000  
Line of credit facility, credit commitment 25,000,000    
Line of credit facility, credit sub-commitment 5,000,000    
Line of credit facility, swingline commitment 25,000,000    
Deferred financing charges | Other noncurrent liabilities      
Disclosure of detailed information about borrowings [line items]      
Borrowings 1,000,000 500,000  
Letters of credit outstanding      
Disclosure of detailed information about borrowings [line items]      
Borrowings $ 1,500,000 $ 1,800,000  
v3.24.1.1.u2
Borrowings - Term Loan (Details) - Term Loan
$ in Thousands, $ in Millions
Mar. 31, 2024
CAD ($)
Mar. 31, 2024
USD ($)
Apr. 02, 2023
CAD ($)
Apr. 02, 2023
USD ($)
Oct. 07, 2020
USD ($)
Disclosure of detailed information about borrowings [line items]          
Borrowings $ 392.5   $ 395.7   $ 300,000
Borrowings, quarterly repayment         $ 750
Borrowings, interest rate 8.94% 8.94%      
Borrowings, outstanding amount $ 393.1 $ 290,300 $ 396.3 $ 293,300  
Secured Overnight Financing Rate          
Disclosure of detailed information about borrowings [line items]          
Borrowings, interest rate         3.50%
Borrowings interest rate, additional rate (%)         0.11448%
Minimum | Secured Overnight Financing Rate          
Disclosure of detailed information about borrowings [line items]          
Borrowings, interest rate         0.75%
v3.24.1.1.u2
Borrowings - Schedule of Term Loan (Details) - Term Loan
$ in Millions, $ in Millions
Mar. 31, 2024
CAD ($)
Mar. 31, 2024
USD ($)
Apr. 02, 2023
CAD ($)
Apr. 02, 2023
USD ($)
Oct. 07, 2020
USD ($)
Disclosure of detailed information about borrowings [line items]          
Term Loan $ 393.1 $ 290.3 $ 396.3 $ 293.3  
Unamortized portion of deferred transaction costs (0.6)   (0.6)    
Total borrowings $ 392.5   $ 395.7   $ 300.0
v3.24.1.1.u2
Borrowings - Mainland China Facilities (Details)
¥ in Millions, ¥ in Millions
12 Months Ended
Mar. 31, 2024
CAD ($)
segment
Mar. 31, 2024
JPY (¥)
segment
Mar. 31, 2024
CNY (¥)
segment
Apr. 02, 2023
CAD ($)
Apr. 02, 2023
JPY (¥)
Apr. 02, 2023
CNY (¥)
Disclosure of detailed information about borrowings [line items]            
Short-term borrowings | $ $ 9,400,000     $ 27,600,000    
Mainland China Facilities            
Disclosure of detailed information about borrowings [line items]            
Borrowings, number of loan facilities | segment 2 2 2      
Borrowings $ 50,000,000   ¥ 266.4      
Borrowings, interest rate in terms of loan rate 1 year          
Short-term borrowings $ 0     9,800,000   ¥ 50.0
Mainland China Facilities | Minimum            
Disclosure of detailed information about borrowings [line items]            
Borrowings, adjustment to interest rate basis 0.35% 0.35% 0.35%      
Mainland China Facilities | Maximum            
Disclosure of detailed information about borrowings [line items]            
Borrowings, term 12 months          
Borrowings, adjustment to interest rate basis 0.45% 0.45% 0.45%      
Mainland China Facilities | Term one            
Disclosure of detailed information about borrowings [line items]            
Borrowings, term 1 month          
Borrowings, interest rate payable, period 1 month          
Mainland China Facilities | Term two            
Disclosure of detailed information about borrowings [line items]            
Borrowings, term 3 months          
Borrowings, interest rate payable, period 3 months          
Mainland China Facilities | Term three            
Disclosure of detailed information about borrowings [line items]            
Borrowings, term 6 months          
Borrowings, interest rate payable, period 6 months          
Japan Facility            
Disclosure of detailed information about borrowings [line items]            
Borrowings, term 12 months          
Short-term borrowings $ 5,400,000 ¥ 600.0   $ 13,700,000 ¥ 1,350.0  
Borrowings, interest rate 0.45% 0.45% 0.45%      
v3.24.1.1.u2
Borrowings - Japan Facility (Details)
¥ in Millions, ¥ in Millions
12 Months Ended
Mar. 31, 2024
JPY (¥)
Mar. 31, 2024
CAD ($)
Apr. 02, 2023
JPY (¥)
Apr. 02, 2023
CAD ($)
Apr. 02, 2023
CNY (¥)
Disclosure of detailed information about borrowings [line items]          
Short-term borrowings   $ 9,400,000   $ 27,600,000  
Japan Facility          
Disclosure of detailed information about borrowings [line items]          
Line of credit facility, maximum borrowing capacity ¥ 4,000.0 $ 35,800,000      
Borrowings, interest rate 0.45% 0.45%      
Borrowings, term 12 months        
Short-term borrowings ¥ 600.0 $ 5,400,000 ¥ 1,350.0 13,700,000  
Japan Facility | TIBOR          
Disclosure of detailed information about borrowings [line items]          
Borrowings, adjustment to interest rate basis 0.30% 0.30%      
Mainland China Facilities          
Disclosure of detailed information about borrowings [line items]          
Short-term borrowings   $ 0   $ 9,800,000 ¥ 50.0
v3.24.1.1.u2
Borrowings - Short-term Borrowings (Details)
¥ in Millions, ¥ in Millions
Mar. 31, 2024
CAD ($)
Mar. 31, 2024
JPY (¥)
Apr. 02, 2023
CAD ($)
Apr. 02, 2023
JPY (¥)
Apr. 02, 2023
CNY (¥)
Disclosure of detailed information about borrowings [line items]          
Short-term borrowings $ 9,400,000   $ 27,600,000    
Mainland China Facilities          
Disclosure of detailed information about borrowings [line items]          
Short-term borrowings 0   9,800,000   ¥ 50.0
Japan Facility          
Disclosure of detailed information about borrowings [line items]          
Short-term borrowings 5,400,000 ¥ 600.0 13,700,000 ¥ 1,350.0  
Term Loan          
Disclosure of detailed information about borrowings [line items]          
Short-term borrowings $ 4,000,000   $ 4,100,000    
v3.24.1.1.u2
Borrowings - Schedule of Net Interest and Other Finance Costs (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Disclosure of detailed information about borrowings [line items]      
Standby fees $ 1.2 $ 1.8 $ 0.9
Acceleration of unamortized costs on debt extinguishment 0.0 0.0 9.5
Foreign exchange losses on Term Loan net of hedges 2.1 12.1 2.8
Fair value remeasurement on the put option liability (note 21) 1.6 10.9 0.0
Fair value remeasurement on the contingent consideration (note 21) 2.8 (2.9) 0.0
Interest income (1.3) (0.9) (0.4)
Other costs 1.0 1.0 0.3
Net interest, finance and other costs 48.8 54.1 41.8
Mainland China Facilities      
Disclosure of detailed information about borrowings [line items]      
Interest expense 0.9 0.5 0.4
Japan Facility      
Disclosure of detailed information about borrowings [line items]      
Interest expense 0.1 0.1 0.0
Revolving Facility      
Disclosure of detailed information about borrowings [line items]      
Interest expense 2.8 1.1 1.8
Term Loan      
Disclosure of detailed information about borrowings [line items]      
Interest expense 19.9 18.8 17.4
Lease liabilities      
Disclosure of detailed information about borrowings [line items]      
Interest expense $ 17.7 $ 11.6 $ 9.1
v3.24.1.1.u2
Shareholders' equity - Issued Share Capital (Details)
12 Months Ended
Mar. 31, 2024
vote
Multiple voting shares  
Disclosure of classes of share capital [line items]  
Number of votes per share 10
Conversion ratio of multiple voting shares to subordinate shares 1
Percentage beneficial ownership when shares will automatically be converted (less than) 0.15
Subordinate voting shares  
Disclosure of classes of share capital [line items]  
Number of votes per share 1
v3.24.1.1.u2
Shareholders' equity - Normal Course Issuer Bid (Details) - CAD ($)
$ in Millions
9 Months Ended 12 Months Ended 16 Months Ended
Aug. 06, 2021
Dec. 31, 2023
Nov. 21, 2024
Mar. 31, 2024
Nov. 21, 2023
Apr. 02, 2023
Apr. 03, 2022
Mar. 31, 2024
Disclosure of classes of share capital [line items]                
Number of shares repurchased (in shares)       7,855,007   1,152,802 5,636,763  
Normal course issuer bid purchase of subordinate voting shares       $ 140.2   $ 26.7 $ 253.2  
Share repurchase program, liability to broker       $ 0.0   $ 20.0   $ 0.0
Share repurchase program, percentage of issued and outstanding shares 10.00%              
Subordinate voting shares                
Disclosure of classes of share capital [line items]                
Share repurchase program, period     12 months   12 months      
Number of shares repurchased (in shares)   4,268,883   7,855,007   1,152,802 5,636,763 5,421,685
Normal course issuer bid purchase of subordinate voting shares   $ 83.3       $ 26.7 $ 253.2 $ 111.2
Subordinate voting shares | Maximum                
Disclosure of classes of share capital [line items]                
Number of shares authorized for repurchase (in shares)     4,980,505   5,421,685   5,943,239  
Subordinate voting shares | Automatic Share Purchase Plan (“ASPP”)                
Disclosure of classes of share capital [line items]                
Number of shares repurchased (in shares)   1,184,152   3,088,648   821,622    
Normal course issuer bid purchase of subordinate voting shares   $ 25.3   $ 49.6   $ 20.0    
Subordinate voting shares | Fiscal 2024 NCIB                
Disclosure of classes of share capital [line items]                
Number of shares repurchased (in shares)       3,586,124        
Normal course issuer bid purchase of subordinate voting shares       $ 56.9        
Retained earnings                
Disclosure of classes of share capital [line items]                
Normal course issuer bid purchase of subordinate voting shares       122.4   24.3 $ 241.3  
Retained earnings | Subordinate voting shares                
Disclosure of classes of share capital [line items]                
Normal course issuer bid purchase of subordinate voting shares   $ 73.6       $ 25.4 $ 241.3  
Retained earnings | Subordinate voting shares | Fiscal 2024 NCIB                
Disclosure of classes of share capital [line items]                
Normal course issuer bid purchase of subordinate voting shares       $ 48.8        
v3.24.1.1.u2
Shareholders' equity - Schedule of Transactions Affecting Issued and Outstanding Share Capital (Details) - CAD ($)
$ in Millions
9 Months Ended 12 Months Ended 16 Months Ended
Dec. 31, 2023
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Mar. 31, 2024
Number          
Number of shares outstanding, beginning balance (in shares) 104,188,988 104,188,988 105,194,508 110,439,155  
Purchase of subordinate voting shares (in shares)   (7,855,007) (1,103,102) (5,636,763)  
Purchase of subordinate voting shares held for cancellation (in shares)     (49,700)    
Purchase of subordinate voting shares (in shares)   (7,855,007) (1,152,802) (5,636,763)  
Exercise of stock options (in shares)   64,058 60,248 342,148  
Settlement of RSUs (in shares)   134,475 87,034 49,968  
Total share issuances (in shares)   198,533 147,282 392,116  
Number of shares outstanding, ending balance (in shares)   96,532,514 104,188,988 105,194,508 96,532,514
$          
Shareholders’ equity, beginning balance $ 477.5 $ 477.5 $ 427.9 $ 577.6  
Total share issuances   0.1 0.0 7.1  
Shareholders’ equity, ending balance   $ 423.5 $ 477.5 $ 427.9 $ 423.5
Multiple voting shares          
Number          
Number of shares outstanding, beginning balance (in shares) 51,004,076 51,004,076 51,004,076 51,004,076  
Purchase of subordinate voting shares (in shares)   0 0 0  
Purchase of subordinate voting shares held for cancellation (in shares)     0    
Purchase of subordinate voting shares (in shares)   0 0 0  
Exercise of stock options (in shares)   0 0 0  
Settlement of RSUs (in shares)   0 0 0  
Total share issuances (in shares)   0 0 0  
Number of shares outstanding, ending balance (in shares)   51,004,076 51,004,076 51,004,076 51,004,076
Subordinate voting shares          
Number          
Number of shares outstanding, beginning balance (in shares) 53,184,912 53,184,912 54,190,432 59,435,079  
Purchase of subordinate voting shares (in shares)   (7,855,007) (1,103,102) (5,636,763)  
Purchase of subordinate voting shares held for cancellation (in shares)     (49,700)    
Purchase of subordinate voting shares (in shares) (4,268,883) (7,855,007) (1,152,802) (5,636,763) (5,421,685)
Exercise of stock options (in shares)   64,058 60,248 342,148  
Settlement of RSUs (in shares)   134,475 87,034 49,968  
Total share issuances (in shares)   198,533 147,282 392,116  
Number of shares outstanding, ending balance (in shares)   45,528,438 53,184,912 54,190,432 45,528,438
Share capital          
$          
Shareholders’ equity, beginning balance $ 118.7 $ 118.7 $ 118.5 $ 120.5  
Purchase of subordinate voting shares (in $ per share)   (17.8) (2.4) (11.9)  
Purchase of subordinate voting shares held for cancellation     (0.1)    
Total share purchases   (17.8) (2.5) (11.9)  
Exercise of stock options (in $ per share)   0.2 0.0 8.5  
Settlement of RSUs   3.8 2.7 1.4  
Total share issuances   4.0 2.7 9.9  
Shareholders’ equity, ending balance   104.9 118.7 118.5 $ 104.9
Share capital | Multiple voting shares          
$          
Shareholders’ equity, beginning balance 1.4 1.4 1.4 1.4  
Purchase of subordinate voting shares (in $ per share)   0.0 0.0 0.0  
Purchase of subordinate voting shares held for cancellation     0.0    
Total share purchases   0.0 0.0 0.0  
Exercise of stock options (in $ per share)   0.0 0.0 0.0  
Settlement of RSUs   0.0 0.0 0.0  
Total share issuances   0.0 0.0 0.0  
Shareholders’ equity, ending balance   1.4 1.4 1.4 1.4
Share capital | Subordinate voting shares          
$          
Shareholders’ equity, beginning balance $ 117.3 117.3 117.1 119.1  
Purchase of subordinate voting shares (in $ per share)   (17.8) (2.4) (11.9)  
Purchase of subordinate voting shares held for cancellation     (0.1)    
Total share purchases   (17.8) (2.5) (11.9)  
Exercise of stock options (in $ per share)   0.2 0.0 8.5  
Settlement of RSUs   3.8 2.7 1.4  
Total share issuances   4.0 2.7 9.9  
Shareholders’ equity, ending balance   $ 103.5 $ 117.3 $ 117.1 $ 103.5
v3.24.1.1.u2
Share-based payments - Narrative (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Expiration term of options 10 years    
Contributed surplus and compensation expense for the vesting of stock options $ 10.4 $ 15.0 $ 14.0
Legacy Plan      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Number of future share options issuable in share-based payment arrangement (in shares) 0    
Omnibus Plan      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Vesting period of stock options 4 years    
Vesting rate 25.00%    
Vesting period of RSUs 3 years    
Subordinate voting shares | Omnibus Plan      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Stock issued per RSU upon settlement (in shares) 1    
Maximum number of shares reserved for issuance under equity incentive plans (in shares) 5,310,387    
v3.24.1.1.u2
Share-based payments - Schedule of Stock Option Transactions (Details)
12 Months Ended
Mar. 31, 2024
shares
$ / shares
Apr. 02, 2023
shares
$ / shares
Apr. 03, 2022
shares
$ / shares
Weighted average exercise price      
Options outstanding, beginning balance (in CAD per share) | $ / shares $ 36.58 $ 42.99  
Granted to purchase shares (in CAD per share) | $ / shares 19.77 24.63  
Exercised (in CAD per share) | $ / shares 1.61 0.23  
Cancelled (in CAD per share) | $ / shares 28.83 40.66  
Options outstanding, ending balance (in CAD per share) | $ / shares $ 33.51 $ 36.58 $ 42.99
Number of shares      
Options/RSUs/PSUs outstanding, beginning balance (in shares) | shares 4,055,199 2,722,690  
Granted to purchase shares (in shares) | shares 1,278,211 1,580,506  
Exercised (in shares) | shares (64,058) (60,248) (342,148)
Cancelled (in shares) | shares (660,575) (187,749)  
Options/RSUs/PSUs outstanding, ending balance (in shares) | shares 4,608,777 4,055,199 2,722,690
v3.24.1.1.u2
Share-based payments - Schedule of Stock Options Outstanding and Exercisable (Details)
12 Months Ended
Mar. 31, 2024
shares
$ / shares
Apr. 02, 2023
shares
Apr. 03, 2022
shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Number of options outstanding (in shares) 4,608,777 4,055,199 2,722,690
Weighted average remaining life in years, options outstanding 7 years    
Number of options exercisable (in shares) 2,126,205    
Weighted average remaining life in years, options exercisable 5 years 3 months 18 days    
$0.02      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise price (in CAD per share) | $ / shares $ 0.02    
Number of options outstanding (in shares) 15,434    
Weighted average remaining life in years, options outstanding 0 years    
Number of options exercisable (in shares) 15,434    
Weighted average remaining life in years, options exercisable 0 years    
$1.79      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise price (in CAD per share) | $ / shares $ 1.79    
Number of options outstanding (in shares) 44,307    
Weighted average remaining life in years, options outstanding 9 months 18 days    
Number of options exercisable (in shares) 44,307    
Weighted average remaining life in years, options exercisable 9 months 18 days    
$8.94      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise price (in CAD per share) | $ / shares $ 8.94    
Number of options outstanding (in shares) 122,221    
Weighted average remaining life in years, options outstanding 2 years 9 months 18 days    
Number of options exercisable (in shares) 122,221    
Weighted average remaining life in years, options exercisable 2 years 9 months 18 days    
$14.29      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise price (in CAD per share) | $ / shares $ 14.29    
Number of options outstanding (in shares) 2,565    
Weighted average remaining life in years, options outstanding 9 years 7 months 6 days    
Number of options exercisable (in shares) 0    
Weighted average remaining life in years, options exercisable 0 years    
$16.21      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise price (in CAD per share) | $ / shares $ 16.21    
Number of options outstanding (in shares) 519,884    
Weighted average remaining life in years, options outstanding 9 years 10 months 24 days    
Number of options exercisable (in shares) 0    
Weighted average remaining life in years, options exercisable 0 years    
$22.24      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise price (in CAD per share) | $ / shares $ 22.24    
Number of options outstanding (in shares) 611,798    
Weighted average remaining life in years, options outstanding 9 years 1 month 6 days    
Number of options exercisable (in shares) 0    
Weighted average remaining life in years, options exercisable 0 years    
$23.64      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise price (in CAD per share) | $ / shares $ 23.64    
Number of options outstanding (in shares) 42,576    
Weighted average remaining life in years, options outstanding 3 years 4 months 24 days    
Number of options exercisable (in shares) 42,576    
Weighted average remaining life in years, options exercisable 3 years 4 months 24 days    
$23.77      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise price (in CAD per share) | $ / shares $ 23.77    
Number of options outstanding (in shares) 12,285    
Weighted average remaining life in years, options outstanding 8 years 2 months 12 days    
Number of options exercisable (in shares) 3,072    
Weighted average remaining life in years, options exercisable 8 years 2 months 12 days    
$24.64      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise price (in CAD per share) | $ / shares $ 24.64    
Number of options outstanding (in shares) 1,169,619    
Weighted average remaining life in years, options outstanding 7 years 10 months 24 days    
Number of options exercisable (in shares) 322,809    
Weighted average remaining life in years, options exercisable 7 years 2 months 12 days    
$30.73      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise price (in CAD per share) | $ / shares $ 30.73    
Number of options outstanding (in shares) 48,730    
Weighted average remaining life in years, options outstanding 3 years    
Number of options exercisable (in shares) 48,730    
Weighted average remaining life in years, options exercisable 3 years    
$31.79      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise price (in CAD per share) | $ / shares $ 31.79    
Number of options outstanding (in shares) 35,622    
Weighted average remaining life in years, options outstanding 3 years 7 months 6 days    
Number of options exercisable (in shares) 35,622    
Weighted average remaining life in years, options exercisable 3 years 7 months 6 days    
$33.97      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise price (in CAD per share) | $ / shares $ 33.97    
Number of options outstanding (in shares) 635,096    
Weighted average remaining life in years, options outstanding 5 years 9 months 18 days    
Number of options exercisable (in shares) 462,427    
Weighted average remaining life in years, options exercisable 5 years 7 months 6 days    
$45.34      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise price (in CAD per share) | $ / shares $ 45.34    
Number of options outstanding (in shares) 33,708    
Weighted average remaining life in years, options outstanding 4 years    
Number of options exercisable (in shares) 33,708    
Weighted average remaining life in years, options exercisable 4 years    
$48.93      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise price (in CAD per share) | $ / shares $ 48.93    
Number of options outstanding (in shares) 541,197    
Weighted average remaining life in years, options outstanding 6 years 10 months 24 days    
Number of options exercisable (in shares) 284,064    
Weighted average remaining life in years, options exercisable 6 years 7 months 6 days    
$50.00      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise price (in CAD per share) | $ / shares $ 50.00    
Number of options outstanding (in shares) 250,000    
Weighted average remaining life in years, options outstanding 6 years 2 months 12 days    
Number of options exercisable (in shares) 187,500    
Weighted average remaining life in years, options exercisable 6 years 2 months 12 days    
$63.03      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise price (in CAD per share) | $ / shares $ 63.03    
Number of options outstanding (in shares) 359,157    
Weighted average remaining life in years, options outstanding 4 years 9 months 18 days    
Number of options exercisable (in shares) 359,157    
Weighted average remaining life in years, options exercisable 4 years 9 months 18 days    
$83.53      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]      
Exercise price (in CAD per share) | $ / shares $ 83.53    
Number of options outstanding (in shares) 164,578    
Weighted average remaining life in years, options outstanding 3 years 9 months 18 days    
Number of options exercisable (in shares) 164,578    
Weighted average remaining life in years, options exercisable 3 years 9 months 18 days    
v3.24.1.1.u2
Share-based payments - Schedule of RSU and PSU Transactions (Details)
12 Months Ended
Mar. 31, 2024
shares
share
Apr. 02, 2023
shares
share
Number of shares    
Options/RSUs/PSUs outstanding, beginning balance (in shares) 4,055,199 2,722,690
Granted (in shares) 1,278,211 1,580,506
Cancelled (in shares) (660,575) (187,749)
Options/RSUs/PSUs outstanding, ending balance (in shares) 4,608,777 4,055,199
RSU    
Number of shares    
Options/RSUs/PSUs outstanding, beginning balance (in shares) 318,082 215,590
Granted (in shares) 438,814 209,187
Settled (in shares) (134,475) (87,034)
Cancelled (in shares) (141,903) (19,661)
Options/RSUs/PSUs outstanding, ending balance (in shares) 480,518 318,082
PSU    
Number of shares    
Options/RSUs/PSUs outstanding, beginning balance (in shares) | share 0 0
Granted (in shares) | share 399,349 0
Cancelled (in shares) | share (56,424) 0
Options/RSUs/PSUs outstanding, ending balance (in shares) | share 342,925 0
PSU | Minimum    
Number of shares    
Percentage of the vesting conditions 0.00%  
PSU | Maximum    
Number of shares    
Percentage of the vesting conditions 200.00%  
v3.24.1.1.u2
Share-based payments - Schedule of Assumptions Used to Measure Fair Value of Options Granted (Details)
12 Months Ended
Mar. 31, 2024
Year
$ / shares
Apr. 02, 2023
Year
$ / shares
Share-Based Payment Arrangements [Abstract]    
Weighted average stock price valuation (in CAD per share) $ 19.77 $ 24.63
Weighted average exercise price (in CAD per share) $ 19.77 $ 24.63
Risk-free interest rate 4.09% 2.52%
Expected life in years | Year 5.4 5.0
Expected dividend yield 0.00% 0.00%
Volatility 40.00% 40.00%
Weighted average fair value of options issued (in CAD per share) $ 6.82 $ 7.86
v3.24.1.1.u2
Share-based payment arrangements - Schedule of Assumptions Used to Measure Fair Value of Options Granted - Narrative (Details) - $ / shares
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
PSU    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Weighted average fair value of restricted share units (in CAD per share) $ 22.21  
RSU    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Weighted average fair value of restricted share units (in CAD per share) $ 21.37 $ 24.63
v3.24.1.1.u2
Related party transactions - Narrative (Details) - CAD ($)
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Disclosure of transactions between related parties [line items]      
Expenses incurred with related parties $ 1,100,000 $ 1,300,000 $ 1,700,000
Amounts payable, related party transactions 200,000 400,000  
Lease liabilities 330,500,000 334,800,000 250,700,000
Baffin Inc.      
Disclosure of transactions between related parties [line items]      
Amounts payable, related party transactions 0 0  
Lease liabilities 2,500,000 3,100,000  
Leases as lessee, related party transactions 1,600,000 1,400,000 1,400,000
Sazaby League Ltd      
Disclosure of transactions between related parties [line items]      
Amounts payable, related party transactions 300,000 200,000  
Lease liabilities 1,900,000 2,700,000  
Leases as lessee, related party transactions 5,200,000 5,900,000 0
Sales of inventory, related party transactions   11,900,000  
Sazaby League Ltd | Japan Joint Venture      
Disclosure of transactions between related parties [line items]      
Purchases of inventory, related party transactions   11,900,000  
Sazaby League Group | Japan Joint Venture      
Disclosure of transactions between related parties [line items]      
Sales of inventory, related party transactions 1,500,000 1,700,000 $ 0
Amounts receivable, related party transactions 100,000 $ 100,000  
PCML Vendor      
Disclosure of transactions between related parties [line items]      
Lease liabilities 1,200,000    
Operating expense excluding cost of sales 1,500,000    
Cash outflow for leases $ 100,000    
v3.24.1.1.u2
Related party transactions - Schedule of Transactions between Related Parties (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Related party transactions [abstract]      
Short term employee benefits $ 10.8 $ 10.1 $ 12.5
Long term employee benefits 0.2 0.1 0.1
Termination benefits 1.0 0.0 0.0
Share-based compensation 7.3 11.2 11.5
Compensation expense $ 19.3 $ 21.4 $ 24.1
v3.24.1.1.u2
Financial instruments and fair values (Details) - CAD ($)
$ in Millions
Mar. 31, 2024
Apr. 02, 2023
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial assets $ 1,481.6 $ 1,590.0
Financial liabilities 1,058.1 1,112.5
Carrying value | Derivatives included in accounts payable and accrued liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 1.9 3.3
Carrying value | Mainland China Facilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 9.8
Carrying value | Japan Facility    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 5.4 13.7
Carrying value | Term Loan    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 392.5 395.7
Carrying value | Derivatives included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 5.3 6.0
Carrying value | Put option liability included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 29.4 32.1
Carrying value | Contingent consideration included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 17.7 16.8
Carrying value | Earn-Out included in other long-term liabilities (note 5)    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 1.5 0.0
Carrying value | Derivatives included in accounts payable and accrued liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial assets 15.1 12.4
Carrying value | Derivatives included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial assets 6.9 12.4
Fair value | Derivatives included in accounts payable and accrued liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 1.9 3.3
Fair value | Mainland China Facilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 9.8
Fair value | Japan Facility    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 5.4 13.7
Fair value | Term Loan    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 389.2 433.1
Fair value | Derivatives included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 5.3 6.0
Fair value | Put option liability included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 29.4 32.1
Fair value | Contingent consideration included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 17.7 16.8
Fair value | Earn-Out included in other long-term liabilities (note 5)    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 1.5 0.0
Fair value | Derivatives included in accounts payable and accrued liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial assets 15.1 12.4
Fair value | Derivatives included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial assets 6.9 12.4
Level 1 | Derivatives included in accounts payable and accrued liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 0.0
Level 1 | Mainland China Facilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 0.0
Level 1 | Japan Facility    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 0.0
Level 1 | Term Loan    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 0.0
Level 1 | Derivatives included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 0.0
Level 1 | Put option liability included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 0.0
Level 1 | Contingent consideration included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 0.0
Level 1 | Earn-Out included in other long-term liabilities (note 5)    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 0.0
Level 1 | Derivatives included in accounts payable and accrued liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial assets 0.0 0.0
Level 1 | Derivatives included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial assets 0.0 0.0
Level 2 | Derivatives included in accounts payable and accrued liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 1.9 3.3
Level 2 | Mainland China Facilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 0.0
Level 2 | Japan Facility    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 5.4 13.7
Level 2 | Term Loan    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 392.5 395.7
Level 2 | Derivatives included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 5.3 6.0
Level 2 | Put option liability included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 0.0
Level 2 | Contingent consideration included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 0.0
Level 2 | Earn-Out included in other long-term liabilities (note 5)    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 0.0
Level 2 | Derivatives included in accounts payable and accrued liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial assets 15.1 12.4
Level 2 | Derivatives included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial assets 6.9 12.4
Level 3 | Derivatives included in accounts payable and accrued liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 0.0
Level 3 | Mainland China Facilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 9.8
Level 3 | Japan Facility    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 0.0
Level 3 | Term Loan    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 0.0
Level 3 | Derivatives included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 0.0 0.0
Level 3 | Put option liability included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 29.4 32.1
Level 3 | Contingent consideration included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 17.7 16.8
Level 3 | Earn-Out included in other long-term liabilities (note 5)    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial liabilities 1.5 0.0
Level 3 | Derivatives included in accounts payable and accrued liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial assets 0.0 0.0
Level 3 | Derivatives included in other long-term liabilities    
Disclosure of fair value measurement of assets and liabilities [Line Items]    
Financial assets $ 0.0 $ 0.0
v3.24.1.1.u2
Financial instruments and fair values - Narrative (Details)
¥ in Millions
12 Months Ended
Mar. 31, 2024
JPY (¥)
Mar. 31, 2024
CAD ($)
Apr. 02, 2023
JPY (¥)
Apr. 02, 2023
CAD ($)
Contingent consideration included in other long-term liabilities        
Disclosure of fair value measurement of assets and liabilities [Line Items]        
Gains (losses) recognised in profit or loss excluding exchange differences, fair value measurement, liabilities ¥ (327.0) $ (900,000) ¥ 301.2 $ 3,200,000
Gains (losses) recognised in profit or loss on exchange differences, fair value measurement, liabilities   (1,900,000)   $ (300,000)
Cash flow forecasts, term (in years)     4 years 4 years
Put option liability included in other long-term liabilities        
Disclosure of fair value measurement of assets and liabilities [Line Items]        
Gains (losses) recognised in profit or loss excluding exchange differences, fair value measurement, liabilities ¥ (129.3) 2,700,000 ¥ (1,079.9) $ (10,900,000)
Gains (losses) recognised in profit or loss on exchange differences, fair value measurement, liabilities   $ (4,300,000)   $ (100,000)
Cash flow forecasts, term (in years) 10 years 10 years    
v3.24.1.1.u2
Financial risk management objectives and policies - Schedule of Contractual Undiscounted Future Cash Flow Requirements (Details)
$ in Millions
Mar. 31, 2024
CAD ($)
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Accounts payable and accrued liabilities $ 177.7
Lease obligations 390.3
Pension obligation 1.8
Total contractual obligations 1,091.4
Japan Facility  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Contractual obligations with banks $ 5.4
Borrowings, interest rate 0.45%
Term Loan  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Contractual obligations with banks $ 393.1
Borrowings, interest rate 8.94%
Interest commitments relating to borrowings  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Interest commitments relating to borrowings $ 123.1
2025  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Accounts payable and accrued liabilities 177.7
Lease obligations 92.0
Pension obligation 0.0
Total contractual obligations 314.3
2025 | Japan Facility  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Contractual obligations with banks 5.4
2025 | Term Loan  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Contractual obligations with banks 4.0
2025 | Interest commitments relating to borrowings  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Interest commitments relating to borrowings 35.2
2026  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Accounts payable and accrued liabilities 0.0
Lease obligations 75.8
Pension obligation 0.0
Total contractual obligations 115.1
2026 | Japan Facility  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Contractual obligations with banks 0.0
2026 | Term Loan  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Contractual obligations with banks 4.1
2026 | Interest commitments relating to borrowings  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Interest commitments relating to borrowings 35.2
2027  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Accounts payable and accrued liabilities 0.0
Lease obligations 66.3
Pension obligation 0.0
Total contractual obligations 105.6
2027 | Japan Facility  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Contractual obligations with banks 0.0
2027 | Term Loan  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Contractual obligations with banks 4.1
2027 | Interest commitments relating to borrowings  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Interest commitments relating to borrowings 35.2
2028  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Accounts payable and accrued liabilities 0.0
Lease obligations 42.1
Pension obligation 0.0
Total contractual obligations 440.5
2028 | Japan Facility  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Contractual obligations with banks 0.0
2028 | Term Loan  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Contractual obligations with banks 380.9
2028 | Interest commitments relating to borrowings  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Interest commitments relating to borrowings 17.5
2029  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Accounts payable and accrued liabilities 0.0
Lease obligations 32.5
Pension obligation 0.0
Total contractual obligations 32.5
2029 | Japan Facility  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Contractual obligations with banks 0.0
2029 | Term Loan  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Contractual obligations with banks 0.0
2029 | Interest commitments relating to borrowings  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Interest commitments relating to borrowings 0.0
Thereafter  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Accounts payable and accrued liabilities 0.0
Lease obligations 81.6
Pension obligation 1.8
Total contractual obligations 83.4
Thereafter | Japan Facility  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Contractual obligations with banks 0.0
Thereafter | Term Loan  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Contractual obligations with banks 0.0
Thereafter | Interest commitments relating to borrowings  
Disclosure of maturity analysis for non-derivative financial liabilities [line items]  
Interest commitments relating to borrowings $ 0.0
v3.24.1.1.u2
Financial risk management objectives and policies - Narrative (Details)
¥ in Thousands, ¥ in Millions, $ in Millions
12 Months Ended
Apr. 14, 2020
CAD ($)
Dec. 23, 2019
EUR (€)
Mar. 31, 2024
CAD ($)
Apr. 02, 2023
CAD ($)
Apr. 03, 2022
CAD ($)
Mar. 31, 2024
JPY (¥)
Mar. 31, 2024
CAD ($)
Mar. 31, 2024
CNY (¥)
Jun. 30, 2023
USD ($)
Apr. 02, 2023
JPY (¥)
Apr. 02, 2023
CAD ($)
Oct. 30, 2020
CAD ($)
Oct. 30, 2020
USD ($)
Oct. 07, 2020
USD ($)
Disclosure of credit risk exposure [line items]                            
Current deposits from customers             $ 22,900,000       $ 200,000      
Trade accounts receivable factored limit | €   € 20,000,000                        
Exchange rate of cash received for trade accounts receivable   100.00%                        
Trade accounts receivable factor fee rate   1.15%                        
Proceeds from sale of trade accounts receivable     $ 46,300,000 $ 45,700,000                    
Trade accounts receivable factor fee expense (less than)     400,000 300,000                    
Trade accounts receivable derecognized but serviced             600,000       1,100,000      
Settlement of term loan derivative contracts     0 8,600,000 $ 0                  
Foreign exchange risk                            
Disclosure of credit risk exposure [line items]                            
Unrealized gains (losses) on foreign exchange contracts not treated as hedges     1,700,000 4,500,000 4,700,000                  
Fair value hedges | Foreign currency risk | Forward contract                            
Disclosure of credit risk exposure [line items]                            
Borrowings                         $ 270.0  
Hedging instrument, term                       5 years 5 years  
Notional amount of derivative                       $ 368,500,000    
Cash flow hedges | Foreign exchange risk | Long-dated forward exchange contract                            
Disclosure of credit risk exposure [line items]                            
Unrealized gains (losses) on foreign exchange contracts not treated as hedges     $ (1,300,000) $ 17,500,000 $ (4,600,000)                  
Third party | Credit risk                            
Disclosure of credit risk exposure [line items]                            
Accounts receivable, insurance lossess, deductible amount             100,000              
Accounts receivable, insurance losses, maximum annual amount insured             30,000,000              
Accounts receivable insured under the agreement             14,800,000       10,300,000      
Third party | Credit risk | Canada Goose Japan, K.K.                            
Disclosure of credit risk exposure [line items]                            
Accounts receivable, insurance losses, maximum annual amount insured | ¥           ¥ 540,000                
Accounts receivable insured under the agreement           ¥ 32,500 $ 300,000     ¥ 72,800 700,000      
Accounts receivable, insurance losses, percentage deductible           10.00% 10.00% 10.00%            
Accounts receivable, insurance losses, minimum account receivables | ¥           ¥ 100                
Third party | Maximum | Credit risk                            
Disclosure of credit risk exposure [line items]                            
Accounts receivable, insurance losses, coverage percentage           90.00% 90.00% 90.00%            
Short-term borrowings                            
Disclosure of credit risk exposure [line items]                            
Line of credit facility, maximum borrowing capacity $ 10,000,000                          
Line of credit facility, maximum term 12 months                          
Line of credit, annual percentage 1.00%                          
Line of credit, outstanding amount             $ 7,400,000              
Short-term borrowings | Mainland China Facilities                            
Disclosure of credit risk exposure [line items]                            
Line of credit, outstanding amount             9,100,000              
Mainland China Facilities                            
Disclosure of credit risk exposure [line items]                            
Borrowings             50,000,000 ¥ 266.4            
Japan Facility                            
Disclosure of credit risk exposure [line items]                            
Line of credit facility, maximum borrowing capacity           ¥ 4,000,000 $ 35,800,000              
Borrowings, interest rate           0.45% 0.45% 0.45%            
Japan Facility | Interest rate risk                            
Disclosure of credit risk exposure [line items]                            
Borrowings, interest rate           0.45% 0.45% 0.45%            
Term Loan                            
Disclosure of credit risk exposure [line items]                            
Borrowings             $ 392,500,000       $ 395,700,000     $ 300.0
Borrowings, interest rate           8.94% 8.94% 8.94%            
Term Loan | Interest rate risk                            
Disclosure of credit risk exposure [line items]                            
Borrowings, interest rate           8.94% 8.94% 8.94%            
Term Loan | Interest rate risk | Interest rate swap contract                            
Disclosure of credit risk exposure [line items]                            
Hedging instrument, term                       5 years 5 years  
Notional amount of derivative                 $ 300.0       $ 270.0  
v3.24.1.1.u2
Financial risk management objectives and policies - Schedule of Aging of Trade Receivables (Details) - CAD ($)
$ in Millions
Mar. 31, 2024
Apr. 02, 2023
Trade And Other Current Receivables [Line Items]    
Trade accounts receivable $ 57.1 $ 30.4
Credit card receivables 3.7 2.5
Other receivables 12.3 19.5
Current receivables 73.1 52.4
Credit risk | Carrying value    
Trade And Other Current Receivables [Line Items]    
Trade accounts receivable 57.1 30.4
Credit card receivables 3.7 2.5
Other receivables 12.3 19.5
Current receivables 73.1 52.4
Credit risk | Current | Carrying value    
Trade And Other Current Receivables [Line Items]    
Trade accounts receivable 33.5 22.2
Credit card receivables 3.7 2.5
Other receivables 11.8 18.9
Current receivables 49.0 43.6
Credit risk | Less than 30 days | Carrying value    
Trade And Other Current Receivables [Line Items]    
Trade accounts receivable 10.0 4.4
Credit card receivables 0.0 0.0
Other receivables 0.3 0.5
Current receivables 10.3 4.9
Credit risk | 31-60 days | Carrying value    
Trade And Other Current Receivables [Line Items]    
Trade accounts receivable 5.1 1.1
Credit card receivables 0.0 0.0
Other receivables 0.0 0.0
Current receivables 5.1 1.1
Credit risk | > 61 days | Carrying value    
Trade And Other Current Receivables [Line Items]    
Trade accounts receivable 8.5 2.7
Credit card receivables 0.0 0.0
Other receivables 0.2 0.1
Current receivables $ 8.7 $ 2.8
v3.24.1.1.u2
Financial risk management objectives and policies - Schedule of Unrealized Losses in Fair Value of Cash Flow Hedges in Other Comprehensive Income (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Disclosure of detailed information about hedges [line items]      
Gains (losses) on cash flow hedges, net of tax $ (0.5) $ 0.4 $ 8.7
Foreign exchange risk | Operating hedge program | Cash flow hedges      
Disclosure of detailed information about hedges [line items]      
Gains (losses) on cash flow hedges, net of tax 1.3 (3.7) (4.5)
Tax expense (recovery) $ 0.1 $ 0.9 $ (0.1)
v3.24.1.1.u2
Financial risk management objectives and policies - Schedule of Losses (Gains) Reclassified from Other Comprehensive Income on Cash Flow Hedges to the Consolidated Financial Statements (Details) - Foreign exchange risk - Operating hedge program - Cash flow hedges - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Disclosure of detailed information about hedges [line items]      
Revenue $ 1.8 $ 5.5 $ 3.9
SG&A expenses (0.4) 0.1 (0.4)
Inventory $ 0.5 $ 0.8 $ (0.9)
v3.24.1.1.u2
Financial risk management objectives and policies - Schedule of Foreign Currency Forward Exchange Contracts (Details) - Mar. 31, 2024
€ in Millions, ¥ in Millions, ¥ in Millions, £ in Millions, SFr in Millions, $ in Millions, $ in Millions
USD ($)
EUR (€)
JPY (¥)
CNY (¥)
GBP (£)
HKD ($)
CHF (SFr)
Forward contract to purchase Canadian dollars              
Disclosure of nature and extent of risks arising from financial instruments [line items]              
Aggregate Amounts $ 62.1 € 89.3 ¥ 2,085.8        
Forward contract to sell Canadian dollars              
Disclosure of nature and extent of risks arising from financial instruments [line items]              
Aggregate Amounts $ 22.4 € 40.1          
Forward contract to purchase euros              
Disclosure of nature and extent of risks arising from financial instruments [line items]              
Aggregate Amounts       ¥ 525.4 £ 25.5 $ 32.9 SFr 0.1
Forward contract to sell euros              
Disclosure of nature and extent of risks arising from financial instruments [line items]              
Aggregate Amounts       ¥ 9.2 £ 1.5 $ 7.0 SFr 3.3
v3.24.1.1.u2
Financial risk management objectives and policies - Schedule of Unrealized Gains (Losses) in Fair Value of Hedging Instruments in Other Comprehensive Income (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Disclosure of detailed information about hedges [line items]      
Net loss $ (0.5) $ 0.4 $ 8.7
Foreign exchange risk | Cross currency swap | Cash flow hedges      
Disclosure of detailed information about hedges [line items]      
Net loss (1.8) 4.1 13.2
Tax recovery $ 0.3 $ (0.8) $ (4.5)
v3.24.1.1.u2
Financial risk management objectives and policies - Schedule of Losses (Gains) Reclassified from Other Comprehensive Income on Hedging Instruments to the Consolidated Financial Statements (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Disclosure of detailed information about hedges [line items]      
Swaps designated as cash flow hedges $ 1.1 $ (6.0) $ (4.7)
Foreign exchange risk | Cross currency swap | Cash flow hedges      
Disclosure of detailed information about hedges [line items]      
Swaps designated as cash flow hedges $ (2.0) $ 0.5 $ 0.9
v3.24.1.1.u2
Financial risk management objectives and policies - Schedule of Sensitivity Analysis for Interest Rate Risk (Details)
$ in Millions, $ in Millions
12 Months Ended
Mar. 31, 2024
CAD ($)
Apr. 02, 2023
CAD ($)
Jun. 30, 2023
USD ($)
Jun. 29, 2023
Oct. 30, 2020
USD ($)
Interest rate risk          
Disclosure of credit risk exposure [line items]          
Reasonably possible increase in average interest rate 1.00%        
Floating interest rate [member] | Interest rate swap contract          
Disclosure of credit risk exposure [line items]          
Average rate of hedging instrument     1.76% 1.97%  
Japan Facility          
Disclosure of credit risk exposure [line items]          
Borrowings, interest rate 0.45%        
Japan Facility | Interest rate risk          
Disclosure of credit risk exposure [line items]          
Borrowings, interest rate 0.45%        
Increase in interest expense from change in average interest rate $ 0.1 $ 0.3      
Term Loan          
Disclosure of credit risk exposure [line items]          
Borrowings, interest rate 8.94%        
Term Loan | Interest rate risk          
Disclosure of credit risk exposure [line items]          
Borrowings, interest rate 8.94%        
Increase in interest expense from change in average interest rate $ 3.9 $ 3.9      
Term Loan | Interest rate risk | Interest rate swap contract          
Disclosure of credit risk exposure [line items]          
Hedging instrument, term         5 years
Notional amount of derivative     $ 300.0   $ 270.0
v3.24.1.1.u2
Selected cash flow information - Schedule of Changes in Non-Cash Operating Items (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Cash Flow Information [Abstract]      
Trade receivables $ (12.4) $ (4.6) $ (8.7)
Inventories 27.2 (49.9) (60.7)
Other current assets 2.8 (9.4) (3.4)
Amounts settled or written off during the year (9.5) (16.8) (8.5)
Provisions 5.2 9.0 3.7
Other (2.8) (3.7) (5.2)
Change in non-cash operating items $ 10.5 $ (75.4) $ (82.8)
v3.24.1.1.u2
Selected cash flow information - Schedule of Changes in Liabilities and Equity Arising from Financing Activities (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Share capital    
Disclosure of reconciliation of liabilities arising from financing activities [line items]    
Liabilities arising from financing activities at beginning of period $ 118.7 $ 118.5
Cash flows:    
Normal course issuer bid purchase of subordinate voting shares (140.2) (26.7)
Issuance of shares 0.1  
Non-cash items:    
Share purchase charge to retained earnings (note 18) 122.4 24.3
Normal course issuer bid purchase of subordinate voting shares held for cancellation (note 18)   (0.1)
Contributed surplus on share issuances (note 18) 3.9 2.7
Liabilities arising from financing activities at end of period 104.9 118.7
Mainland China Facilities    
Disclosure of reconciliation of liabilities arising from financing activities [line items]    
Liabilities arising from financing activities at beginning of period 9.8 0.0
Cash flows:    
Repayments and principal payments (9.8)  
Mainland China Facilities borrowings   9.8
Non-cash items:    
Liabilities arising from financing activities at end of period 0.0 9.8
Japan Facility    
Disclosure of reconciliation of liabilities arising from financing activities [line items]    
Liabilities arising from financing activities at beginning of period 13.7 0.0
Cash flows:    
Repayments and principal payments (8.3) (5.7)
Cash inflow from business combination   19.4
Non-cash items:    
Liabilities arising from financing activities at end of period 5.4 13.7
Revolving Facility    
Disclosure of reconciliation of liabilities arising from financing activities [line items]    
Liabilities arising from financing activities at beginning of period (0.5) (0.9)
Cash flows:    
Transactions costs on financing activities (0.1)  
Non-cash items:    
Accrued transaction costs (0.7)  
Amortization of deferred transaction costs 0.3 0.4
Liabilities arising from financing activities at end of period (1.0) (0.5)
Term Loan    
Disclosure of reconciliation of liabilities arising from financing activities [line items]    
Liabilities arising from financing activities at beginning of period 395.7 370.0
Cash flows:    
Repayments and principal payments (4.0) (4.0)
Transactions costs on financing activities (0.1)  
Non-cash items:    
Amortization of deferred transaction costs 0.2 0.2
Unrealized foreign exchange loss (gain) 0.7 29.5
Liabilities arising from financing activities at end of period 392.5 395.7
Lease liabilities    
Disclosure of reconciliation of liabilities arising from financing activities [line items]    
Liabilities arising from financing activities at beginning of period 334.8 250.7
Cash flows:    
Repayments and principal payments (69.2) (62.2)
Cash inflow from business combination 1.2 3.2
Non-cash items:    
Unrealized foreign exchange loss (gain) (2.2) 11.5
Additions and amendments to lease liabilities (note 13) 65.9 132.3
Derecognition on termination of lease liabilities (note 13)   (0.7)
Liabilities arising from financing activities at end of period 330.5 334.8
Net derivative asset on terminated contracts    
Disclosure of reconciliation of liabilities arising from financing activities [line items]    
Liabilities arising from financing activities at beginning of period $ 0.0 (7.3)
Cash flows:    
Settlement of term loan derivative contracts   8.6
Non-cash items:    
Fair market valuation   (0.6)
Unrealized foreign exchange loss (gain)   (0.7)
Liabilities arising from financing activities at end of period   $ 0.0
v3.24.1.1.u2
Subsequent Events (Details)
Mar. 31, 2024
Term Loan  
Disclosure of non-adjusting events after reporting period [line items]  
Borrowings, interest rate 8.94%
v3.24.1.1.u2
Schedule I - Condensed Financial Information of Canada Goose Holdings Inc. - Condensed Statements of Income (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Disclosure of transactions between related parties [line items]      
Gross profit $ 917.4 $ 815.2 $ 733.6
Selling, general & administrative expenses 792.9 667.6 574.1
Net interest, finance and other costs 48.8 54.1 41.8
Income before income taxes 75.7 93.5 117.7
Income tax recovery 17.6 24.6 23.1
Net income 58.1 68.9 94.6
Attributable to:      
Shareholders of the Company 58.4 72.7 94.6
Non-controlling interest (0.3) (3.8) 0.0
Net income 58.1 68.9 94.6
Parent company      
Disclosure of transactions between related parties [line items]      
Equity in comprehensive income of subsidiary 63.6 97.5 88.6
Fee income from subsidiary 6.9 10.2 10.8
Gross profit 70.5 107.7 99.4
Selling, general & administrative expenses 16.7 16.8 16.9
Net interest, finance and other costs 0.0 0.5 1.9
Income before income taxes 53.8 90.4 80.6
Income tax recovery (2.5) (1.6) (2.0)
Net income 56.3 92.0 82.6
Attributable to:      
Shareholders of the Company 57.8 95.7 82.6
Non-controlling interest (1.5) (3.7) 0.0
Net income $ 56.3 $ 92.0 $ 82.6
v3.24.1.1.u2
Schedule I - Condensed Financial Information of Canada Goose Holdings Inc. - Condensed Statements of Financial Position (Details) - CAD ($)
$ in Millions
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Mar. 28, 2021
Current assets        
Cash $ 144.9 $ 286.5 $ 287.7 $ 477.9
Total current assets 740.8 863.2    
Deferred income taxes 76.3 67.5    
Total assets 1,481.6 1,590.0    
Current liabilities        
Accounts payable and accrued liabilities 177.7 195.6    
Total current liabilities 309.9 352.4    
Total liabilities 1,058.1 1,112.5    
Equity        
Equity attributable to shareholders of the Company 417.0 469.5    
Non-controlling interests 6.5 8.0    
Total equity 423.5 477.5 427.9 577.6
Total liabilities and equity 1,481.6 1,590.0    
Parent company        
Current assets        
Cash 0.0 6.9 0.3 4.3
Total current assets 0.0 6.9    
Note receivable from subsidiary 92.6 76.4    
Investment in subsidiary 408.9 479.8    
Deferred income taxes 13.4 10.9    
Total assets 514.9 574.0    
Current liabilities        
Accounts payable and accrued liabilities 1.6 20.1    
Due to subsidiary 60.4 44.3    
Total current liabilities 62.0 64.4    
Other non-current liabilities 29.4 32.1    
Total liabilities 91.4 96.5    
Equity        
Equity attributable to shareholders of the Company 417.0 469.5    
Non-controlling interests 6.5 8.0    
Total equity 423.5 477.5 $ 427.9 $ 577.6
Total liabilities and equity $ 514.9 $ 574.0    
v3.24.1.1.u2
Schedule I - Condensed Financial Information of Canada Goose Holdings Inc. - Condensed Statements of Changes in Equity (Details) - CAD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Disclosure of transactions between related parties [line items]      
Shareholders’ equity, beginning balance $ 477.5 $ 427.9 $ 577.6
Non-controlling interest on business combination   11.7  
Put option for non-controlling interest   (21.2)  
Normal course issuer bid purchase of subordinate voting shares (140.2) (26.7) (253.2)
Normal course issuer bid purchase of subordinate voting shares held for cancellation   (1.2)  
Liability to broker under automatic share purchase plan 20.0 (20.0)  
Issuance of shares 0.1 0.0 7.1
Net income 58.1 68.9 94.6
Share-based payment 9.8 15.0 14.0
Deferred tax on share-based payment     (0.2)
Shareholders’ equity, ending balance 423.5 477.5 427.9
Total attributable to shareholders      
Disclosure of transactions between related parties [line items]      
Shareholders’ equity, beginning balance 469.5 427.9 577.6
Put option for non-controlling interest   (21.2)  
Normal course issuer bid purchase of subordinate voting shares (140.2) (26.7) (253.2)
Normal course issuer bid purchase of subordinate voting shares held for cancellation   (1.2)  
Liability to broker under automatic share purchase plan 20.0 (20.0)  
Issuance of shares 0.1 0.0 7.1
Net income 58.4 72.7 94.6
Share-based payment 9.8 15.0 14.0
Deferred tax on share-based payment     (0.2)
Shareholders’ equity, ending balance 417.0 469.5 427.9
Share capital      
Disclosure of transactions between related parties [line items]      
Shareholders’ equity, beginning balance 118.7 118.5 120.5
Normal course issuer bid purchase of subordinate voting shares (17.8) (2.4) (11.9)
Normal course issuer bid purchase of subordinate voting shares held for cancellation   (0.1)  
Issuance of shares 4.0 2.7 9.9
Shareholders’ equity, ending balance 104.9 118.7 118.5
Contributed surplus      
Disclosure of transactions between related parties [line items]      
Shareholders’ equity, beginning balance 28.5 36.2 25.2
Liability to broker under automatic share purchase plan 20.0 (20.0)  
Issuance of shares (3.9) (2.7) (2.8)
Share-based payment 9.8 15.0 14.0
Deferred tax on share-based payment     (0.2)
Shareholders’ equity, ending balance 54.4 28.5 36.2
Retained earnings      
Disclosure of transactions between related parties [line items]      
Shareholders’ equity, beginning balance 316.5 290.4 437.1
Put option for non-controlling interest   (21.2)  
Normal course issuer bid purchase of subordinate voting shares (122.4) (24.3) (241.3)
Normal course issuer bid purchase of subordinate voting shares held for cancellation   (1.1)  
Net income 58.4 72.7 94.6
Shareholders’ equity, ending balance 252.5 316.5 290.4
Non-controlling interest      
Disclosure of transactions between related parties [line items]      
Shareholders’ equity, beginning balance 8.0 0.0 0.0
Non-controlling interest on business combination   11.7  
Net income (0.3) (3.8)  
Shareholders’ equity, ending balance 6.5 8.0 0.0
Parent company      
Disclosure of transactions between related parties [line items]      
Shareholders’ equity, beginning balance 477.5 427.9 577.6
Non-controlling interest on business combination   11.7  
Put option for non-controlling interest   (21.2)  
Normal course issuer bid purchase of subordinate voting shares (140.2) (26.7) (253.2)
Normal course issuer bid purchase of subordinate voting shares held for cancellation   (1.2)  
Liability to broker under automatic share purchase plan 20.0 (20.0)  
Issuance of shares 0.1 0.0 7.1
Net income 56.3 92.0 82.6
Share-based payment 9.8 15.0 14.0
Deferred tax on share-based payment     (0.2)
Shareholders’ equity, ending balance 423.5 477.5 427.9
Parent company | Total attributable to shareholders      
Disclosure of transactions between related parties [line items]      
Shareholders’ equity, beginning balance 469.5 427.9 577.6
Put option for non-controlling interest   (21.2)  
Normal course issuer bid purchase of subordinate voting shares (140.2) (26.7) (253.2)
Normal course issuer bid purchase of subordinate voting shares held for cancellation   (1.2)  
Liability to broker under automatic share purchase plan 20.0 (20.0)  
Issuance of shares 0.1 0.0 7.1
Net income 57.8 95.7 82.6
Share-based payment 9.8 15.0 14.0
Deferred tax on share-based payment     (0.2)
Shareholders’ equity, ending balance 417.0 469.5 427.9
Parent company | Share capital      
Disclosure of transactions between related parties [line items]      
Shareholders’ equity, beginning balance 118.7 118.5 120.5
Normal course issuer bid purchase of subordinate voting shares (17.8) (2.4) (11.9)
Normal course issuer bid purchase of subordinate voting shares held for cancellation   (0.1)  
Issuance of shares 4.0 2.7 9.9
Shareholders’ equity, ending balance 104.9 118.7 118.5
Parent company | Contributed surplus      
Disclosure of transactions between related parties [line items]      
Shareholders’ equity, beginning balance 28.5 36.2 25.2
Liability to broker under automatic share purchase plan 20.0 (20.0)  
Issuance of shares (3.9) (2.7) (2.8)
Share-based payment 9.8 15.0 14.0
Deferred tax on share-based payment     (0.2)
Shareholders’ equity, ending balance 54.4 28.5 36.2
Parent company | Retained earnings      
Disclosure of transactions between related parties [line items]      
Shareholders’ equity, beginning balance 322.3 273.2 431.9
Put option for non-controlling interest   (21.2)  
Normal course issuer bid purchase of subordinate voting shares (122.4) (24.3) (241.3)
Normal course issuer bid purchase of subordinate voting shares held for cancellation   (1.1)  
Net income 57.8 95.7 82.6
Shareholders’ equity, ending balance 257.7 322.3 273.2
Parent company | Non-controlling interest      
Disclosure of transactions between related parties [line items]      
Shareholders’ equity, beginning balance 8.0 0.0 0.0
Non-controlling interest on business combination   11.7  
Net income (1.5) (3.7)  
Shareholders’ equity, ending balance $ 6.5 $ 8.0 $ 0.0
v3.24.1.1.u2
Schedule I - Condensed Financial Information of Canada Goose Holdings Inc. - Condensed Statements of Cash Flows (Details) - CAD ($)
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Operating activities      
Net income (loss) $ 58,100,000 $ 68,900,000 $ 94,600,000
Items not affecting cash:      
Income tax recovery 17,600,000 24,600,000 23,100,000
Share-based compensation 10,200,000 15,000,000.0 14,000,000.0
Total items not affecting cash 262,800,000 260,800,000 291,900,000
Changes in non-cash operating items 10,500,000 (75,400,000) (82,800,000)
Net cash from operating activities 164,600,000 116,300,000 151,600,000
Investing activities      
Net cash used in investing activities (72,400,000) (45,300,000) (37,200,000)
Financing activities      
Normal course issuer bid purchase of subordinate voting shares (141,400,000) (26,700,000) (253,200,000)
Exercise of stock options 100,000 0 7,100,000
Net cash used in financing activities (232,800,000) (80,700,000) (298,200,000)
Decrease in cash (141,600,000) (1,200,000) (190,200,000)
Cash, beginning of period 286,500,000 287,700,000 477,900,000
Cash, end of period 144,900,000 286,500,000 287,700,000
Parent company      
Operating activities      
Net income (loss) 56,300,000 92,000,000.0 82,600,000
Items not affecting cash:      
Equity in undistributed earnings of subsidiary (63,600,000) (97,500,000) (88,600,000)
Net interest expense 0 500,000 1,900,000
Income tax recovery (2,500,000) (1,600,000) (2,000,000.0)
Share-based compensation 9,800,000 15,000,000.0 14,000,000.0
Total items not affecting cash 0 8,400,000 7,900,000
Changes in non-cash operating items 1,700,000 (493,500,000) (20,200,000)
Intercompany accounts payable 0 240,000,000.0 242,500,000
Net cash from operating activities 1,700,000 (245,100,000) 230,200,000
Investing activities      
Dividend received 131,500,000 198,400,000 0
Investment in shares of subsidiary 0 80,000,000.0 0
Net cash used in investing activities 131,500,000 278,400,000 0
Financing activities      
Normal course issuer bid purchase of subordinate voting shares (140,200,000) (26,700,000) (241,300,000)
Exercise of stock options 100,000 0 7,100,000
Net cash used in financing activities (140,100,000) (26,700,000) (234,200,000)
Decrease in cash (6,900,000) 6,600,000 (4,000,000.0)
Cash, beginning of period 6,900,000 300,000 4,300,000
Cash, end of period $ 0 $ 6,900,000 $ 300,000
v3.24.1.1.u2
Schedule I - Condensed Financial Information of Canada Goose Holdings Inc. - Narrative (Details) - CAD ($)
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Parent company      
Disclosure of transactions between related parties [line items]      
Dividend received $ 131,500,000 $ 198,400,000 $ 0